group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00001,1.1376361743527366,FUN_000185-T1,Peve_00037402,Pocillopora_meandrina_HIv1___RNAseq.g28886.t1,three_way,71.059,FUN_000185-T1,Q32LQ0,AMPE_BOVIN,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Bos taurus (Bovine),41.5,881.0,1.4e-197,691.4,sp|Q32LQ0|AMPE_BOVIN Glutamyl aminopeptidase OS=Bos taurus OX=9913 GN=ENPEP PE=2 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00033,1.3236817495440287,FUN_000239-T1,Peve_00033353,Pocillopora_meandrina_HIv1___RNAseq.g28955.t1,three_way,97.61933333333332,FUN_000239-T1,Q2KHT7,,,,,89.3,84.0,1.7e-38,159.5,sp|Q2KHT7|RS27_BOVIN Small ribosomal subunit protein eS27 OS=Bos taurus OX=9913 GN=RPS27 PE=1 SV=3,,,,,,
OG_00082,2.7122595880171625,FUN_000411-T1,Peve_00010961,Pocillopora_meandrina_HIv1___RNAseq.g2317.t1,three_way,32.01166666666666,,,,,,,,,,,,,,,,,
OG_00085,1.0104928200468335,FUN_000433-T1,Peve_00011195,Pocillopora_meandrina_HIv1___RNAseq.g2325.t1,three_way,73.84433333333334,FUN_000433-T1,P26714,,,,,33.7,291.0,2.3e-51,204.9,sp|P26714|GBRB_LYMST Gamma-aminobutyric acid receptor subunit beta OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_00087,1.045773499292134,FUN_000440-T1,Peve_00003439,Pocillopora_meandrina_HIv1___RNAseq.g2328.t2,three_way,87.82716666666667,FUN_000440-T1,P11029,,,,,63.2,2251.0,0.0,2921.0,sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1,,,,,,
OG_00089,1.106276281453718,FUN_000445-T1,Peve_00019114,Pocillopora_meandrina_HIv1___RNAseq.g2334.t1,three_way,76.51133333333333,,,,,,,,,,,,,,,,,
OG_00111,1.087163906224225,FUN_000503-T1,Peve_00043531,Pocillopora_meandrina_HIv1___RNAseq.g18598.t1,three_way,56.31033333333333,,,,,,,,,,,,,,,,,
OG_00127,1.017134439526487,FUN_000554-T1,Peve_00039816,Pocillopora_meandrina_HIv1___RNAseq.g2466.t1,three_way,58.334,,,,,,,,,,,,,,,,,
OG_00129,1.000722096955251,FUN_000556-T1,Peve_00039813,Pocillopora_meandrina_HIv1___RNAseq.g2463.t1,three_way,76.964,FUN_000556-T1,P47747,,,,,27.6,322.0,1.8e-17,91.7,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_00132,1.1843391835619934,FUN_000563-T1,Peve_00041882,Pocillopora_meandrina_HIv1___RNAseq.g2457.t1,three_way,50.783,,,,,,,,,,,,,,,,,
OG_00133,1.6408534066657714,FUN_000564-T1,Peve_00041880,Pocillopora_meandrina_HIv1___TS.g4968.t1,three_way,70.89666666666666,,,,,,,,,,,,,,,,,
OG_00144,2.101340609251304,FUN_000586-T1,Peve_00025314,Pocillopora_meandrina_HIv1___TS.g6498.t2,three_way,63.92666666666666,FUN_000586-T1,O00339,MATN2_HUMAN,,Matrilin-2,Homo sapiens (Human),30.2,192.0,2.3e-14,82.4,sp|O00339|MATN2_HUMAN Matrilin-2 OS=Homo sapiens OX=9606 GN=MATN2 PE=1 SV=4,GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_00163,1.2191918263269168,FUN_000637-T1,Peve_00012867,Pocillopora_meandrina_HIv1___RNAseq.g16016.t1,three_way,83.68833333333333,FUN_000637-T1,O97125,,,,,74.2,613.0,9.1e-265,914.1,sp|O97125|HSP68_DROME Heat shock protein 68 OS=Drosophila melanogaster OX=7227 GN=Hsp68 PE=1 SV=1,,,,,,
OG_00195,2.59815472851367,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00228,1.168472892775942,FUN_000971-T1,Peve_00007801,Pocillopora_meandrina_HIv1___RNAseq.g29136.t1,three_way,71.03666666666668,FUN_000971-T1,Q2QRV3,PIOX_ORYSJ,,Alpha-dioxygenase PIOX (EC 1.13.11.92) (Pathogen-induced oxygenase),Oryza sativa subsp. japonica (Rice),37.0,549.0,1.7999999999999998e-96,355.1,sp|Q2QRV3|PIOX_ORYSJ Alpha-dioxygenase PIOX OS=Oryza sativa subsp. japonica OX=39947 GN=PIOX PE=1 SV=2,GO:0001561; GO:0004601; GO:0009627; GO:0009737; GO:0012511; GO:0016702; GO:0020037; GO:0031408; GO:0034614; GO:0042742; GO:0046872; GO:0050832; GO:0071446; GO:0071732; GO:1902609,(R)-2-hydroxy-alpha-linolenic acid biosynthetic process [GO:1902609]; cellular response to nitric oxide [GO:0071732]; cellular response to reactive oxygen species [GO:0034614]; cellular response to salicylic acid stimulus [GO:0071446]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; fatty acid alpha-oxidation [GO:0001561]; oxylipin biosynthetic process [GO:0031408]; response to abscisic acid [GO:0009737]; systemic acquired resistance [GO:0009627],monolayer-surrounded lipid storage body [GO:0012511],"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005811; GO:0006629; GO:0016209; GO:0016491; GO:0043226; GO:0098542,catalytic activity; lipid droplet; lipid metabolic process; antioxidant activity; oxidoreductase activity; organelle; defense response to other organism
OG_00242,1.0375122763789624,FUN_001005-T1,Peve_00015285,Pocillopora_meandrina_HIv1___TS.g6390.t1,three_way,40.208,,,,,,,,,,,,,,,,,
OG_00246,2.131794311179849,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_00253,1.0588793274008257,FUN_001017-T2,Peve_00041044,Pocillopora_meandrina_HIv1___RNAseq.g29159.t1,three_way,66.55,,,,,,,,,,,,,,,,,
OG_00257,1.184848064565102,FUN_001021-T1,Peve_00041049,Pocillopora_meandrina_HIv1___RNAseq.g29605.t1,three_way,73.93249999999999,FUN_001021-T1,P25931,,,,,31.4,258.0,2.5000000000000002e-22,107.8,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_00258,1.9798454516307544,FUN_001025-T1,Peve_00041055,Pocillopora_meandrina_HIv1___RNAseq.g16888.t1,three_way,40.96733333333333,,,,,,,,,,,,,,,,,
OG_00274,1.0810268574442805,FUN_001054-T1,Peve_00023871,Pocillopora_meandrina_HIv1___RNAseq.g29645.t1,three_way,68.80666666666667,,,,,,,,,,,,,,,,,
OG_00281,1.4827584966015028,FUN_001067-T1,Peve_00029706,Pocillopora_meandrina_HIv1___RNAseq.g29656.t1,three_way,64.9165,FUN_001067-T1,A0AVK6,E2F8_HUMAN,,Transcription factor E2F8 (E2F-8),Homo sapiens (Human),40.1,304.0,1.1e-41,173.3,sp|A0AVK6|E2F8_HUMAN Transcription factor E2F8 OS=Homo sapiens OX=9606 GN=E2F8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0048144; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837,cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0000278; GO:0003677; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,mitotic cell cycle; DNA binding; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00294,1.1555811814532977,FUN_001085-T1,Peve_00003173,Pocillopora_meandrina_HIv1___RNAseq.g29389.t1,three_way,62.842,FUN_001085-T1,Q9W770,,,,,33.3,435.0,3.7000000000000004e-59,230.7,sp|Q9W770|SPON1_CHICK Spondin-1 OS=Gallus gallus OX=9031 GN=SPON1 PE=2 SV=1,,,,,,
OG_00304,2.4700761047302016,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_00314,1.879993251826179,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_00319,1.03699798902497,FUN_001137-T1,Peve_00029385,Pocillopora_meandrina_HIv1___RNAseq.g29339.t1,three_way,81.55166666666666,FUN_001137-T1,Q9Y345,,,,,44.3,625.0,1.2e-152,541.6,sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3,,,,,,
OG_00332,1.0543093885096635,FUN_001153-T1,Peve_00002864,Pocillopora_meandrina_HIv1___RNAseq.g29322.t2,three_way,50.12916666666666,,,,,,,,,,,,,,,,,
OG_00349,1.217819468726258,FUN_001176-T1,Peve_00015993,Pocillopora_meandrina_HIv1___TS.g6373.t1,three_way,71.25133333333333,FUN_001176-T1,O43451,MGA_HUMAN,,"Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20)",Homo sapiens (Human),48.8,853.0,2.6e-247,856.7,sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6,GO:0000025; GO:0003824; GO:0004339; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027,dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821],"alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; oligo-1,6-glucosidase activity [GO:0004574]",GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0043226,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; organelle
OG_00360,1.139682594264389,FUN_001193-T1,Peve_00006937,Pocillopora_meandrina_HIv1___RNAseq.g29527.t1,three_way,63.272,FUN_001193-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),34.4,326.0,6.6e-40,166.4,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_00380,1.0354706977163886,FUN_001228-T1,Peve_00027708,Pocillopora_meandrina_HIv1___RNAseq.g29245.t1,three_way,84.69233333333334,FUN_001228-T1,Q569D5,,,,,71.9,469.0,1.8e-212,740.0,sp|Q569D5|SBP1_XENTR Methanethiol oxidase OS=Xenopus tropicalis OX=8364 GN=selenbp1 PE=2 SV=1,,,,,,
OG_00386,1.2046157387585206,FUN_001238-T1,Peve_00002842,Pocillopora_meandrina_HIv1___RNAseq.g2515.t2,three_way,45.375,FUN_001238-T1,Q8IVU1,,,,,32.5,517.0,1.1e-67,260.4,sp|Q8IVU1|IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens OX=9606 GN=IGDCC3 PE=1 SV=2,,,,,,
OG_00396,1.184730813683085,FUN_001258-T1,Peve_00008780,Pocillopora_meandrina_HIv1___RNAseq.g2178.t1,three_way,48.20666666666666,FUN_001258-T1,F7J220,,,,,29.4,595.0,1.9e-54,216.1,sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1,,,,,,
OG_00408,1.032852260841643,FUN_001298-T1,Peve_00037001,Pocillopora_meandrina_HIv1___RNAseq.g2230.t1,three_way,69.0665,,,,,,,,,,,,,,,,,
OG_00411,1.0130114501712064,FUN_001309-T1,Peve_00036985,Pocillopora_meandrina_HIv1___RNAseq.g2248.t1,three_way,53.03933333333333,,,,,,,,,,,,,,,,,
OG_00450,1.0582878145622066,FUN_001370-T2,Peve_00025098,Pocillopora_meandrina_HIv1___RNAseq.g2140.t1,three_way,55.64983333333333,FUN_001370-T2,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),39.1,422.0,6.900000000000001e-67,257.3,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_00453,2.523452602171305,FUN_001377-T1,Peve_00021886,Pocillopora_meandrina_HIv1___RNAseq.g2136.t1,three_way,56.78516666666667,,,,,,,,,,,,,,,,,
OG_00455,1.2458571759459631,FUN_001384-T1,Peve_00019346,Pocillopora_meandrina_HIv1___TS.g4636.t2,three_way,67.6845,,,,,,,,,,,,,,,,,
OG_00474,1.1474438127011637,FUN_001413-T1,Peve_00008749,Pocillopora_meandrina_HIv1___RNAseq.g2101.t1,three_way,46.56633333333333,,,,,,,,,,,,,,,,,
OG_00487,1.2328925475842083,FUN_001453-T1,Peve_00018442,Pocillopora_meandrina_HIv1___RNAseq.g1954.t1,three_way,80.51,FUN_001453-T1,Q9UBR2,CATZ_HUMAN,,Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X),Homo sapiens (Human),61.6,297.0,1.4000000000000005e-111,404.1,sp|Q9UBR2|CATZ_HUMAN Cathepsin Z OS=Homo sapiens OX=9606 GN=CTSZ PE=1 SV=1,GO:0002003; GO:0004180; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0005886; GO:0005938; GO:0006508; GO:0008234; GO:0009986; GO:0010757; GO:0016807; GO:0030134; GO:0030426; GO:0031410; GO:0033116; GO:0035580; GO:0043231; GO:0051603; GO:0060441; GO:0062023; GO:0070062; GO:1904813,angiotensin maturation [GO:0002003]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580],carboxypeptidase activity [GO:0004180]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234],GO:0003824; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; lysosome; vacuole; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_00491,1.078239757328552,FUN_001461-T1,Peve_00027130,Pocillopora_meandrina_HIv1___TS.g4468.t1,three_way,90.859,FUN_001461-T1,Q8BTQ0,PCGF3_MOUSE,,Polycomb group RING finger protein 3 (RING finger protein 3A),Mus musculus (Mouse),57.9,242.0,6.200000000000001e-73,275.4,sp|Q8BTQ0|PCGF3_MOUSE Polycomb group RING finger protein 3 OS=Mus musculus OX=10090 GN=PcgF3 PE=1 SV=1,GO:0005654; GO:0008270; GO:0031519; GO:0060816; GO:0140862,random inactivation of X chromosome [GO:0060816],nucleoplasm [GO:0005654]; PcG protein complex [GO:0031519],histone H2AK119 ubiquitin ligase activity [GO:0140862]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006325; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; chromatin organization; transferase activity; catalytic activity, acting on a protein"
OG_00499,1.2208673644394323,FUN_001472-T1,Peve_00026259,Pocillopora_meandrina_HIv1___RNAseq.g1911.t1,three_way,72.17666666666666,FUN_001472-T1,Q8VHT6,AS3MT_RAT,,Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase),Rattus norvegicus (Rat),46.2,366.0,6.1e-86,319.3,sp|Q8VHT6|AS3MT_RAT Arsenite methyltransferase OS=Rattus norvegicus OX=10116 GN=As3mt PE=1 SV=1,GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685,arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404],cytosol [GO:0005829],arsenite methyltransferase activity [GO:0030791]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_00509,1.23908615695212,FUN_001493-T1,Peve_00002848,Pocillopora_meandrina_HIv1___RNAseq.g1906.t1,three_way,65.069,FUN_001493-T1,Q9NQA5,TRPV5_HUMAN,,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),Homo sapiens (Human),28.2,170.0,3.5e-07,58.9,sp|Q9NQA5|TRPV5_HUMAN Transient receptor potential cation channel subfamily V member 5 OS=Homo sapiens OX=9606 GN=TRPV5 PE=1 SV=3,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809],apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003014; GO:0005215; GO:0005886; GO:0055085; GO:0065003,renal system process; transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_00511,2.667006773978541,FUN_001503-T1,Peve_00018430,Pocillopora_meandrina_HIv1___RNAseq.g1086.t1,three_way,61.830666666666666,FUN_001503-T1,P86982,,,,,41.6,137.0,3.9e-21,103.6,sp|P86982|IMSP1_RUDPH Insoluble matrix shell protein 1 (Fragment) OS=Ruditapes philippinarum OX=129788 PE=1 SV=1,,,,,,
OG_00531,4.411619352651149,FUN_001545-T1,Peve_00033291,Pocillopora_meandrina_HIv1___RNAseq.g15386.t1,three_way,49.809666666666665,,,,,,,,,,,,,,,,,
OG_00587,1.1204494357814891,FUN_001665-T1,Peve_00038394,Pocillopora_meandrina_HIv1___RNAseq.g29391.t1,three_way,65.37583333333333,FUN_001665-T1,C3ZQF9,,,,,34.8,339.0,8.8e-39,162.5,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_00622,1.1242725060257883,FUN_001793-T1,Peve_00008718,Pocillopora_meandrina_HIv1___RNAseq.g2635.t1a,three_way,54.11416666666666,FUN_001793-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.2,112.0,1.9e-13,79.3,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_00623,1.3007646492779978,FUN_001794-T1,Peve_00037091,Pocillopora_meandrina_HIv1___RNAseq.g15131.t1,three_way,57.70583333333334,FUN_001794-T1,P05183,CP3A2_RAT,,Cytochrome P450 3A2 (EC 1.14.14.1) (CYPIIIA2) (Cytochrome P450-PCN2) (Cytochrome P450/6-beta-A) (Testosterone 6-beta-hydroxylase),Rattus norvegicus (Rat),39.3,504.0,7.0000000000000015e-90,332.8,sp|P05183|CP3A2_RAT Cytochrome P450 3A2 OS=Rattus norvegicus OX=10116 GN=Cyp3a2 PE=1 SV=2,GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006706; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0032451; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021,alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789],"1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity
OG_00633,1.529204646526659,FUN_001856-T1,Peve_00043869,Pocillopora_meandrina_HIv1___RNAseq.g2601.t1,three_way,76.085,FUN_001856-T1,P70699,LYAG_MOUSE,,Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase),Mus musculus (Mouse),49.0,880.0,5.3999999999999995e-247,855.5,sp|P70699|LYAG_MOUSE Lysosomal alpha-glucosidase OS=Mus musculus OX=10090 GN=Gaa PE=1 SV=2,GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0035904; GO:0043181; GO:0043896; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0120282,aorta development [GO:0035904]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181],autolysosome lumen [GO:0120282]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,6-alpha-glucosidase activity [GO:0043896]",GO:0003012; GO:0003016; GO:0003824; GO:0005764; GO:0005773; GO:0005975; GO:0006091; GO:0006914; GO:0007040; GO:0016787; GO:0043226; GO:0048856; GO:0050877,muscle system process; respiratory system process; catalytic activity; lysosome; vacuole; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lysosome organization; hydrolase activity; organelle; anatomical structure development; nervous system process
OG_00643,2.4714822560042125,FUN_001887-T1,Peve_00030489,Pocillopora_meandrina_HIv1___RNAseq.g29129.t1,three_way,64.38266666666667,FUN_001887-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),40.6,286.0,1.8000000000000002e-44,181.8,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_00678,1.3547338014046602,FUN_002093-T1,Peve_00004291,Pocillopora_meandrina_HIv1___RNAseq.g1731.t2,three_way,44.53733333333333,,,,,,,,,,,,,,,,,
OG_00698,1.3417196437128405,FUN_002428-T1,Peve_00034033,Pocillopora_meandrina_HIv1___RNAseq.g14846.t1,three_way,88.449,,,,,,,,,,,,,,,,,
OG_00714,1.5141375257826342,FUN_002582-T1,Peve_00002778,Pocillopora_meandrina_HIv1___RNAseq.g25727.t1,three_way,60.239666666666665,,,,,,,,,,,,,,,,,
OG_00725,1.288400820799638,FUN_002670-T1,Peve_00005202,Pocillopora_meandrina_HIv1___TS.g27719.t1,three_way,57.01833333333333,FUN_002670-T1,Q2KJ34,,,,,30.4,184.0,6.3e-13,76.6,sp|Q2KJ34|HBP1_BOVIN HMG box-containing protein 1 OS=Bos taurus OX=9913 GN=HBP1 PE=2 SV=1,,,,,,
OG_00731,1.2402633697784944,FUN_002697-T1,Peve_00034498,Pocillopora_meandrina_HIv1___RNAseq.g20722.t1,three_way,78.81233333333333,FUN_002697-T1,C1C4R8,DHRS6_AQUCT,,Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.-) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (EC 1.1.1.30) (4-oxo-L-proline reductase) (EC 1.1.1.104) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1),Aquarana catesbeiana (American bullfrog) (Rana catesbeiana),63.9,244.0,5.9e-83,308.9,sp|C1C4R8|DHRS6_AQUCT Dehydrogenase/reductase SDR family member 6 OS=Aquarana catesbeiana OX=8400 GN=bdh2 PE=2 SV=1,GO:0003858; GO:0005737; GO:0006629; GO:0016617; GO:0016628; GO:0019290; GO:0042168,heme metabolic process [GO:0042168]; lipid metabolic process [GO:0006629]; siderophore biosynthetic process [GO:0019290],cytoplasm [GO:0005737],"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; 4-oxoproline reductase activity [GO:0016617]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_00732,1.1913447914002566,FUN_002698-T1,Peve_00034497,Pocillopora_meandrina_HIv1___RNAseq.g20728.t1,three_way,72.25633333333333,FUN_002698-T1,Q6IRB2,HES1A_XENLA,,Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1),Xenopus laevis (African clawed frog),39.2,245.0,2.4e-26,120.6,sp|Q6IRB2|HES1A_XENLA Transcription factor HES-1-A OS=Xenopus laevis OX=8355 GN=hes1-a PE=1 SV=1,GO:0000122; GO:0000978; GO:0005634; GO:0007219; GO:0043425; GO:0043565; GO:0045665; GO:0045892; GO:0046982; GO:0048635; GO:0050767,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],bHLH transcription factor binding [GO:0043425]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_00738,1.012025381741504,FUN_002720-T1,Peve_00025045,Pocillopora_meandrina_HIv1___RNAseq.g14938.t1,three_way,56.15233333333333,,,,,,,,,,,,,,,,,
OG_00767,1.074032522475408,FUN_003693-T1,Peve_00040660,Pocillopora_meandrina_HIv1___RNAseq.g30052.t1,three_way,45.812,FUN_003693-T1,P06582,,,,,43.8,80.0,2.9e-12,75.1,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_00769,1.2162784716559083,FUN_003713-T1,Peve_00001357,Pocillopora_meandrina_HIv1___RNAseq.g17373.t2,three_way,74.59033333333333,FUN_003713-T1,A7RX69,TIKI1_NEMVE,,Metalloprotease TIKI homolog (EC 3.4.-.-),Nematostella vectensis (Starlet sea anemone),59.5,373.0,5.4999999999999996e-129,462.6,sp|A7RX69|TIKI1_NEMVE Metalloprotease TIKI homolog OS=Nematostella vectensis OX=45351 GN=v1g27680 PE=2 SV=2,GO:0004222; GO:0006508; GO:0016020; GO:0030178; GO:0046872,negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508],membrane [GO:0016020],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00817,1.3968866130898865,FUN_004035-T1,Peve_00008958,Pocillopora_meandrina_HIv1___RNAseq.g11552.t1,three_way,38.5565,,,,,,,,,,,,,,,,,
OG_00818,1.0657628767672311,FUN_004036-T1,Peve_00013897,Pocillopora_meandrina_HIv1___RNAseq.g12511.t1,three_way,63.136,FUN_004036-T1,Q641Z7,ASM3A_RAT,,"Cyclic GMP-AMP phosphodiesterase SMPDL3A (2',3'-cGAMP phosphodiesterase SMPDL3A) (EC 3.1.4.-) (Acid sphingomyelinase-like phosphodiesterase 3a) (ASM-like phosphodiesterase 3a) (EC 3.6.1.15)",Rattus norvegicus (Rat),29.2,366.0,6.299999999999997e-35,150.2,sp|Q641Z7|ASM3A_RAT Cyclic GMP-AMP phosphodiesterase SMPDL3A OS=Rattus norvegicus OX=10116 GN=Smpdl3a PE=2 SV=1,GO:0005576; GO:0005615; GO:0008081; GO:0008270; GO:0009143; GO:0016887; GO:0160049,negative regulation of cGAS/STING signaling pathway [GO:0160049]; nucleoside triphosphate catabolic process [GO:0009143],extracellular region [GO:0005576]; extracellular space [GO:0005615],ATP hydrolysis activity [GO:0016887]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0055086,catalytic activity; extracellular region; extracellular space; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_00843,1.523904258519326,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_00853,1.0246224547054257,FUN_004115-T1,Peve_00008071,Pocillopora_meandrina_HIv1___RNAseq.g11666.t1,three_way,69.32233333333333,FUN_004115-T1,O94632,EGT1_SCHPO,,Ergothioneine biosynthesis protein 1 (Meiotically up-regulated gene 158 protein) [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.21.3.10)],Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),28.3,184.0,1.9e-09,66.2,sp|O94632|EGT1_SCHPO Ergothioneine biosynthesis protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt1 PE=1 SV=4,GO:0004497; GO:0005509; GO:0005634; GO:0005829; GO:0032259; GO:0051321; GO:0052699; GO:0052706; GO:0061686; GO:1903257,ergothioneine biosynthetic process [GO:0052699]; meiotic cell cycle [GO:0051321]; methylation [GO:0032259]; selenoneine biosynthetic process [GO:1903257],cytosol [GO:0005829]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; hercynylcysteine sulfoxide synthase activity [GO:0061686]; L-histidine N(alpha)-methyltransferase activity [GO:0052706]; monooxygenase activity [GO:0004497],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740; GO:0022414; GO:0043226,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity; reproductive process; organelle
OG_00877,1.1705611345047406,FUN_004170-T1,Peve_00031564,Pocillopora_meandrina_HIv1___RNAseq.g16738.t1,three_way,85.395,,,,,,,,,,,,,,,,,
OG_00879,1.4152358996435634,FUN_004172-T1,Peve_00035080,Pocillopora_meandrina_HIv1___TS.g17566.t1,three_way,84.42933333333333,FUN_004172-T1,Q9H841,,,,,50.5,291.0,9.2e-76,285.4,sp|Q9H841|NPAL2_HUMAN NIPA-like protein 2 OS=Homo sapiens OX=9606 GN=NIPAL2 PE=1 SV=2,,,,,,
OG_00880,1.2530199249760587,FUN_004174-T1,Peve_00019597,Pocillopora_meandrina_HIv1___TS.g17559.t2,three_way,57.525333333333336,FUN_004174-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),35.1,1661.0,5.0999999999999996e-250,867.1,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_00883,1.0051333207593554,FUN_004198-T1,Peve_00030902,Pocillopora_meandrina_HIv1___RNAseq.g17020.t1,three_way,77.056,FUN_004198-T1,A2VDD2,,,,,46.6,178.0,5.9e-36,152.5,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_00887,1.545470126983226,FUN_004202-T1,Peve_00008456,Pocillopora_meandrina_HIv1___RNAseq.g16814.t1,three_way,83.68566666666666,FUN_004202-T1,Q91W43,GCSP_MOUSE,,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))",Mus musculus (Mouse),66.0,968.0,0.0,1327.0,"sp|Q91W43|GCSP_MOUSE Glycine dehydrogenase (decarboxylating), mitochondrial OS=Mus musculus OX=10090 GN=Gldc PE=1 SV=1",GO:0004375; GO:0005654; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0065003; GO:0070280; GO:1903442; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein-containing complex assembly [GO:0065003]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005886; GO:0006520; GO:0016491; GO:0016829; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; plasma membrane; amino acid metabolic process; oxidoreductase activity; lyase activity; organelle; protein-containing complex assembly
OG_00918,1.491133117336007,FUN_004255-T1,Peve_00008965,Pocillopora_meandrina_HIv1___TS.g7526.t1,three_way,53.65533333333333,,,,,,,,,,,,,,,,,
OG_00946,1.7450124017901565,FUN_004303-T1,Peve_00033932,Pocillopora_meandrina_HIv1___RNAseq.g11775.t1,three_way,66.79366666666667,FUN_004303-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),39.8,698.0,4.9e-140,500.0,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00948,1.6032084131902438,FUN_004307-T1,Peve_00033930,Pocillopora_meandrina_HIv1___RNAseq.g11779.t1,three_way,63.568666666666665,FUN_004307-T1,O96952,,,,,51.0,102.0,1.3e-23,111.3,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_00952,1.0610642824503198,FUN_004312-T1,Peve_00033934,Pocillopora_meandrina_HIv1___RNAseq.g16986.t1,three_way,70.072,FUN_004312-T1,Q98864,,,,,42.5,1133.0,1.3999999999999999e-244,847.8,sp|Q98864|PTC1_DANRE Protein patched homolog 1 OS=Danio rerio OX=7955 GN=ptch1 PE=2 SV=1,,,,,,
OG_00957,1.7258439949329902,FUN_004321-T1,Peve_00016506,Pocillopora_meandrina_HIv1___RNAseq.g11786.t1,three_way,75.91266666666667,FUN_004321-T1,P54357,,,,,42.0,143.0,3.7e-23,109.4,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_01007,1.0472901797498178,FUN_004431-T1,Peve_00033220,Pocillopora_meandrina_HIv1___RNAseq.g11379.t1,three_way,81.504,FUN_004431-T1,Q7ZW46,,,,,57.3,321.0,2.5e-101,370.2,sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1,,,,,,
OG_01009,1.2282936221526448,FUN_004436-T1,Peve_00033216,Pocillopora_meandrina_HIv1___RNAseq.g11488.t1,three_way,71.79266666666666,FUN_004436-T1,Q9H3R0,,,,,38.8,1037.0,4.0999999999999996e-191,669.8,sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2,,,,,,
OG_01013,1.223547441055904,FUN_004441-T1,Peve_00033211,Pocillopora_meandrina_HIv1___RNAseq.g11480.t1,three_way,74.31,FUN_004441-T1,Q0P5N6,ARL16_HUMAN,,ADP-ribosylation factor-like protein 16,Homo sapiens (Human),43.7,174.0,6.4000000000000005e-28,125.6,sp|Q0P5N6|ARL16_HUMAN ADP-ribosylation factor-like protein 16 OS=Homo sapiens OX=9606 GN=ARL16 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005737,,cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016787,catalytic activity; GTPase activity; hydrolase activity
OG_01055,1.6276432807140264,FUN_004508-T1,Peve_00012959,Pocillopora_meandrina_HIv1___RNAseq.g11640.t1,three_way,76.12733333333334,FUN_004508-T1,H9JW43,,,,,39.8,364.0,4.4e-76,286.6,sp|H9JW43|CDA8_BOMMO Chitin deacetylase 8 OS=Bombyx mori OX=7091 GN=CDA8 PE=1 SV=2,,,,,,
OG_01062,1.8505412091617293,FUN_004517-T1,Peve_00044062,Pocillopora_meandrina_HIv1___RNAseq.g11317.t1,three_way,69.30250000000001,FUN_004517-T1,Q5R5M5,ENPP3_PONAB,,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Dinucleoside polyphosphatase) (EC 3.6.1.-) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.5,766.0,1.2e-133,478.8,sp|Q5R5M5|ENPP3_PONAB Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Pongo abelii OX=9601 GN=ENPP3 PE=2 SV=1,GO:0002276; GO:0003676; GO:0004081; GO:0004528; GO:0005509; GO:0005524; GO:0005576; GO:0005886; GO:0006220; GO:0008270; GO:0009143; GO:0009897; GO:0016324; GO:0033007; GO:0034432; GO:0036219; GO:0036221; GO:0046034; GO:0047429; GO:0047693; GO:0047710; GO:0050728; GO:0070667,ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; pyrimidine nucleotide metabolic process [GO:0006220],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; calcium ion binding [GO:0005509]; GTP diphosphatase activity [GO:0036219]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; UTP diphosphatase activity [GO:0036221]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0055086; GO:1901135,immune system process; catalytic activity; extracellular region; plasma membrane; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01068,1.0537258545399095,FUN_004549-T1,Peve_00042944,Pocillopora_meandrina_HIv1___RNAseq.15379_t,three_way,64.58533333333334,FUN_004549-T1,P9WIT2,,,,,20.5,493.0,1.5e-10,69.3,"sp|P9WIT2|GULDH_MYCTO L-gulono-1,4-lactone dehydrogenase OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=MT1821 PE=3 SV=1",,,,,,
OG_01089,1.2310370919982212,FUN_004582-T1,Peve_00012392,Pocillopora_meandrina_HIv1___RNAseq.g6604.t1,three_way,71.762,,,,,,,,,,,,,,,,,
OG_01092,1.1824951633986704,FUN_004588-T1,Peve_00012396,Pocillopora_meandrina_HIv1___RNAseq.g6598.t1,three_way,60.343833333333336,,,,,,,,,,,,,,,,,
OG_01095,1.650880255402264,FUN_004591-T2,Peve_00012404,Pocillopora_meandrina_HIv1___RNAseq.g6591.t1,three_way,63.417,,,,,,,,,,,,,,,,,
OG_01116,1.0043556344510831,FUN_004660-T1,Peve_00035113,Pocillopora_meandrina_HIv1___TS.g20469.t1,three_way,89.59433333333334,,,,,,,,,,,,,,,,,
OG_01117,1.3302843940486813,FUN_004661-T1,Peve_00035114,Pocillopora_meandrina_HIv1___TS.g20470.t1,three_way,62.39216666666666,FUN_004661-T1,Q2KJ63,KLKB1_BOVIN,,Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain],Bos taurus (Bovine),33.2,250.0,1.4000000000000001e-30,136.3,sp|Q2KJ63|KLKB1_BOVIN Plasma kallikrein OS=Bos taurus OX=9913 GN=KLKB1 PE=2 SV=1,GO:0004252; GO:0005576; GO:0006508; GO:0006954; GO:0007596; GO:0042730; GO:0042803,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; proteolysis [GO:0006508],extracellular region [GO:0005576],protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0006954; GO:0016787; GO:0140096,"catalytic activity; extracellular region; inflammatory response; hydrolase activity; catalytic activity, acting on a protein"
OG_01143,1.0359250435181355,FUN_004723-T1,Peve_00005075,Pocillopora_meandrina_HIv1___RNAseq.g8839.t1,three_way,56.89366666666667,FUN_004723-T1,Q8WZ42,TITIN_HUMAN,,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),Homo sapiens (Human),25.3,194.0,5.5e-09,64.7,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,GO:0000794; GO:0002020; GO:0003009; GO:0003300; GO:0004672; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0045214; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733,cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433],GO:0000228; GO:0003012; GO:0003824; GO:0005198; GO:0005576; GO:0005694; GO:0005829; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"nuclear chromosome; muscle system process; catalytic activity; structural molecule activity; extracellular region; chromosome; cytosol; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01147,1.711999132788708,FUN_004740-T1,Peve_00007775,Pocillopora_meandrina_HIv1___RNAseq.g8829.t1,three_way,86.16033333333334,FUN_004740-T1,Q92963,RIT1_HUMAN,,GTP-binding protein Rit1 (EC 3.6.5.2) (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1),Homo sapiens (Human),61.7,196.0,1.0999999999999999e-62,241.1,sp|Q92963|RIT1_HUMAN GTP-binding protein Rit1 OS=Homo sapiens OX=9606 GN=RIT1 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0007265; GO:0019003,Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165],plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; plasma membrane; hydrolase activity; molecular function regulator activity
OG_01155,1.135968437494293,FUN_004766-T1,Peve_00019319,Pocillopora_meandrina_HIv1___RNAseq.g6698.t2,three_way,68.8935,FUN_004766-T1,Q5R4N8,,,,,40.4,779.0,6.3e-146,519.6,sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1,,,,,,
OG_01177,1.5282858625815352,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_01188,1.1490756023852675,FUN_004841-T1,Peve_00019429,Pocillopora_meandrina_HIv1___RNAseq.g8617.t1,three_way,76.224,FUN_004841-T1,P32297,ACHA3_HUMAN,,Neuronal acetylcholine receptor subunit alpha-3,Homo sapiens (Human),35.1,490.0,2.6e-86,320.9,sp|P32297|ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens OX=9606 GN=CHRNA3 PE=1 SV=4,GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0014056; GO:0015276; GO:0015464; GO:0016020; GO:0016607; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0043231; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098878; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005730; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; nucleolus; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; signaling; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_01248,1.1879961700178503,FUN_004947-T1,Peve_00043267,Pocillopora_meandrina_HIv1___RNAseq.g8394.t1,three_way,76.3205,FUN_004947-T1,Q9BY12,SCAPE_HUMAN,,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),Homo sapiens (Human),41.5,1440.0,9.2e-140,500.0,sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2,GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917,antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0005654; GO:0005783; GO:0005829; GO:0022414; GO:0043226; GO:0048856,nucleoplasm; endoplasmic reticulum; cytosol; reproductive process; organelle; anatomical structure development
OG_01250,1.6280748641656877,FUN_004969-T1,Peve_00043270,Pocillopora_meandrina_HIv1___TS.g20136.t1,three_way,49.14716666666666,,,,,,,,,,,,,,,,,
OG_01279,1.6736184618465866,FUN_005059-T2,Peve_00030172,Pocillopora_meandrina_HIv1___TS.g20044.t1,three_way,73.71433333333334,FUN_005059-T2,Q16348,,,,,37.5,704.0,2.9e-116,421.0,sp|Q16348|S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens OX=9606 GN=SLC15A2 PE=1 SV=2,,,,,,
OG_01297,2.008511287564827,FUN_005131-T1,Peve_00027431,Pocillopora_meandrina_HIv1___RNAseq.g22688.t1,three_way,57.669,FUN_005131-T1,P12256,,,,,31.2,321.0,7.1e-39,162.9,sp|P12256|PAC_LYSSH Penicillin V acylase OS=Lysinibacillus sphaericus OX=1421 PE=1 SV=1,,,,,,
OG_01312,1.446799773304926,FUN_005175-T1,Peve_00011874,Pocillopora_meandrina_HIv1___RNAseq.g7581.t1,three_way,61.32216666666667,FUN_005175-T1,Q9VW71,,,,,22.0,2889.0,4.9e-74,283.1,sp|Q9VW71|FAT2_DROME Fat-like cadherin-related tumor suppressor homolog OS=Drosophila melanogaster OX=7227 GN=kug PE=2 SV=3,,,,,,
OG_01314,1.07305148937877,FUN_005177-T1,Peve_00022720,Pocillopora_meandrina_HIv1___RNAseq.g7584.t1,three_way,78.689,FUN_005177-T1,Q7Z401,MYCPP_HUMAN,,C-myc promoter-binding protein (DENN domain-containing protein 4A),Homo sapiens (Human),34.8,1885.0,8.6e-282,971.8,sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2,GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483,regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_01324,1.271197729445903,FUN_005194-T1,Peve_00001277,Pocillopora_meandrina_HIv1___RNAseq.g15136.t1,three_way,66.81283333333333,,,,,,,,,,,,,,,,,
OG_01333,1.5810713657669249,FUN_005230-T1,Peve_00042881,Pocillopora_meandrina_HIv1___RNAseq.g8115.t1,three_way,67.631,FUN_005230-T1,Q8C9M2,,,,,67.3,49.0,1.1e-13,79.7,sp|Q8C9M2|CCD15_MOUSE Coiled-coil domain-containing protein 15 OS=Mus musculus OX=10090 GN=Ccdc15 PE=2 SV=2,,,,,,
OG_01346,1.1146142991146482,FUN_005247-T1,Peve_00003363,Pocillopora_meandrina_HIv1___RNAseq.g8143.t1,three_way,51.63783333333333,FUN_005247-T1,P59926,,,,,27.9,287.0,1.6e-12,75.9,sp|P59926|SYT15_RAT Synaptotagmin-15 OS=Rattus norvegicus OX=10116 GN=Syt15 PE=2 SV=1,,,,,,
OG_01354,1.565595008137932,FUN_005267-T1,Peve_00003352,Pocillopora_meandrina_HIv1___RNAseq.g8154.t1,three_way,58.39033333333333,FUN_005267-T1,B5X4E0,,,,,38.4,289.0,2.6000000000000003e-44,180.6,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_01364,1.1142065397700385,FUN_005307-T1,Peve_00003314,Pocillopora_meandrina_HIv1___RNAseq.g8172.t1,three_way,66.42383333333333,FUN_005307-T1,A7YSY2,AFG2B_BOVIN,,ATPase family gene 2 protein homolog B (EC 3.6.4.10) (AFG2 AAA ATPase homolog B) (Ribosome biogenesis protein SPATA5L1) (Spermatogenesis-associated protein 5-like protein 1),Bos taurus (Bovine),41.4,789.0,4.1000000000000005e-161,570.1,sp|A7YSY2|AFG2B_BOVIN ATPase family gene 2 protein homolog B OS=Bos taurus OX=9913 GN=AFG2B PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0016887; GO:0030970; GO:0031593; GO:0034098; GO:0042273; GO:0042802; GO:0043161; GO:0051228; GO:0097352; GO:1990275,"autophagosome maturation [GO:0097352]; mitotic spindle disassembly [GO:0051228]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ribosomal large subunit biogenesis [GO:0042273]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; preribosome binding [GO:1990275],GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0007010; GO:0016787; GO:0030163; GO:0043226,catalytic activity; nucleus; cytosol; intracellular protein transport; cytoskeleton organization; hydrolase activity; protein catabolic process; organelle
OG_01396,1.5803908912461582,FUN_005372-T2,Peve_00041488,Pocillopora_meandrina_HIv1___RNAseq.g6635.t1,three_way,84.41483333333333,FUN_005372-T2,P19120,HSP7C_BOVIN,,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8),Bos taurus (Bovine),82.6,650.0,4.8e-293,1008.1,sp|P19120|HSP7C_BOVIN Heat shock cognate 71 kDa protein OS=Bos taurus OX=9913 GN=HSPA8 PE=1 SV=2,GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016191; GO:0016887; GO:0030674; GO:0031072; GO:0042026; GO:0042470; GO:0044183; GO:0045892; GO:0051085; GO:0061740; GO:0072318; GO:0098793; GO:0140662; GO:1990904,chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; RNA splicing [GO:0008380]; synaptic vesicle uncoating [GO:0016191],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0006457; GO:0006886; GO:0016071; GO:0016787; GO:0031410; GO:0043226; GO:0044183; GO:0060090; GO:0140657,catalytic activity; nucleus; nucleolus; cytosol; plasma membrane; regulation of DNA-templated transcription; protein folding; intracellular protein transport; mRNA metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; protein folding chaperone; molecular adaptor activity; ATP-dependent activity
OG_01399,1.6948684992998977,FUN_005387-T1,Peve_00044223,Pocillopora_meandrina_HIv1___RNAseq.g6614.t1,three_way,86.572,FUN_005387-T1,Q32LQ4,,,,,68.3,262.0,1.9e-105,384.0,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_01450,1.052951222798345,FUN_005904-T1,Peve_00035815,Pocillopora_meandrina_HIv1___RNAseq.2460_t,three_way,73.63866666666667,FUN_005904-T1,P55115,,,,,42.3,239.0,1e-48,195.3,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_01462,1.2780407268179956,FUN_005996-T1,Peve_00036051,Pocillopora_meandrina_HIv1___TS.g29328.t1,three_way,73.044,FUN_005996-T1,Q6GMK0,MGT4B_DANRE,,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,508.0,6e-143,509.2,"sp|Q6GMK0|MGT4B_DANRE Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B OS=Danio rerio OX=7955 GN=mgat4bQ9UQ53 PE=2 SV=1",GO:0000139; GO:0005783; GO:0005793; GO:0005795; GO:0006486; GO:0006487; GO:0008375; GO:0008454; GO:0046872,protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]",GO:0003824; GO:0005783; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01463,1.3674125036137328,FUN_005998-T1,Peve_00036045,Pocillopora_meandrina_HIv1___RNAseq.g19934.t1,three_way,70.90683333333334,FUN_005998-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),50.4,625.0,1.3e-181,637.9,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_01472,1.7540336688583638,FUN_006009-T1,Peve_00032112,Pocillopora_meandrina_HIv1___RNAseq.g28362.t1,three_way,43.14983333333333,,,,,,,,,,,,,,,,,
OG_01482,1.3885589862492156,FUN_006116-T1,Peve_00011320,Pocillopora_meandrina_HIv1___RNAseq.g20399.t1,three_way,43.202666666666666,FUN_006116-T1,A0A0K3AV08,MLK1_CAEEL,,Mitogen-activated protein kinase kinase kinase mlk-1 (EC 2.7.11.25) (Mixed lineage kinase homolog 1),Caenorhabditis elegans,29.0,207.0,7.1e-10,67.4,sp|A0A0K3AV08|MLK1_CAEEL Mitogen-activated protein kinase kinase kinase mlk-1 OS=Caenorhabditis elegans OX=6239 GN=mlk-1 PE=1 SV=1,GO:0000165; GO:0001934; GO:0004672; GO:0004709; GO:0005080; GO:0005524; GO:0005737; GO:0007165; GO:0007254; GO:0008340; GO:0019901; GO:0030971; GO:0031103; GO:0038066; GO:0042594; GO:0046688; GO:0046872; GO:0048680; GO:0048691; GO:0050829; GO:0097110; GO:0106310,axon regeneration [GO:0031103]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein phosphorylation [GO:0001934]; response to copper ion [GO:0046688]; response to starvation [GO:0042594]; signal transduction [GO:0007165],cytoplasm [GO:0005737],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_01483,1.8617537915023457,FUN_006117-T1,Peve_00011322,Pocillopora_meandrina_HIv1___RNAseq.g20401.t1,three_way,36.36283333333333,,,,,,,,,,,,,,,,,
OG_01486,2.48606320293028,FUN_006162-T1,Peve_00024180,Pocillopora_meandrina_HIv1___RNAseq.g20422.t1,three_way,46.14,FUN_006162-T1,Q90827,,,,,30.2,129.0,2.5e-09,65.1,sp|Q90827|NEL_CHICK Protein NEL OS=Gallus gallus OX=9031 GN=NEL PE=2 SV=1,,,,,,
OG_01490,1.1163508343059074,FUN_006166-T1,Peve_00021031,Pocillopora_meandrina_HIv1___RNAseq.g20430.t1,three_way,77.292,FUN_006166-T1,Q9VQ37,RIM2_DROME,,Mitochondrial carrier protein Rim2,Drosophila melanogaster (Fruit fly),46.1,345.0,5.000000000000001e-78,292.7,sp|Q9VQ37|RIM2_DROME Mitochondrial carrier protein Rim2 OS=Drosophila melanogaster OX=7227 GN=Rim2 PE=2 SV=2,GO:0000002; GO:0005739; GO:0005743; GO:0006390; GO:0007005; GO:0015218; GO:0030302; GO:0040011; GO:0045333; GO:0048311; GO:1990519,cellular respiration [GO:0045333]; deoxynucleotide transport [GO:0030302]; locomotion [GO:0040011]; mitochondrial genome maintenance [GO:0000002]; mitochondrial transcription [GO:0006390]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],pyrimidine nucleotide transmembrane transporter activity [GO:0015218],GO:0005215; GO:0005739; GO:0006091; GO:0006351; GO:0007005; GO:0043226; GO:0055085,transporter activity; mitochondrion; generation of precursor metabolites and energy; DNA-templated transcription; mitochondrion organization; organelle; transmembrane transport
OG_01503,1.3119115693842835,FUN_006230-T1,Peve_00002942,Pocillopora_meandrina_HIv1___RNAseq.g20449.t1,three_way,69.12416666666667,FUN_006230-T1,Q5SZK8,FREM2_HUMAN,,FRAS1-related extracellular matrix protein 2 (ECM3 homolog),Homo sapiens (Human),41.5,1242.0,4.8e-265,916.0,sp|Q5SZK8|FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens OX=9606 GN=FREM2 PE=1 SV=3,GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0009653; GO:0042733; GO:0046872; GO:0048839; GO:0062023; GO:0070062,anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],metal ion binding [GO:0046872],GO:0005886; GO:0007155; GO:0030312; GO:0031012; GO:0043226; GO:0048856,plasma membrane; cell adhesion; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_01518,1.2665442578978752,FUN_006261-T1,Peve_00015046,Pocillopora_meandrina_HIv1___RNAseq.g20376.t1,three_way,47.83533333333333,,,,,,,,,,,,,,,,,
OG_01576,1.1686424486948284,FUN_006581-T1,Peve_00015613,Pocillopora_meandrina_HIv1___RNAseq.g20271.t1,three_way,58.029,FUN_006581-T1,P18460,,,,,34.3,769.0,1.3e-91,339.3,sp|P18460|FGFR3_CHICK Fibroblast growth factor receptor 3 OS=Gallus gallus OX=9031 GN=FGFR3 PE=2 SV=1,,,,,,
OG_01583,1.369253719951412,FUN_006619-T1,Peve_00040865,Pocillopora_meandrina_HIv1___RNAseq.g20179.t1,three_way,71.24033333333334,FUN_006619-T1,Q92598,HS105_HUMAN,,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) (Heat shock protein family H member 1),Homo sapiens (Human),51.3,686.0,5.6e-181,636.0,sp|Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:0140662,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0008092; GO:0043226; GO:0044183; GO:0098772; GO:0140657,extracellular region; nucleus; nucleoplasm; cytosol; protein folding; cytoskeletal protein binding; organelle; protein folding chaperone; molecular function regulator activity; ATP-dependent activity
OG_01588,1.6458350369225123,FUN_006627-T1,Peve_00040871,Pocillopora_meandrina_HIv1___RNAseq.g20168.t1,three_way,32.273,,,,,,,,,,,,,,,,,
OG_01589,1.6851925433757724,FUN_006629-T1,Peve_00040873,Pocillopora_meandrina_HIv1___RNAseq.g20167.t1,three_way,52.60733333333334,,,,,,,,,,,,,,,,,
OG_01605,1.022407074540437,FUN_006649-T1,Peve_00029032,Pocillopora_meandrina_HIv1___RNAseq.g19952.t1,three_way,81.72066666666667,FUN_006649-T1,Q9W7L4,,,,,61.3,333.0,1.2e-117,424.5,sp|Q9W7L4|LDHB_SCEUN L-lactate dehydrogenase B chain OS=Sceloporus undulatus OX=8520 GN=LDHB PE=2 SV=3,,,,,,
OG_01606,1.2672325151300907,FUN_006650-T1,Peve_00029034,Pocillopora_meandrina_HIv1___RNAseq.g19953.t1,three_way,78.253,FUN_006650-T1,Q9UI36,DACH1_HUMAN,,Dachshund homolog 1 (Dach1),Homo sapiens (Human),27.6,479.0,9.2e-19,96.7,sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279,development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0022414; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle; transcription regulator activity
OG_01620,1.518695308494389,FUN_006729-T1,Peve_00039560,Pocillopora_meandrina_HIv1___RNAseq.g20015.t1,three_way,68.16666666666667,FUN_006729-T1,O55240,RDH5_MOUSE,,Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (Cis-retinol dehydrogenase),Mus musculus (Mouse),44.6,285.0,1.7999999999999994e-68,261.2,sp|O55240|RDH5_MOUSE Retinol dehydrogenase 5 OS=Mus musculus OX=10090 GN=Rdh5 PE=1 SV=1,GO:0001523; GO:0004745; GO:0005788; GO:0005789; GO:0007601; GO:0008202; GO:0042572; GO:0042803; GO:0044297; GO:0047023; GO:0047044; GO:0106429,retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; visual perception [GO:0007601],cell body [GO:0044297]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],"11-cis-retinol dehydrogenase [GO:0106429]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0006629; GO:0016491; GO:0050877,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process
OG_01642,1.0718281026285503,FUN_006790-T1,Peve_00028070,Pocillopora_meandrina_HIv1___RNAseq.g20501.t1,three_way,54.868,FUN_006790-T1,P35918,,,,,31.5,961.0,9.8e-99,363.6,sp|P35918|VGFR2_MOUSE Vascular endothelial growth factor receptor 2 OS=Mus musculus OX=10090 GN=Kdr PE=1 SV=2,,,,,,
OG_01645,1.7730134497471182,FUN_006796-T1,Peve_00019185,Pocillopora_meandrina_HIv1___RNAseq.g20496.t1,three_way,33.34466666666667,FUN_006796-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),28.9,287.0,1.3e-17,92.4,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_01659,1.1526216998678736,FUN_006830-T1,Peve_00023775,Pocillopora_meandrina_HIv1___RNAseq.g20471.t1,three_way,73.49133333333333,FUN_006830-T1,Q9U637,,,,,37.9,198.0,7.3e-17,89.0,sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1,,,,,,
OG_01668,1.1107981899293624,FUN_006855-T1,Peve_00042995,Pocillopora_meandrina_HIv1___RNAseq.g19915.t1,three_way,55.54816666666667,FUN_006855-T1,Q3KRG3,,,,,36.7,109.0,2.5e-20,100.5,sp|Q3KRG3|TSR2_DANRE Pre-rRNA-processing protein TSR2 homolog OS=Danio rerio OX=7955 GN=tsr2 PE=2 SV=1,,,,,,
OG_01669,1.0232946653468242,FUN_006856-T1,Peve_00016201,Pocillopora_meandrina_HIv1___RNAseq.g19911.t1,three_way,74.561,FUN_006856-T1,P24861,,,,,48.5,454.0,1.7e-95,351.3,sp|P24861|CCNA_PATVU G2/mitotic-specific cyclin-A OS=Patella vulgata OX=6465 PE=2 SV=1,,,,,,
OG_01672,1.7686916142050204,FUN_006861-T1,Peve_00006606,Pocillopora_meandrina_HIv1___RNAseq.g19909.t1,three_way,69.55666666666666,FUN_006861-T1,O97860,,,,,48.4,304.0,4.8e-84,312.8,sp|O97860|PPA5_RABIT Tartrate-resistant acid phosphatase type 5 OS=Oryctolagus cuniculus OX=9986 GN=ACP5 PE=2 SV=1,,,,,,
OG_01674,1.863217624682135,FUN_006869-T2,Peve_00039239,Pocillopora_meandrina_HIv1___RNAseq.g19796.t1,three_way,64.51466666666667,FUN_006869-T2,P00530,,,,,25.6,437.0,2e-18,96.7,sp|P00530|FPS_FUJSV Tyrosine-protein kinase transforming protein Fps OS=Fujinami sarcoma virus OX=11885 GN=V-FPS PE=3 SV=1,,,,,,
OG_01680,1.3816551102478227,FUN_006890-T1,Peve_00009370,Pocillopora_meandrina_HIv1___RNAseq.g19814.t1,three_way,60.797666666666665,FUN_006890-T1,Q19791,GON1_CAEEL,,A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1),Caenorhabditis elegans,25.1,338.0,3.3e-18,94.4,sp|Q19791|GON1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs gon-1 OS=Caenorhabditis elegans OX=6239 GN=gon-1 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005604; GO:0005783; GO:0005794; GO:0006508; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607,cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]; proteolysis [GO:0006508],basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0016192; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; vesicle-mediated transport; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_01695,1.0570339728790954,FUN_006936-T2,Peve_00001498,Pocillopora_meandrina_HIv1___RNAseq.g20120.t2,three_way,80.58433333333333,FUN_006936-T2,A7SBF0,,,,,67.5,664.0,4e-279,961.8,sp|A7SBF0|INT9_NEMVE Integrator complex subunit 9 homolog OS=Nematostella vectensis OX=45351 GN=ints9 PE=3 SV=1,,,,,,
OG_01704,1.3727274700261658,FUN_006949-T1,Peve_00001501,Pocillopora_meandrina_HIv1___RNAseq.g20122.t1,three_way,65.41066666666667,FUN_006949-T1,Q9D4H7,,,,,35.5,617.0,9e-100,365.9,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_01727,1.0644189227720948,FUN_007019-T1,Peve_00037183,Pocillopora_meandrina_HIv1___TS.g29924.t1,three_way,69.06633333333333,FUN_007019-T1,P0DPD6,ECE2_HUMAN,,Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71),Homo sapiens (Human),35.5,761.0,4e-129,463.8,sp|P0DPD6|ECE2_HUMAN Endothelin-converting enzyme 2 OS=Homo sapiens OX=9606 GN=ECE2 PE=1 SV=1,GO:0000139; GO:0004222; GO:0005886; GO:0007186; GO:0007267; GO:0008168; GO:0016485; GO:0016486; GO:0030658; GO:0030659; GO:0032259; GO:0046872,cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; methylation [GO:0032259]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485],cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168],GO:0003824; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; transferase activity; hydrolase activity; signaling; protein maturation; catalytic activity, acting on a protein"
OG_01746,1.220889211779207,FUN_007072-T2,Peve_00019898,Pocillopora_meandrina_HIv1___RNAseq.g20086.t1,three_way,53.24433333333334,FUN_007072-T2,B1AT66,MOT7_MOUSE,,Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6),Mus musculus (Mouse),24.3,202.0,2.2e-15,85.1,sp|B1AT66|MOT7_MOUSE Monocarboxylate transporter 7 OS=Mus musculus OX=10090 GN=Slc16a6 PE=1 SV=1,GO:0005368; GO:0016323,,basolateral plasma membrane [GO:0016323],taurine transmembrane transporter activity [GO:0005368],GO:0005215,transporter activity
OG_01759,2.268345705422943,FUN_007111-T1,Peve_00017835,Pocillopora_meandrina_HIv1___RNAseq.g19017.t1,three_way,39.03566666666666,,,,,,,,,,,,,,,,,
OG_01784,1.2194410757451186,FUN_007160-T1,Peve_00028234,Pocillopora_meandrina_HIv1___RNAseq.g19727.t1,three_way,78.381,FUN_007160-T1,Q9JMD3,STA10_MOUSE,,START domain-containing protein 10 (StARD10) (PCTP-like protein) (PCTP-L) (Serologically defined colon cancer antigen 28 homolog) (StAR-related lipid transfer protein 10),Mus musculus (Mouse),43.5,237.0,4.3e-54,213.0,sp|Q9JMD3|STA10_MOUSE START domain-containing protein 10 OS=Mus musculus OX=10090 GN=Stard10 PE=1 SV=1,GO:0005829; GO:0005902; GO:0006869; GO:0008289; GO:0016020; GO:0031514; GO:0032782; GO:0035360; GO:0046581,bile acid secretion [GO:0032782]; lipid transport [GO:0006869]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360],cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226,cytosol; cilium; lipid binding; organelle
OG_01788,1.3101591377112545,FUN_007166-T1,Peve_00042484,Pocillopora_meandrina_HIv1___RNAseq.g19745.t1,three_way,75.658,FUN_007166-T1,P57695,,,,,37.9,457.0,8.7e-76,285.8,sp|P57695|GLRA1_BOVIN Glycine receptor subunit alpha-1 OS=Bos taurus OX=9913 GN=GLRA1 PE=1 SV=1,,,,,,
OG_01817,1.059783573499359,FUN_007690-T1,Peve_00012973,Pocillopora_meandrina_HIv1___RNAseq.g18009.t1b,three_way,56.254666666666665,,,,,,,,,,,,,,,,,
OG_01872,1.4600850685889313,FUN_007839-T1,Peve_00019308,Pocillopora_meandrina_HIv1___TS.g21414.t1,three_way,62.15633333333333,FUN_007839-T1,Q61830,,,,,29.1,299.0,1.1e-23,112.8,sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2,,,,,,
OG_01897,1.3704507122755667,FUN_007904-T1,Peve_00040656,Pocillopora_meandrina_HIv1___RNAseq.g30059.t1,three_way,60.9685,FUN_007904-T1,P06582,,,,,37.0,100.0,1.1e-11,72.0,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_01918,1.0362933204981708,FUN_007947-T1,Peve_00021143,Pocillopora_meandrina_HIv1___TS.g21111.t2,three_way,56.5525,,,,,,,,,,,,,,,,,
OG_01919,1.1502308551966176,FUN_007948-T1,Peve_00044442,Pocillopora_meandrina_HIv1___RNAseq.g18135.t1,three_way,64.81733333333334,FUN_007948-T1,Q3TTY0,PLB1_MOUSE,,"Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3)",Mus musculus (Mouse),39.7,345.0,6.200000000000003e-66,253.4,"sp|Q3TTY0|PLB1_MOUSE Phospholipase B1, membrane-associated OS=Mus musculus OX=10090 GN=Plb1 PE=1 SV=2",GO:0004622; GO:0004806; GO:0016324; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344,diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; positive regulation of acrosome reaction [GO:2000344]; triglyceride catabolic process [GO:0019433],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526],calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_01941,1.244972907081958,FUN_007993-T1,Peve_00018053,Pocillopora_meandrina_HIv1___RNAseq.g5090.t1,three_way,42.72566666666666,FUN_007993-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),25.9,587.0,7.1e-39,163.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_01952,1.1767120171200969,FUN_008018-T1,Peve_00031314,Pocillopora_meandrina_HIv1___RNAseq.g30339.t1,three_way,80.18366666666667,FUN_008018-T1,P18754,RCC1_HUMAN,,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),Homo sapiens (Human),49.0,433.0,2.4e-107,390.6,sp|P18754|RCC1_HUMAN Regulator of chromosome condensation OS=Homo sapiens OX=9606 GN=RCC1 PE=1 SV=1,GO:0000082; GO:0000785; GO:0000794; GO:0003682; GO:0005085; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007052; GO:0007059; GO:0007084; GO:0007088; GO:0007346; GO:0016032; GO:0031267; GO:0031491; GO:0031492; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301; GO:1901673,cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032],chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199],GO:0000228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0007010; GO:0007059; GO:0042393; GO:0043226; GO:0061024; GO:0098772,nuclear chromosome; DNA binding; nucleus; nucleoplasm; chromosome; cytoskeleton organization; chromosome segregation; histone binding; organelle; membrane organization; molecular function regulator activity
OG_01955,2.70069332829034,FUN_008021-T1,Peve_00031303,Pocillopora_meandrina_HIv1___RNAseq.g30342.t1,three_way,69.569,,,,,,,,,,,,,,,,,
OG_01957,1.152131875238924,FUN_008025-T1,Peve_00011341,Pocillopora_meandrina_HIv1___RNAseq.g30350.t1,three_way,62.04266666666667,,,,,,,,,,,,,,,,,
OG_01967,1.1048403408073793,FUN_008051-T1,Peve_00045153,Pocillopora_meandrina_HIv1___RNAseq.g30357.t1,three_way,45.46666666666667,,,,,,,,,,,,,,,,,
OG_01995,2.258038896514796,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_02040,1.6592924349594893,FUN_008245-T1,Peve_00031789,Pocillopora_meandrina_HIv1___RNAseq.g17949.t1,three_way,80.146,,,,,,,,,,,,,,,,,
OG_02048,1.2192498782955046,FUN_008256-T1,Peve_00035501,Pocillopora_meandrina_HIv1___RNAseq.g17961.t1,three_way,85.40433333333334,FUN_008256-T1,Q9Y6V7,DDX49_HUMAN,,Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49),Homo sapiens (Human),60.0,423.0,1.1999999999999999e-141,504.6,sp|Q9Y6V7|DDX49_HUMAN Probable ATP-dependent RNA helicase DDX49 OS=Homo sapiens OX=9606 GN=DDX49 PE=1 SV=1,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016887; GO:0030307; GO:0044357,positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02083,1.2812802957830518,FUN_008306-T1,Peve_00015428,Pocillopora_meandrina_HIv1___TS.g24507.t2,three_way,73.73883333333333,FUN_008306-T1,Q9CQE8,,,,,50.2,245.0,1.6e-63,244.2,"sp|Q9CQE8|RTRAF_MOUSE RNA transcription, translation and transport factor protein OS=Mus musculus OX=10090 GN=RTRAF PE=1 SV=1",,,,,,
OG_02088,1.4223346330096336,FUN_008314-T1,Peve_00026747,Pocillopora_meandrina_HIv1___RNAseq.g5785.t1,three_way,57.846,,,,,,,,,,,,,,,,,
OG_02094,1.8558748902312685,FUN_008365-T1,Peve_00005520,Pocillopora_meandrina_HIv1___RNAseq.g5716.t1,three_way,73.69866666666667,FUN_008365-T1,H9J9M0,,,,,27.5,258.0,2.9e-20,100.5,sp|H9J9M0|CDA1_BOMMO Chitin deacetylase 1 OS=Bombyx mori OX=7091 GN=CDA1 PE=1 SV=1,,,,,,
OG_02101,1.193748996306394,FUN_008377-T1,Peve_00024686,Pocillopora_meandrina_HIv1___RNAseq.g18396.t1,three_way,53.3375,,,,,,,,,,,,,,,,,
OG_02119,1.564990344403068,FUN_008404-T1,Peve_00031485,Pocillopora_meandrina_HIv1___RNAseq.g18034.t1,three_way,63.198,,,,,,,,,,,,,,,,,
OG_02137,1.089554394586543,FUN_008443-T1,Peve_00024979,Pocillopora_meandrina_HIv1___TS.g21051.t1,three_way,76.96133333333333,FUN_008443-T1,P82458,TRI18_RAT,,E3 ubiquitin-protein ligase Midline-1 (EC 2.3.2.27) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18),Rattus norvegicus (Rat),28.6,704.0,1.1e-67,260.4,sp|P82458|TRI18_RAT E3 ubiquitin-protein ligase Midline-1 OS=Rattus norvegicus OX=10116 GN=Mid1 PE=2 SV=1,GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005881; GO:0007026; GO:0008017; GO:0008270; GO:0015630; GO:0016740; GO:0019899; GO:0031625; GO:0032874; GO:0034451; GO:0035372; GO:0042802; GO:0042803; GO:0051219; GO:0070507,negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372]; regulation of microtubule cytoskeleton organization [GO:0070507],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005829; GO:0005856; GO:0008092; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; cytosol; cytoskeleton; cytoskeletal protein binding; transferase activity; organelle
OG_02144,1.244862296119816,FUN_008450-T1,Peve_00015484,Pocillopora_meandrina_HIv1___RNAseq.g18070.t1,three_way,41.653,FUN_008450-T1,Q9QVP9,FAK2_MOUSE,,Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK),Mus musculus (Mouse),37.5,277.0,1.7e-45,187.2,sp|Q9QVP9|FAK2_MOUSE Protein-tyrosine kinase 2-beta OS=Mus musculus OX=10090 GN=Ptk2b PE=1 SV=2,GO:0001764; GO:0001954; GO:0002040; GO:0002250; GO:0002315; GO:0004672; GO:0004683; GO:0004715; GO:0005524; GO:0005634; GO:0005856; GO:0005925; GO:0005938; GO:0006968; GO:0007010; GO:0007030; GO:0007166; GO:0007172; GO:0007229; GO:0008284; GO:0008285; GO:0008360; GO:0010595; GO:0010758; GO:0010976; GO:0014069; GO:0017146; GO:0018108; GO:0030027; GO:0030155; GO:0030425; GO:0030426; GO:0030502; GO:0030546; GO:0030838; GO:0030865; GO:0032956; GO:0033209; GO:0035235; GO:0035255; GO:0043025; GO:0043066; GO:0043267; GO:0043524; GO:0044297; GO:0045453; GO:0045638; GO:0045766; GO:0045860; GO:0046330; GO:0048010; GO:0048471; GO:0051279; GO:0051897; GO:0051968; GO:0060291; GO:0070098; GO:0070374; GO:0071300; GO:0071498; GO:0086100; GO:0097440; GO:0098793; GO:0098978; GO:0099092; GO:0099151; GO:0099602; GO:2000060; GO:2000463; GO:2000538,"adaptive immune response [GO:0002250]; bone resorption [GO:0045453]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to fluid shear stress [GO:0071498]; cellular response to retinoic acid [GO:0071300]; chemokine-mediated signaling pathway [GO:0070098]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton organization [GO:0007010]; endothelin receptor signaling pathway [GO:0086100]; Golgi organization [GO:0007030]; integrin-mediated signaling pathway [GO:0007229]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic potentiation [GO:0060291]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of potassium ion transport [GO:0043267]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; regulation of macrophage chemotaxis [GO:0010758]; regulation of postsynaptic density assembly [GO:0099151]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; signal complex assembly [GO:0007172]; sprouting angiogenesis [GO:0002040]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","apical dendrite [GO:0097440]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]",ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; ionotropic glutamate receptor binding [GO:0035255]; neurotransmitter receptor regulator activity [GO:0099602]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; signaling receptor activator activity [GO:0030546],GO:0002376; GO:0003824; GO:0005634; GO:0005856; GO:0007010; GO:0016740; GO:0030154; GO:0043226; GO:0048870; GO:0065003; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytoskeleton; cytoskeleton organization; transferase activity; cell differentiation; organelle; cell motility; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02145,1.6507357736004855,FUN_008451-T1,Peve_00015483,Pocillopora_meandrina_HIv1___RNAseq.g18071.t1,three_way,76.60533333333333,,,,,,,,,,,,,,,,,
OG_02164,1.1375264552542232,FUN_008512-T1,Peve_00000372,Pocillopora_meandrina_HIv1___RNAseq.g425.t1,three_way,73.32933333333334,FUN_008512-T1,P51955,NEK2_HUMAN,,Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1),Homo sapiens (Human),69.3,270.0,6e-113,409.1,sp|P51955|NEK2_HUMAN Serine/threonine-protein kinase Nek2 OS=Homo sapiens OX=9606 GN=NEK2 PE=1 SV=1,GO:0000278; GO:0000776; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0006468; GO:0007059; GO:0007088; GO:0019903; GO:0030496; GO:0032206; GO:0032991; GO:0036064; GO:0045171; GO:0046602; GO:0046777; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051988; GO:0090307; GO:0106310; GO:1903126,blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; positive regulation of telomere maintenance [GO:0032206]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000228; GO:0000278; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"nuclear chromosome; mitotic cell cycle; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02180,1.0752275488896306,FUN_008531-T1,Peve_00011876,Pocillopora_meandrina_HIv1___RNAseq.g14744.t1,three_way,54.064,,,,,,,,,,,,,,,,,
OG_02187,1.4970311843834143,FUN_008541-T1,Peve_00026391,Pocillopora_meandrina_HIv1___RNAseq.g6362.t1,three_way,76.138,,,,,,,,,,,,,,,,,
OG_02190,1.1058771673057264,FUN_008544-T1,Peve_00013775,Pocillopora_meandrina_HIv1___RNAseq.g6331.t2,three_way,81.17266666666667,FUN_008544-T1,Q99MD6,TRXR3_MOUSE,,Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2),Mus musculus (Mouse),60.5,588.0,1.7000000000000002e-209,730.3,sp|Q99MD6|TRXR3_MOUSE Thioredoxin reductase 3 OS=Mus musculus OX=10090 GN=Txnrd3 PE=1 SV=3,GO:0001825; GO:0004791; GO:0005634; GO:0005783; GO:0006749; GO:0007283; GO:0030154; GO:0045454; GO:0050660,blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],flavin adenine dinucleotide binding [GO:0050660]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005783; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_02201,1.454241503692251,FUN_008576-T1,Peve_00044725,Pocillopora_meandrina_HIv1___RNAseq.g12787.t1,three_way,63.60733333333333,,,,,,,,,,,,,,,,,
OG_02226,2.282619338517869,FUN_008631-T1,Peve_00012388,Pocillopora_meandrina_HIv1___RNAseq.g14912.t1,three_way,62.56166666666666,,,,,,,,,,,,,,,,,
OG_02227,1.0070885750887544,FUN_008633-T1,Peve_00012386,Pocillopora_meandrina_HIv1___RNAseq.g14915.t1,three_way,74.2705,FUN_008633-T1,Q8VDT1,,,,,45.9,573.0,4.5e-140,500.0,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_02229,1.471162398925048,FUN_008635-T1,Peve_00024235,Pocillopora_meandrina_HIv1___RNAseq.g14918.t1,three_way,76.26733333333334,FUN_008635-T1,Q6NWJ4,DNJC2_DANRE,,DnaJ homolog subfamily C member 2,Danio rerio (Zebrafish) (Brachydanio rerio),55.8,618.0,1.4000000000000002e-124,448.4,sp|Q6NWJ4|DNJC2_DANRE DnaJ homolog subfamily C member 2 OS=Danio rerio OX=7955 GN=dnajc2 PE=2 SV=1,GO:0003682; GO:0005634; GO:0005829; GO:0006450; GO:0030544; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649,'de novo' cotranslational protein folding [GO:0051083]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of translational fidelity [GO:0006450],cytosol [GO:0005829]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin-modified histone reader activity [GO:0061649],GO:0005634; GO:0005829; GO:0006355; GO:0006457; GO:0042393; GO:0043226; GO:0060090,nucleus; cytosol; regulation of DNA-templated transcription; protein folding; histone binding; organelle; molecular adaptor activity
OG_02259,1.0426267357178376,FUN_008706-T1,Peve_00034988,Pocillopora_meandrina_HIv1___RNAseq.g25666.t1,three_way,78.29466666666666,FUN_008706-T1,P55145,MANF_HUMAN,,Mesencephalic astrocyte-derived neurotrophic factor (Arginine-rich protein) (Protein ARMET),Homo sapiens (Human),55.3,170.0,1.0999999999999999e-47,191.0,sp|P55145|MANF_HUMAN Mesencephalic astrocyte-derived neurotrophic factor OS=Homo sapiens OX=9606 GN=MANF PE=1 SV=3,GO:0002014; GO:0003723; GO:0005576; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0005829; GO:0008083; GO:0031175; GO:0033018; GO:0036500; GO:0071542; GO:0120146; GO:1905897,ATF6-mediated unfolded protein response [GO:0036500]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; regulation of response to endoplasmic reticulum stress [GO:1905897]; vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure [GO:0002014],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; sarcoplasmic reticulum lumen [GO:0033018],growth factor activity [GO:0008083]; RNA binding [GO:0003723]; sulfatide binding [GO:0120146],GO:0003013; GO:0003723; GO:0005576; GO:0005615; GO:0005634; GO:0005783; GO:0005829; GO:0008289; GO:0030154; GO:0043226; GO:0048018; GO:0098772,circulatory system process; RNA binding; extracellular region; extracellular space; nucleus; endoplasmic reticulum; cytosol; lipid binding; cell differentiation; organelle; receptor ligand activity; molecular function regulator activity
OG_02280,1.2869936431638664,FUN_008772-T1,Peve_00036716,Pocillopora_meandrina_HIv1___RNAseq.g12702.t1,three_way,55.00416666666666,FUN_008772-T1,P30974,,,,,26.0,412.0,1.6e-18,95.9,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_02289,1.5681438388920428,FUN_008798-T1,Peve_00042590,Pocillopora_meandrina_HIv1___RNAseq.g54.t1,three_way,49.41266666666667,,,,,,,,,,,,,,,,,
OG_02291,1.1068370793257254,FUN_008858-T1,Peve_00002939,Pocillopora_meandrina_HIv1___TS.g25452.t1,three_way,61.41666666666667,,,,,,,,,,,,,,,,,
OG_02294,1.0048467941328385,FUN_008872-T1,Peve_00000784,Pocillopora_meandrina_HIv1___RNAseq.g4010.t1,three_way,45.396166666666666,,,,,,,,,,,,,,,,,
OG_02311,1.429246449586972,FUN_008898-T1,Peve_00041461,Pocillopora_meandrina_HIv1___RNAseq.g3963.t1,three_way,52.316500000000005,FUN_008898-T1,Q2EMV9,PAR14_MOUSE,,Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14),Mus musculus (Mouse),31.0,775.0,1.8e-87,326.6,sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3,GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0045087; GO:0060336; GO:0140807; GO:1902216; GO:1990404,innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_02325,1.7246018484935122,FUN_008917-T1,Peve_00033005,Pocillopora_meandrina_HIv1___RNAseq.g3982.t1,three_way,74.89333333333333,FUN_008917-T1,Q6V5K9,,,,,46.8,269.0,1e-59,232.6,sp|Q6V5K9|ZN474_MOUSE Zinc finger protein 474 OS=Mus musculus OX=10090 GN=Znf474 PE=2 SV=2,,,,,,
OG_02343,1.0340516468419263,FUN_008944-T1,Peve_00011189,Pocillopora_meandrina_HIv1___RNAseq.g4060.t1,three_way,64.23383333333334,FUN_008944-T1,Q6P0U3,,,,,31.3,211.0,1.6000000000000002e-23,112.1,sp|Q6P0U3|RSLBB_DANRE Ras-like protein family member 11B OS=Danio rerio OX=7955 GN=rasl11b PE=2 SV=1,,,,,,
OG_02355,1.1846285808218149,FUN_008958-T1,Peve_00021624,Pocillopora_meandrina_HIv1___RNAseq.g4045.t1,three_way,88.27633333333334,FUN_008958-T1,P36241,,,,,80.5,77.0,5.2e-27,121.7,sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2,,,,,,
OG_02359,1.0779683239444755,FUN_008962-T1,Peve_00007353,Pocillopora_meandrina_HIv1___RNAseq.g3914.t1,three_way,53.4015,FUN_008962-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),31.7,489.0,3.1e-54,214.9,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02408,1.681278360058127,FUN_009228-T2,Peve_00014803,Pocillopora_meandrina_HIv1___RNAseq.g6343.t1,three_way,63.64683333333333,FUN_009228-T2,Q24JV9,,,,,50.0,106.0,4.5000000000000003e-23,113.6,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02414,1.0948429862161455,FUN_009283-T1,Peve_00000866,Pocillopora_meandrina_HIv1___RNAseq.g15507.t1,three_way,65.01933333333334,,,,,,,,,,,,,,,,,
OG_02424,1.0261764110493277,FUN_009349-T1,Peve_00038081,Pocillopora_meandrina_HIv1___RNAseq.g14427.t2,three_way,67.24183333333333,,,,,,,,,,,,,,,,,
OG_02431,1.1158648483291995,FUN_009401-T1,Peve_00004579,Pocillopora_meandrina_HIv1___RNAseq.g4531.t1,three_way,45.29166666666666,,,,,,,,,,,,,,,,,
OG_02439,1.4384074844702996,FUN_009459-T2,Peve_00010355,Pocillopora_meandrina_HIv1___RNAseq.g25133.t1,three_way,61.281333333333336,FUN_009459-T2,Q24JV9,,,,,58.1,105.0,3.1999999999999997e-31,139.0,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02443,1.0369726552094956,FUN_009512-T1,Peve_00040630,Pocillopora_meandrina_HIv1___TS.g24209.t1,three_way,57.00666666666667,FUN_009512-T1,A6LX31,,,,,46.4,252.0,2.1e-56,221.5,sp|A6LX31|Y2760_CLOB8 Putative hydro-lyase Cbei_2760 OS=Clostridium beijerinckii (strain ATCC 51743 / NCIMB 8052) OX=290402 GN=Cbei_2760 PE=3 SV=1,,,,,,
OG_02473,1.2094974399493326,FUN_009675-T1,Peve_00009262,Pocillopora_meandrina_HIv1___RNAseq.g24569.t1,three_way,75.73666666666666,FUN_009675-T1,Q8K078,SO4A1_MOUSE,,Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),Mus musculus (Mouse),38.1,637.0,2.3e-114,414.5,sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2,GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015711,monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711],plasma membrane [GO:0005886],organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_02484,1.5789493179829217,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_02486,1.667685698797562,FUN_009818-T1,Peve_00042916,Pocillopora_meandrina_HIv1___RNAseq.g24548.t1,three_way,67.266,FUN_009818-T1,Q8MIR4,,,,,38.3,574.0,3.8e-94,347.1,sp|Q8MIR4|COASY_PIG Bifunctional coenzyme A synthase OS=Sus scrofa OX=9823 GN=COASY PE=1 SV=1,,,,,,
OG_02490,1.0309123664192934,FUN_009822-T1,Peve_00042911,Pocillopora_meandrina_HIv1___RNAseq.g24544.t1,three_way,83.21233333333333,FUN_009822-T1,O77460,,,,,68.7,211.0,6.9e-87,321.6,sp|O77460|IPYR_DROME Inorganic pyrophosphatase OS=Drosophila melanogaster OX=7227 GN=Nurf-38 PE=1 SV=3,,,,,,
OG_02502,1.8681710321508949,FUN_009857-T2,Peve_00009100,Pocillopora_meandrina_HIv1___RNAseq.g24506.t1,three_way,84.31183333333333,FUN_009857-T2,Q92005,,,,,85.1,462.0,2.1999999999999998e-231,802.7,sp|Q92005|EF1A_DANRE Elongation factor 1-alpha OS=Danio rerio OX=7955 GN=eef1a PE=2 SV=1,,,,,,
OG_02504,2.20716580577544,FUN_009960-T1,Peve_00007862,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1b,three_way,73.25516666666667,,,,,,,,,,,,,,,,,
OG_02523,1.0357866474630704,FUN_010591-T1,Peve_00032703,Pocillopora_meandrina_HIv1___RNAseq.g21510.t1,three_way,77.489,FUN_010591-T1,B1VTI5,GRIF_STRGG,,Grixazone synthase (EC 1.10.3.15) (Phenoxazinone synthase) (PHS) (o-aminophenol oxidase) (EC 1.10.3.4),Streptomyces griseus subsp. griseus (strain JCM 4626 / CBS 651.72 / NBRC 13350 / KCC S-0626 / ISP 5235),30.5,269.0,1.4e-13,79.0,sp|B1VTI5|GRIF_STRGG Grixazone synthase OS=Streptomyces griseus subsp. griseus (strain JCM 4626 / CBS 651.72 / NBRC 13350 / KCC S-0626 / ISP 5235) OX=455632 GN=griF PE=1 SV=1,GO:0005507; GO:0017000; GO:0050149,antibiotic biosynthetic process [GO:0017000],,copper ion binding [GO:0005507]; o-aminophenol oxidase activity [GO:0050149],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_02524,1.1417920601034717,FUN_010592-T2,Peve_00032705,Pocillopora_meandrina_HIv1___RNAseq.g21509.t1,three_way,78.5945,FUN_010592-T2,E9PVD1,CCD62_MOUSE,,Coiled-coil domain-containing protein 62,Mus musculus (Mouse),29.6,324.0,1.0000000000000001e-29,133.3,sp|E9PVD1|CCD62_MOUSE Coiled-coil domain-containing protein 62 OS=Mus musculus OX=10090 GN=Ccdc62 PE=1 SV=1,GO:0001669; GO:0001835; GO:0003713; GO:0005634; GO:0007286; GO:0030331; GO:0030520; GO:0045944; GO:0071392,blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; nucleus [GO:0005634],nuclear estrogen receptor binding [GO:0030331]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0006355; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; regulation of DNA-templated transcription; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_02525,1.1279877488576282,FUN_010597-T1,Peve_00032712,Pocillopora_meandrina_HIv1___RNAseq.g21497.t1,three_way,66.67666666666666,FUN_010597-T1,Q9LQV2,,,,,31.0,432.0,1.0999999999999999e-47,193.0,sp|Q9LQV2|RDR1_ARATH RNA-dependent RNA polymerase 1 OS=Arabidopsis thaliana OX=3702 GN=RDR1 PE=2 SV=1,,,,,,
OG_02532,4.363138912422253,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_02537,1.2244704631564818,FUN_010620-T1,Peve_00031460,Pocillopora_meandrina_HIv1___TS.g26115.t1,three_way,50.77283333333333,FUN_010620-T1,O14514,AGRB1_HUMAN,,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],Homo sapiens (Human),29.6,659.0,1.9999999999999999e-63,246.9,sp|O14514|AGRB1_HUMAN Adhesion G protein-coupled receptor B1 OS=Homo sapiens OX=9606 GN=ADGRB1 PE=1 SV=2,GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016020; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]",cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786],GO:0002376; GO:0005615; GO:0005886; GO:0007155; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0060089; GO:0061024; GO:0098542,immune system process; extracellular space; plasma membrane; cell adhesion; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; molecular transducer activity; membrane organization; defense response to other organism
OG_02550,1.186887881119889,FUN_010638-T1,Peve_00009636,Pocillopora_meandrina_HIv1___RNAseq.g21309.t1,three_way,85.60366666666667,FUN_010638-T1,P79733,RIR2_DANRE,,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),Danio rerio (Zebrafish) (Brachydanio rerio),79.4,335.0,5.3e-151,535.4,sp|P79733|RIR2_DANRE Ribonucleoside-diphosphate reductase subunit M2 OS=Danio rerio OX=7955 GN=rrm2 PE=1 SV=1,GO:0004748; GO:0005829; GO:0009263; GO:0046872,deoxyribonucleotide biosynthetic process [GO:0009263],cytosol [GO:0005829],"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",GO:0003824; GO:0005829; GO:0016491; GO:0055086; GO:1901135,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02574,1.176687986106784,FUN_010680-T1,Peve_00044789,Pocillopora_meandrina_HIv1___RNAseq.g21344.t1,three_way,49.747,,,,,,,,,,,,,,,,,
OG_02623,1.4948679861438388,FUN_010772-T1,Peve_00004496,Pocillopora_meandrina_HIv1___RNAseq.g21195.t1,three_way,63.85333333333333,FUN_010772-T1,Q8HZN9,,,,,24.3,276.0,1.8e-09,65.1,sp|Q8HZN9|BKRB1_PIG B1 bradykinin receptor OS=Sus scrofa OX=9823 GN=BDKRB1 PE=3 SV=1,,,,,,
OG_02633,1.39774201352938,FUN_010786-T1,Peve_00014207,Pocillopora_meandrina_HIv1___RNAseq.g21213.t1,three_way,53.632,,,,,,,,,,,,,,,,,
OG_02635,1.0442068880767672,FUN_010802-T1,Peve_00007033,Pocillopora_meandrina_HIv1___TS.g25986.t1,three_way,47.278,FUN_010802-T1,Q8NDA2,,,,,20.6,880.0,4.9e-29,131.7,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_02638,1.1716662680728296,FUN_010805-T1,Peve_00006505,Pocillopora_meandrina_HIv1___RNAseq.g26670.t1,three_way,61.43866666666667,FUN_010805-T1,P31228,OXDD_BOVIN,,D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1),Bos taurus (Bovine),26.8,406.0,3.7999999999999995e-24,114.0,sp|P31228|OXDD_BOVIN D-aspartate oxidase OS=Bos taurus OX=9913 GN=DDO PE=1 SV=3,GO:0005737; GO:0005782; GO:0005829; GO:0008445; GO:0019478; GO:0047821; GO:0050877; GO:0071949,D-amino acid catabolic process [GO:0019478]; nervous system process [GO:0050877],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782],D-aspartate oxidase activity [GO:0008445]; D-glutamate oxidase activity [GO:0047821]; FAD binding [GO:0071949],GO:0003824; GO:0005829; GO:0006520; GO:0016491; GO:0050877,catalytic activity; cytosol; amino acid metabolic process; oxidoreductase activity; nervous system process
OG_02666,1.5149959559794448,FUN_010885-T1,Peve_00035837,Pocillopora_meandrina_HIv1___RNAseq.g21004.t1,three_way,46.05866666666667,FUN_010885-T1,Q5VXM1,,,,,36.7,109.0,4e-09,64.7,sp|Q5VXM1|CDCP2_HUMAN CUB domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CDCP2 PE=2 SV=2,,,,,,
OG_02676,1.2862151362632694,FUN_010925-T1,Peve_00005955,Pocillopora_meandrina_HIv1___RNAseq.g21797.t1,three_way,57.31033333333333,,,,,,,,,,,,,,,,,
OG_02694,1.2250252907966714,FUN_010957-T1,Peve_00035899,Pocillopora_meandrina_HIv1___RNAseq.g21825.t1,three_way,53.990833333333335,,,,,,,,,,,,,,,,,
OG_02699,1.2922094515195102,FUN_010968-T1,Peve_00035956,Pocillopora_meandrina_HIv1___RNAseq.g21969.t2,three_way,64.66499999999999,FUN_010968-T1,Q98TZ8,,,,,34.2,161.0,1.2e-22,107.8,sp|Q98TZ8|FLOT2_DANRE Flotillin-2a OS=Danio rerio OX=7955 GN=flot2a PE=2 SV=2,,,,,,
OG_02727,1.3011738633043848,FUN_011179-T1,Peve_00006850,Pocillopora_meandrina_HIv1___RNAseq.g22322.t1,three_way,55.33916666666666,FUN_011179-T1,Q0V9E9,KMT5A_XENTR,,N-lysine methyltransferase KMT5A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine-specific methylase 5A) (SET domain-containing protein 8),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),50.6,174.0,1.2999999999999998e-47,191.8,sp|Q0V9E9|KMT5A_XENTR N-lysine methyltransferase KMT5A OS=Xenopus tropicalis OX=8364 GN=kmt5a PE=2 SV=1,GO:0005634; GO:0005694; GO:0032259; GO:0042054; GO:0051301; GO:0140944,cell division [GO:0051301]; methylation [GO:0032259],chromosome [GO:0005694]; nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054],GO:0003824; GO:0005634; GO:0005694; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02728,2.04015724108202,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_02744,1.0011826673252753,FUN_011308-T1,Peve_00024988,Pocillopora_meandrina_HIv1___RNAseq.g22351.t1,three_way,73.087,FUN_011308-T1,Q8L7W2,,,,,39.7,214.0,6.0999999999999996e-43,176.0,sp|Q8L7W2|NUDT8_ARATH Nudix hydrolase 8 OS=Arabidopsis thaliana OX=3702 GN=NUDT8 PE=2 SV=2,,,,,,
OG_02791,1.7481899661864897,FUN_011747-T1,Peve_00034099,Pocillopora_meandrina_HIv1___RNAseq.9509_t,three_way,56.78566666666666,FUN_011747-T1,C5H5C4,NOT1A_DANRE,,Palmitoleoyl-protein carboxylesterase notum1a (EC 3.1.1.98),Danio rerio (Zebrafish) (Brachydanio rerio),40.0,417.0,7.7e-82,305.8,sp|C5H5C4|NOT1A_DANRE Palmitoleoyl-protein carboxylesterase notum1a OS=Danio rerio OX=7955 GN=notum1a PE=2 SV=1,GO:0004621; GO:0005576; GO:0009952; GO:0016055; GO:0021532; GO:0030178; GO:0090090; GO:1990697; GO:1990699,anterior/posterior pattern specification [GO:0009952]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005576; GO:0016787; GO:0030163,catalytic activity; extracellular region; hydrolase activity; protein catabolic process
OG_02792,1.067060652263125,FUN_011749-T1,Peve_00034098,Pocillopora_meandrina_HIv1___RNAseq.g23883.t1,three_way,76.81333333333333,FUN_011749-T1,P48279,,,,,25.2,222.0,9.8e-07,55.5,sp|P48279|YCF39_CYAPA Photosystem II assembly factor Ycf39 OS=Cyanophora paradoxa OX=2762 GN=ycf39 PE=3 SV=1,,,,,,
OG_02828,1.4787592517144024,FUN_011843-T1,Peve_00034373,Pocillopora_meandrina_HIv1___RNAseq.g23373.t1,three_way,84.43299999999999,FUN_011843-T1,Q9SEE4,,,,,41.8,297.0,9.3e-61,235.3,sp|Q9SEE4|PIRL_SOLLC Pirin-like protein OS=Solanum lycopersicum OX=4081 PE=2 SV=1,,,,,,
OG_02920,1.0016063695386763,FUN_012003-T1,Peve_00016378,Pocillopora_meandrina_HIv1___RNAseq.g24026.t1,three_way,71.5695,FUN_012003-T1,Q5VVH5,IKBP1_HUMAN,,Interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1),Homo sapiens (Human),45.4,119.0,6.2e-23,109.0,sp|Q5VVH5|IKBP1_HUMAN Interleukin-1 receptor-associated kinase 1-binding protein 1 OS=Homo sapiens OX=9606 GN=IRAK1BP1 PE=1 SV=1,GO:0005634; GO:0005737; GO:0006955; GO:0035591; GO:0043123,immune response [GO:0006955]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],cytoplasm [GO:0005737]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591],GO:0002376; GO:0005634; GO:0043226; GO:0060090,immune system process; nucleus; organelle; molecular adaptor activity
OG_02927,1.323056875471995,FUN_012020-T1,Peve_00030377,Pocillopora_meandrina_HIv1___RNAseq.g24050.t1,three_way,58.77833333333333,FUN_012020-T1,Q5UAW9,GP157_HUMAN,,G-protein coupled receptor 157,Homo sapiens (Human),34.6,289.0,1.7e-39,164.9,sp|Q5UAW9|GP157_HUMAN G-protein coupled receptor 157 OS=Homo sapiens OX=9606 GN=GPR157 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0007200; GO:0048512; GO:0060019; GO:0060170,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; radial glial cell differentiation [GO:0060019],ciliary membrane [GO:0060170]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0030154; GO:0060089,plasma membrane; cell differentiation; molecular transducer activity
OG_02929,1.0667940548416874,FUN_012028-T1,Peve_00030379,Pocillopora_meandrina_HIv1___RNAseq.g24047.t2,three_way,77.09433333333334,FUN_012028-T1,Q14192,FHL2_HUMAN,,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),Homo sapiens (Human),42.1,273.0,1.7000000000000002e-74,282.0,sp|Q14192|FHL2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885,atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018],bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_02942,2.0924690229505907,FUN_012054-T3,Peve_00004085,Pocillopora_meandrina_HIv1___RNAseq.g23646.t1,three_way,73.15266666666666,FUN_012054-T3,Q7Z020,,,,,22.2,504.0,9.3e-26,120.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02948,1.3958988237930734,FUN_012066-T1,Peve_00004089,Pocillopora_meandrina_HIv1___RNAseq.g23637.t1,three_way,63.71233333333333,FUN_012066-T1,Q7Z020,,,,,25.4,562.0,7.2e-37,157.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02949,1.7419315770842827,FUN_012067-T1,Peve_00004104,Pocillopora_meandrina_HIv1___RNAseq.g23636.t1,three_way,67.023,FUN_012067-T1,Q7Z020,,,,,28.6,553.0,9.3e-45,184.1,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02951,1.0581463913723217,FUN_012070-T1,Peve_00025863,Pocillopora_meandrina_HIv1___TS.g16508.t1,three_way,72.754,,,,,,,,,,,,,,,,,
OG_02957,1.0136829485882124,FUN_012102-T1,Peve_00007426,Pocillopora_meandrina_HIv1___RNAseq.g23946.t1,three_way,60.24616666666667,FUN_012102-T1,P18956,GGT_ECOLI,,Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (GGT) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain],Escherichia coli (strain K12),30.7,267.0,7.9000000000000025e-22,107.5,sp|P18956|GGT_ECOLI Glutathione hydrolase proenzyme OS=Escherichia coli (strain K12) OX=83333 GN=ggt PE=1 SV=1,GO:0006750; GO:0006751; GO:0030288; GO:0034722; GO:0036374; GO:0042597; GO:0043102; GO:0097264; GO:0103068,amino acid salvage [GO:0043102]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; self proteolysis [GO:0097264],outer membrane-bounded periplasmic space [GO:0030288]; periplasmic space [GO:0042597],gamma-glutamyl-peptidase activity [GO:0034722]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068],GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0016740; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_02998,1.4922725149111955,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03003,1.2949543806634616,FUN_012187-T2,Peve_00027771,Pocillopora_meandrina_HIv1___RNAseq.g23457.t1,three_way,57.22,,,,,,,,,,,,,,,,,
OG_03068,1.372996731086782,FUN_012338-T1,Peve_00021550,Pocillopora_meandrina_HIv1___RNAseq.g24073.t1,three_way,51.0305,,,,,,,,,,,,,,,,,
OG_03070,1.6968195761609677,FUN_012340-T1,Peve_00042542,Pocillopora_meandrina_HIv1___RNAseq.g23343.t1,three_way,61.76633333333333,FUN_012340-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),30.7,205.0,2.5e-17,91.7,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_03084,1.6002298023910086,FUN_012357-T1,Peve_00042558,Pocillopora_meandrina_HIv1___TS.g16156.t2,three_way,49.562333333333335,,,,,,,,,,,,,,,,,
OG_03085,1.222291563673477,FUN_012358-T1,Peve_00042557,Pocillopora_meandrina_HIv1___RNAseq.g23273.t1,three_way,74.58133333333333,FUN_012358-T1,Q24133,DNAJ1_DROME,,DnaJ protein homolog 1 (DROJ1),Drosophila melanogaster (Fruit fly),53.0,332.0,1.4e-84,314.7,sp|Q24133|DNAJ1_DROME DnaJ protein homolog 1 OS=Drosophila melanogaster OX=7227 GN=DnaJ-1 PE=1 SV=3,GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408],cytosol [GO:0005829],DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005829; GO:0006457,cytosol; protein folding
OG_03103,1.2958711712269333,FUN_012390-T1,Peve_00022229,Pocillopora_meandrina_HIv1___RNAseq.g23656.t1,three_way,66.252,,,,,,,,,,,,,,,,,
OG_03108,1.6968511090413148,FUN_012405-T1,Peve_00002856,Pocillopora_meandrina_HIv1___RNAseq.g9951.t1,three_way,66.98066666666666,,,,,,,,,,,,,,,,,
OG_03116,1.080073292246753,FUN_012430-T1,Peve_00026925,Pocillopora_meandrina_HIv1___RNAseq.g23681.t1,three_way,55.942,FUN_012430-T1,Q7TXL8,,,,,25.4,2226.0,7.9e-140,501.5,sp|Q7TXL8|PPSC_MYCBO Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=ppsC PE=1 SV=1,,,,,,
OG_03122,1.125284655867738,FUN_012476-T1,Peve_00004005,Pocillopora_meandrina_HIv1___RNAseq.g23990.t1,three_way,74.48633333333333,FUN_012476-T1,O15247,CLIC2_HUMAN,,Chloride intracellular channel protein 2 (Glutaredoxin-like oxidoreductase CLIC2) (EC 1.8.-.-) (Glutaredoxin-like peroxidase CLIC2) (EC 1.11.1.-) (XAP121),Homo sapiens (Human),31.7,230.0,1.5e-23,111.3,sp|O15247|CLIC2_HUMAN Chloride intracellular channel protein 2 OS=Homo sapiens OX=9606 GN=CLIC2 PE=1 SV=3,GO:0004602; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707,chloride transport [GO:0006821]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602],GO:0003824; GO:0005215; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016209; GO:0016491; GO:0043226,catalytic activity; transporter activity; nucleus; nucleoplasm; cytosol; plasma membrane; antioxidant activity; oxidoreductase activity; organelle
OG_03146,1.0326115623091536,FUN_012532-T1,Peve_00013905,Pocillopora_meandrina_HIv1___RNAseq.g23955.t1,three_way,55.178666666666665,,,,,,,,,,,,,,,,,
OG_03147,1.5679125461533607,FUN_012533-T1,Peve_00034230,Pocillopora_meandrina_HIv1___RNAseq.g23954.t1,three_way,57.28066666666667,,,,,,,,,,,,,,,,,
OG_03163,1.1175174567901711,FUN_012561-T1,Peve_00016373,Pocillopora_meandrina_HIv1___RNAseq.g23582.t1,three_way,69.20983333333334,FUN_012561-T1,Q92834,RPGR_HUMAN,,X-linked retinitis pigmentosa GTPase regulator,Homo sapiens (Human),44.0,448.0,1.1e-68,263.1,sp|Q92834|RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens OX=9606 GN=RPGR PE=1 SV=2,GO:0001750; GO:0003723; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0006511; GO:0006886; GO:0007601; GO:0010508; GO:0016567; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0060271; GO:0061630; GO:0097499,cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; positive regulation of autophagy [GO:0010508]; protein localization to non-motile cilium [GO:0097499]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630],GO:0003723; GO:0003824; GO:0005794; GO:0005815; GO:0005929; GO:0006886; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0098772; GO:0140096,"RNA binding; catalytic activity; Golgi apparatus; microtubule organizing center; cilium; intracellular protein transport; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; nervous system process; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03171,2.2784265382521123,FUN_012594-T1,Peve_00042400,Pocillopora_meandrina_HIv1___RNAseq.g13631.t1,three_way,63.02033333333333,FUN_012594-T1,Q91YI6,GLD2_MOUSE,,Poly(A) RNA polymerase GLD2 (mGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2),Mus musculus (Mouse),35.1,328.0,2.3e-38,161.0,sp|Q91YI6|GLD2_MOUSE Poly(A) RNA polymerase GLD2 OS=Mus musculus OX=10090 GN=Tent2 PE=1 SV=1,GO:0002244; GO:0005524; GO:0005634; GO:0005737; GO:0031124; GO:0046872; GO:0071044; GO:0140958; GO:1990817; GO:2000626,hematopoietic progenitor cell differentiation [GO:0002244]; histone mRNA catabolic process [GO:0071044]; mRNA 3'-end processing [GO:0031124]; negative regulation of miRNA catabolic process [GO:2000626]; target-directed miRNA degradation [GO:0140958],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; mRNA metabolic process; transferase activity; cell differentiation; organelle
OG_03179,1.1139627085240715,FUN_012625-T1,Peve_00040110,Pocillopora_meandrina_HIv1___RNAseq.g13729.t1,three_way,75.87533333333333,FUN_012625-T1,Q55FK2,RAB6_DICDI,,Ras-related protein Rab-6,Dictyostelium discoideum (Social amoeba),48.7,189.0,7.6e-44,178.7,sp|Q55FK2|RAB6_DICDI Ras-related protein Rab-6 OS=Dictyostelium discoideum OX=44689 GN=rab6 PE=3 SV=1,GO:0003924; GO:0005525; GO:0005794; GO:0005811; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0042147; GO:0140220,"intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; pathogen-containing vacuole [GO:0140220],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0005811; GO:0005829; GO:0006886; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; Golgi apparatus; lipid droplet; cytosol; intracellular protein transport; vesicle-mediated transport; hydrolase activity; organelle
OG_03193,1.2056953086201396,FUN_012670-T1,Peve_00008660,Pocillopora_meandrina_HIv1___RNAseq.g22885.t1,three_way,76.15866666666666,FUN_012670-T1,Q5F464,,,,,48.0,256.0,2.8e-72,273.5,sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1,,,,,,
OG_03252,1.0542287588816976,FUN_012983-T1,Peve_00028830,Pocillopora_meandrina_HIv1___RNAseq.g30380.t2,three_way,73.10633333333334,,,,,,,,,,,,,,,,,
OG_03263,1.3576532689875684,FUN_013089-T1,Peve_00034077,Pocillopora_meandrina_HIv1___RNAseq.g216.t1,three_way,78.51933333333334,FUN_013089-T1,Q8WXG1,RSAD2_HUMAN,,"S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (EC 4.2.-.-) (Cytomegalovirus-induced gene 5 protein) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin)",Homo sapiens (Human),74.7,292.0,4.3000000000000004e-134,479.2,sp|Q8WXG1|RSAD2_HUMAN S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 OS=Homo sapiens OX=9606 GN=RSAD2 PE=1 SV=1,GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553,"CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],"4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]",GO:0002376; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005811; GO:0016829; GO:0030154; GO:0043226; GO:0098542,immune system process; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; lipid droplet; lyase activity; cell differentiation; organelle; defense response to other organism
OG_03267,1.366247181697772,FUN_013135-T1,Peve_00013805,Pocillopora_meandrina_HIv1___TS.g15910.t1,three_way,63.35666666666666,FUN_013135-T1,P05208,CEL2A_MOUSE,,Chymotrypsin-like elastase family member 2A (EC 3.4.21.71) (Elastase-2) (Elastase-2A),Mus musculus (Mouse),37.8,275.0,4.1999999999999996e-47,189.9,sp|P05208|CEL2A_MOUSE Chymotrypsin-like elastase family member 2A OS=Mus musculus OX=10090 GN=Cela2a PE=1 SV=1,GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0017171; GO:0032868; GO:0036457; GO:0050796; GO:0061436; GO:0062023; GO:0090330; GO:1901143,establishment of skin barrier [GO:0061436]; insulin catabolic process [GO:1901143]; proteolysis [GO:0006508]; regulation of insulin secretion [GO:0050796]; regulation of platelet aggregation [GO:0090330]; response to insulin [GO:0032868],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457],endopeptidase activity [GO:0004175]; serine hydrolase activity [GO:0017171]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0030163; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; protein catabolic process; anatomical structure development; catalytic activity, acting on a protein"
OG_03268,1.2965256029995726,FUN_013137-T1,Peve_00042384,Pocillopora_meandrina_HIv1___RNAseq.g23023.t1,three_way,71.50933333333333,FUN_013137-T1,Q7M3E1,,,,,42.1,254.0,7.8e-44,179.5,sp|Q7M3E1|CTRC_BOVIN Chymotrypsin-C OS=Bos taurus OX=9913 GN=CTRC PE=1 SV=2,,,,,,
OG_03269,1.7740115970116876,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_03276,1.427782957666132,FUN_013155-T1,Peve_00022447,Pocillopora_meandrina_HIv1___RNAseq.g12980.t1,three_way,66.7205,FUN_013155-T1,P47843,GTR3_SHEEP,,"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)",Ovis aries (Sheep),45.7,466.0,1.4000000000000001e-101,371.7,"sp|P47843|GTR3_SHEEP Solute carrier family 2, facilitated glucose transporter member 3 OS=Ovis aries OX=9940 GN=SLC2A3 PE=2 SV=1",GO:0005354; GO:0005536; GO:0005886; GO:0015757; GO:0016020; GO:0042995; GO:0043204; GO:0046323; GO:0055056; GO:0070837; GO:1904659,D-glucose import [GO:0046323]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; galactose transmembrane transport [GO:0015757],cell projection [GO:0042995]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],D-glucose binding [GO:0005536]; D-glucose transmembrane transporter activity [GO:0055056]; galactose transmembrane transporter activity [GO:0005354],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_03288,1.054579369480154,FUN_013329-T1,Peve_00022430,Pocillopora_meandrina_HIv1___RNAseq.g12994.t1,three_way,67.42033333333333,FUN_013329-T1,Q8IS64,,,,,36.0,688.0,9.5e-131,469.2,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_03299,1.289034312572192,FUN_013366-T1,Peve_00001190,Pocillopora_meandrina_HIv1___RNAseq.g13343.t1,three_way,74.01916666666666,FUN_013366-T1,Q28IJ3,,,,,50.0,80.0,6.2e-13,74.7,sp|Q28IJ3|PXL2B_XENTR Prostamide/prostaglandin F synthase OS=Xenopus tropicalis OX=8364 GN=prxl2b PE=2 SV=1,,,,,,
OG_03311,1.052768224951355,FUN_013389-T1,Peve_00031288,Pocillopora_meandrina_HIv1___TS.g15861.t1,three_way,67.08366666666667,,,,,,,,,,,,,,,,,
OG_03320,1.0584188463785749,FUN_013399-T1,Peve_00028082,Pocillopora_meandrina_HIv1___RNAseq.g22938.t1,three_way,78.69366666666667,FUN_013399-T1,Q7T3H7,,,,,49.5,194.0,3.4e-48,193.0,sp|Q7T3H7|MED18_DANRE Mediator of RNA polymerase II transcription subunit 18 OS=Danio rerio OX=7955 GN=med18 PE=2 SV=1,,,,,,
OG_03327,2.150907769069889,FUN_013418-T1,Peve_00028073,Pocillopora_meandrina_HIv1___RNAseq.g22949.t1,three_way,55.11866666666667,FUN_013418-T1,Q8X187,,,,,28.7,143.0,4e-10,67.4,sp|Q8X187|CALM_PAXIN Calmodulin OS=Paxillus involutus OX=71150 GN=calA PE=2 SV=3,,,,,,
OG_03334,1.3432586076254358,FUN_013555-T1,Peve_00024216,Pocillopora_meandrina_HIv1___RNAseq.g22959.t1,three_way,90.33133333333332,FUN_013555-T1,Q9YHT2,,,,,83.1,249.0,8.500000000000001e-126,451.4,"sp|Q9YHT2|SDHB_CHICK Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial OS=Gallus gallus OX=9031 GN=SDHB PE=1 SV=1",,,,,,
OG_03342,1.0146626352990562,FUN_013572-T1,Peve_00022291,Pocillopora_meandrina_HIv1___RNAseq.g13520.t1,three_way,69.9175,FUN_013572-T1,Q9TRC7,AOC1_PIG,,Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein) (Amine oxidase copper domain-containing protein 1) (Histaminase),Sus scrofa (Pig),39.3,746.0,1.2e-157,558.5,sp|Q9TRC7|AOC1_PIG Diamine oxidase [copper-containing] OS=Sus scrofa OX=9823 GN=AOC1 PE=1 SV=3,GO:0005507; GO:0005509; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0009445; GO:0042803; GO:0048038; GO:0050232; GO:0052597; GO:0052598; GO:0070062,putrescine metabolic process [GO:0009445],bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; primary methylamine oxidase activity [GO:0008131]; protein homodimerization activity [GO:0042803]; putrescine oxidase activity [GO:0050232]; quinone binding [GO:0048038],GO:0003824; GO:0005615; GO:0005886; GO:0016491; GO:0043226,catalytic activity; extracellular space; plasma membrane; oxidoreductase activity; organelle
OG_03383,1.111310536028674,FUN_013638-T1,Peve_00039072,Pocillopora_meandrina_HIv1___RNAseq.g13562.t1,three_way,66.89450000000001,FUN_013638-T1,Q3V3Z3,AGRG5_MOUSE,,"Adhesion G-protein coupled receptor G5 (G-protein coupled receptor 114) (G-protein coupled receptor PGR27) [Cleaved into: Adhesion G-protein coupled receptor G5, N-terminal fragment (ADGRG5 N-terminal fragment); Adhesion G-protein coupled receptor G5, C-terminal fragment (ADGRG5 C-terminal fragment)]",Mus musculus (Mouse),29.5,292.0,5.4e-16,87.4,sp|Q3V3Z3|AGRG5_MOUSE Adhesion G-protein coupled receptor G5 OS=Mus musculus OX=10090 GN=Adgrg5 PE=1 SV=3,GO:0004930; GO:0005886; GO:0007166; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_03422,2.3342077538885344,FUN_014476-T1,Peve_00037307,Pocillopora_meandrina_HIv1___RNAseq.g22818.t1,three_way,61.25033333333334,,,,,,,,,,,,,,,,,
OG_03429,1.448758970443186,FUN_014485-T1,Peve_00037303,Pocillopora_meandrina_HIv1___RNAseq.g22811.t1,three_way,75.97416666666666,FUN_014485-T1,O35887,,,,,29.0,155.0,5.5e-09,63.5,sp|O35887|CALU_MOUSE Calumenin OS=Mus musculus OX=10090 GN=Calu PE=1 SV=1,,,,,,
OG_03445,1.328747908518954,FUN_014509-T1,Peve_00031996,Pocillopora_meandrina_HIv1___RNAseq.g22632.t1,three_way,69.32416666666667,FUN_014509-T1,Q5F3V0,SMYD4_CHICK,,Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4),Gallus gallus (Chicken),28.4,401.0,4.9999999999999996e-26,121.3,sp|Q5F3V0|SMYD4_CHICK Protein-lysine N-methyltransferase SMYD4 OS=Gallus gallus OX=9031 GN=SMYD4 PE=2 SV=1,GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0008270; GO:0032259; GO:0042826,heart development [GO:0007507]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],histone deacetylase binding [GO:0042826]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; transferase activity; organelle; anatomical structure development
OG_03478,1.112152820397648,FUN_014572-T1,Peve_00027631,Pocillopora_meandrina_HIv1___RNAseq.1861_t,three_way,78.95566666666666,FUN_014572-T1,Q6DDL7,,,,,50.4,282.0,2.600000000000001e-71,270.4,sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1,,,,,,
OG_03479,1.3205096811841897,FUN_014573-T3,Peve_00027630,Pocillopora_meandrina_HIv1___RNAseq.g22711.t1,three_way,76.72633333333333,FUN_014573-T3,Q6DFR1,,,,,31.8,494.0,5.1e-54,213.8,sp|Q6DFR1|S22AF_XENTR Solute carrier family 22 member 15 OS=Xenopus tropicalis OX=8364 GN=slc22a15 PE=2 SV=2,,,,,,
OG_03480,1.138755574213609,FUN_014574-T1,Peve_00027629,Pocillopora_meandrina_HIv1___TS.g27474.t1,three_way,69.878,FUN_014574-T1,Q9VCA2,,,,,36.1,527.0,8.1e-84,312.8,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_03500,1.420732029444403,FUN_014610-T1,Peve_00027567,Pocillopora_meandrina_HIv1___TS.g27529.t1,three_way,75.49566666666666,FUN_014610-T1,P27465,,,,,48.5,361.0,3.7e-97,356.7,"sp|P27465|PISD_CRIGR Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Cricetulus griseus OX=10029 GN=Pisd PE=1 SV=2",,,,,,
OG_03531,1.1366819129057977,FUN_014646-T1,Peve_00025654,Pocillopora_meandrina_HIv1___RNAseq.g22686.t1,three_way,77.64233333333333,FUN_014646-T1,Q9D1L0,,,,,56.7,60.0,7.4e-11,68.6,sp|Q9D1L0|CHCH2_MOUSE Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 OS=Mus musculus OX=10090 GN=Chchd2 PE=2 SV=1,,,,,,
OG_03551,1.6383495048029657,FUN_014683-T2,Peve_00033420,Pocillopora_meandrina_HIv1___RNAseq.g22591.t1,three_way,70.162,FUN_014683-T2,Q9Y3E5,PTH2_HUMAN,,"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1)",Homo sapiens (Human),59.4,160.0,4.000000000000001e-45,182.6,"sp|Q9Y3E5|PTH2_HUMAN Peptidyl-tRNA hydrolase 2, mitochondrial OS=Homo sapiens OX=9606 GN=PTRH2 PE=1 SV=1",GO:0004045; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0010629; GO:0016020; GO:2000210; GO:2000811,apoptotic process [GO:0006915]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],peptidyl-tRNA hydrolase activity [GO:0004045],GO:0003824; GO:0005739; GO:0005829; GO:0012501; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; mitochondrion; cytosol; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03559,1.078548185524976,FUN_014706-T1,Peve_00021213,Pocillopora_meandrina_HIv1___RNAseq.g22534.t1,three_way,85.49499999999999,FUN_014706-T1,Q2KIR8,,,,,63.2,307.0,4.6e-117,422.5,"sp|Q2KIR8|TDH_BOVIN L-threonine 3-dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=TDH PE=2 SV=1",,,,,,
OG_03560,1.1236750358885703,FUN_014707-T1,Peve_00021214,Pocillopora_meandrina_HIv1___RNAseq.g22533.t1,three_way,80.39150000000001,FUN_014707-T1,P50897,PPT1_HUMAN,,Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.2) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1),Homo sapiens (Human),64.8,273.0,4.1e-106,386.0,sp|P50897|PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens OX=9606 GN=PPT1 PE=1 SV=1,GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005765; GO:0005794; GO:0005829; GO:0006897; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0030672; GO:0031579; GO:0034164; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0052816; GO:0070062; GO:0099523; GO:0120146,adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; endocytosis [GO:0006897]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601],axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; sulfatide binding [GO:0120146],GO:0003824; GO:0005576; GO:0005634; GO:0005764; GO:0005773; GO:0005794; GO:0005829; GO:0006629; GO:0006790; GO:0008289; GO:0016192; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:0061024; GO:0140096,"catalytic activity; extracellular region; nucleus; lysosome; vacuole; Golgi apparatus; cytosol; lipid metabolic process; sulfur compound metabolic process; lipid binding; vesicle-mediated transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; membrane organization; catalytic activity, acting on a protein"
OG_03565,1.323818493767917,FUN_014714-T1,Peve_00023481,Pocillopora_meandrina_HIv1___RNAseq.g22526.t1,three_way,80.59266666666667,FUN_014714-T1,Q6GQN5,PPR42_DANRE,,Protein phosphatase 1 regulatory subunit 42 (Leucine-rich repeat-containing protein 67),Danio rerio (Zebrafish) (Brachydanio rerio),66.7,252.0,2.1e-35,151.4,sp|Q6GQN5|PPR42_DANRE Protein phosphatase 1 regulatory subunit 42 OS=Danio rerio OX=7955 GN=ppp1r42 PE=2 SV=1,GO:0002177; GO:0003779; GO:0005737; GO:0005813; GO:0005815; GO:0015630; GO:0015631; GO:0070840,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815],actin binding [GO:0003779]; dynein complex binding [GO:0070840]; tubulin binding [GO:0015631],GO:0005815; GO:0005856; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton; cytoskeletal protein binding; organelle
OG_03574,1.549811822870447,FUN_014728-T1,Peve_00009505,Pocillopora_meandrina_HIv1___RNAseq.g22491.t1,three_way,50.2435,,,,,,,,,,,,,,,,,
OG_03581,1.420192687215727,FUN_014736-T1,Peve_00010443,Pocillopora_meandrina_HIv1___RNAseq.g22481.t1,three_way,65.606,,,,,,,,,,,,,,,,,
OG_03616,1.0420717057646596,FUN_014798-T1,Peve_00028870,Pocillopora_meandrina_HIv1___RNAseq.g22416.t1,three_way,83.49866666666667,FUN_014798-T1,O00560,SDCB1_HUMAN,,Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),Homo sapiens (Human),53.2,301.0,5.7e-84,312.4,sp|O00560|SDCB1_HUMAN Syntenin-1 OS=Homo sapiens OX=9606 GN=SDCBP PE=1 SV=1,GO:0000122; GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007265; GO:0007268; GO:0007346; GO:0008093; GO:0008284; GO:0010718; GO:0016020; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0035556; GO:0035578; GO:0042327; GO:0042470; GO:0042802; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046982; GO:0070062; GO:0072562; GO:0140311; GO:1903543; GO:1903553; GO:1903561,"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]",adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],"cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; syndecan binding [GO:0045545]",GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0007010; GO:0008289; GO:0023052; GO:0031410; GO:0043226; GO:0060090; GO:0140313,extracellular region; extracellular space; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; lipid binding; signaling; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular sequestering activity
OG_03627,1.6034870648573467,FUN_014818-T1,Peve_00038833,Pocillopora_meandrina_HIv1___RNAseq.g22396.t1,three_way,36.711666666666666,,,,,,,,,,,,,,,,,
OG_03671,1.19406217288012,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_03683,1.050718435655151,FUN_014942-T1,Peve_00037148,Pocillopora_meandrina_HIv1___RNAseq.g21099.t1,three_way,86.43466666666666,FUN_014942-T1,Q8AX98,TBX1A_XENLA,,T-box transcription factor TBX1-A (T-box protein 1-A),Xenopus laevis (African clawed frog),74.0,196.0,1.3e-84,315.1,sp|Q8AX98|TBX1A_XENLA T-box transcription factor TBX1-A OS=Xenopus laevis OX=8355 GN=tbx1-a PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006357; GO:0045944; GO:0050793; GO:0060788; GO:0071300,cell fate specification [GO:0001708]; cellular response to retinoic acid [GO:0071300]; ectodermal placode formation [GO:0060788]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_03696,1.0837946892378627,FUN_014965-T1,Peve_00006259,Pocillopora_meandrina_HIv1___RNAseq.g21129.t1,three_way,85.602,FUN_014965-T1,Q8TBY9,,,,,45.2,938.0,2.5999999999999998e-244,846.7,sp|Q8TBY9|CF251_HUMAN Cilia- and flagella-associated protein 251 OS=Homo sapiens OX=9606 GN=CFAP251 PE=1 SV=2,,,,,,
OG_03703,1.0410870448112712,FUN_014975-T1,Peve_00024846,Pocillopora_meandrina_HIv1___RNAseq.g21114.t1,three_way,68.426,FUN_014975-T1,Q6DGR4,,,,,47.2,343.0,1.5e-86,321.2,sp|Q6DGR4|HGH1_DANRE Protein HGH1 homolog OS=Danio rerio OX=7955 GN=hgh1 PE=2 SV=1,,,,,,
OG_03722,1.065376448711376,FUN_015007-T1,Peve_00034683,Pocillopora_meandrina_HIv1___RNAseq.g21247.t1,three_way,90.045,FUN_015007-T1,A6NIH7,U119B_HUMAN,,Protein unc-119 homolog B,Homo sapiens (Human),68.4,193.0,2.3000000000000002e-74,280.0,sp|A6NIH7|U119B_HUMAN Protein unc-119 homolog B OS=Homo sapiens OX=9606 GN=UNC119B PE=1 SV=1,GO:0005829; GO:0005929; GO:0007399; GO:0008289; GO:0035869; GO:0042953; GO:0060271,cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytosol; cilium; lipid binding; organelle; cilium organization; anatomical structure development
OG_03768,1.1024498742486804,FUN_015096-T1,Peve_00043816,Pocillopora_meandrina_HIv1___RNAseq.g22282.t2,three_way,74.82266666666666,,,,,,,,,,,,,,,,,
OG_03791,1.443146319330637,FUN_015156-T2,Peve_00001867,Pocillopora_meandrina_HIv1___RNAseq.g21763.t1,three_way,63.6845,FUN_015156-T2,Q6NS15,MED15_XENLA,,Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (xARC105) (Mediator complex subunit 15),Xenopus laevis (African clawed frog),37.3,314.0,2.2e-45,185.3,sp|Q6NS15|MED15_XENLA Mediator of RNA polymerase II transcription subunit 15 OS=Xenopus laevis OX=8355 GN=med15 PE=1 SV=1,GO:0003712; GO:0005654; GO:0005737; GO:0006355; GO:0070847,regulation of DNA-templated transcription [GO:0006355],core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654],transcription coregulator activity [GO:0003712],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_03845,1.5029685056197444,FUN_015318-T1,Peve_00023982,Pocillopora_meandrina_HIv1___RNAseq.g21728.t1,three_way,82.93366666666667,FUN_015318-T1,Q5QNI2,,,,,31.0,532.0,4.7999999999999997e-54,213.8,sp|Q5QNI2|NCL1_ORYSJ Sodium/calcium exchanger NCL1 OS=Oryza sativa subsp. japonica OX=39947 GN=NCL1 PE=2 SV=1,,,,,,
OG_03864,1.3111288949334448,FUN_015372-T1,Peve_00000220,Pocillopora_meandrina_HIv1___RNAseq.g21694.t1,three_way,63.956,FUN_015372-T1,Q9H6I2,SOX17_HUMAN,,Transcription factor SOX-17,Homo sapiens (Human),47.8,178.0,6.5e-29,129.8,sp|Q9H6I2|SOX17_HUMAN Transcription factor SOX-17 OS=Homo sapiens OX=9606 GN=SOX17 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001570; GO:0001656; GO:0001706; GO:0001714; GO:0001828; GO:0001947; GO:0003142; GO:0003143; GO:0003151; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007493; GO:0007507; GO:0008013; GO:0010467; GO:0010628; GO:0016055; GO:0021903; GO:0023019; GO:0030308; GO:0031648; GO:0035050; GO:0042074; GO:0043279; GO:0045732; GO:0045893; GO:0045944; GO:0045995; GO:0048617; GO:0048866; GO:0050821; GO:0060214; GO:0060913; GO:0060914; GO:0060956; GO:0061009; GO:0061010; GO:0061031; GO:0061629; GO:0072091; GO:0072189; GO:0090090; GO:1903226; GO:1990830; GO:2000035; GO:2000043; GO:2000738,angiogenesis [GO:0001525]; cardiac cell fate determination [GO:0060913]; cardiogenic plate morphogenesis [GO:0003142]; cell migration involved in gastrulation [GO:0042074]; cellular response to leukemia inhibitory factor [GO:1990830]; common bile duct development [GO:0061009]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cell differentiation [GO:0060956]; endocardium formation [GO:0060214]; endoderm formation [GO:0001706]; endodermal cell fate determination [GO:0007493]; endodermal cell fate specification [GO:0001714]; endodermal digestive tract morphogenesis [GO:0061031]; gallbladder development [GO:0061010]; gene expression [GO:0010467]; heart development [GO:0007507]; heart formation [GO:0060914]; heart looping [GO:0001947]; inner cell mass cellular morphogenesis [GO:0001828]; metanephros development [GO:0001656]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; outflow tract morphogenesis [GO:0003151]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of cardiac cell fate specification [GO:2000043]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of stem cell division [GO:2000035]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; rostrocaudal neural tube patterning [GO:0021903]; signal transduction involved in regulation of gene expression [GO:0023019]; spermatogenesis [GO:0007283]; stem cell fate specification [GO:0048866]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_03869,2.216318962760689,FUN_015381-T1,Peve_00000227,Pocillopora_meandrina_HIv1___TS.g26436.t1,three_way,62.752,,,,,,,,,,,,,,,,,
OG_03880,1.31439376867795,FUN_015414-T1,Peve_00000229,Pocillopora_meandrina_HIv1___TS.g26435.t1,three_way,64.94816666666667,FUN_015414-T1,Q9Z2W8,,,,,38.5,436.0,1.3e-81,305.4,sp|Q9Z2W8|GRIA4_MOUSE Glutamate receptor 4 OS=Mus musculus OX=10090 GN=Gria4 PE=1 SV=2,,,,,,
OG_03906,1.2443337979641855,FUN_015982-T1,Peve_00024012,Pocillopora_meandrina_HIv1___RNAseq.g21404.t2,three_way,57.955,FUN_015982-T1,Q00174,LAMA_DROME,,Laminin subunit alpha (Laminin A chain),Drosophila melanogaster (Fruit fly),29.8,729.0,2.6e-88,330.1,sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2,GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711,"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021],extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048856; GO:0098542,immune system process; structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism
OG_03909,1.0905621169769806,FUN_015985-T1,Peve_00024008,Pocillopora_meandrina_HIv1___RNAseq.g21401.t1,three_way,57.967666666666666,,,,,,,,,,,,,,,,,
OG_03910,1.2114326953068444,FUN_015986-T1,Peve_00024004,Pocillopora_meandrina_HIv1___RNAseq.g21398.t1,three_way,64.2585,,,,,,,,,,,,,,,,,
OG_03919,1.2663308295359903,FUN_016017-T1,Peve_00004545,Pocillopora_meandrina_HIv1___TS.g26118.t2,three_way,74.83916666666667,FUN_016017-T1,Q9QZB0,RGS17_MOUSE,,Regulator of G-protein signaling 17 (RGS17) (Regulator of Gz-selective protein signaling 2),Mus musculus (Mouse),49.4,89.0,2.6e-18,93.6,sp|Q9QZB0|RGS17_MOUSE Regulator of G-protein signaling 17 OS=Mus musculus OX=10090 GN=Rgs17 PE=1 SV=1,GO:0001975; GO:0005096; GO:0005634; GO:0005737; GO:0007186; GO:0009968; GO:0016020; GO:0043005; GO:0045202,G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; response to amphetamine [GO:0001975],cytoplasm [GO:0005737]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202],GTPase activator activity [GO:0005096],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_03928,1.2823345436064568,FUN_016043-T1,Peve_00011803,Pocillopora_meandrina_HIv1___RNAseq.g21644.t1,three_way,70.11666666666666,,,,,,,,,,,,,,,,,
OG_03931,1.216552753967778,FUN_016047-T2,Peve_00011791,Pocillopora_meandrina_HIv1___RNAseq.g21637.t1,three_way,75.40733333333333,FUN_016047-T2,O43272,PROD_HUMAN,,"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein)",Homo sapiens (Human),49.1,556.0,4.5e-144,513.1,"sp|O43272|PROD_HUMAN Proline dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PRODH PE=1 SV=4",GO:0004657; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006560; GO:0006562; GO:0008631; GO:0010133; GO:0019470; GO:0043231; GO:0071949; GO:1903376,4-hydroxyproline catabolic process [GO:0019470]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376],intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657],GO:0003824; GO:0005654; GO:0005739; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_03932,1.0576033902513358,FUN_016048-T1,Peve_00011790,Pocillopora_meandrina_HIv1___RNAseq.g26043.t1,three_way,52.87083333333334,,,,,,,,,,,,,,,,,
OG_03933,1.5664128522675085,FUN_016049-T1,Peve_00011814,Pocillopora_meandrina_HIv1___RNAseq.g21636.t1,three_way,52.112,,,,,,,,,,,,,,,,,
OG_03934,1.2285281006514304,FUN_016050-T1,Peve_00011794,Pocillopora_meandrina_HIv1___RNAseq.g21635.t1,three_way,66.26,,,,,,,,,,,,,,,,,
OG_03950,1.3771489187823835,FUN_016089-T1,Peve_00013364,Pocillopora_meandrina_HIv1___RNAseq.g21562.t1,three_way,69.75566666666667,FUN_016089-T1,Q4V9Y5,,,,,40.3,201.0,9.1e-34,146.4,sp|Q4V9Y5|CRLD2_XENTR Cysteine-rich secretory protein LCCL domain-containing 2 OS=Xenopus tropicalis OX=8364 GN=crispld2 PE=2 SV=1,,,,,,
OG_03956,1.240135599079227,FUN_016101-T1,Peve_00010770,Pocillopora_meandrina_HIv1___RNAseq.g21591.t1,three_way,72.2,FUN_016101-T1,Q9W704,,,,,35.9,234.0,6.9e-30,132.5,sp|Q9W704|RIPA_XENLA RPA-interacting protein A OS=Xenopus laevis OX=8355 GN=rpain-a PE=1 SV=1,,,,,,
OG_03963,1.15012952377861,FUN_016112-T1,Peve_00013360,Pocillopora_meandrina_HIv1___RNAseq.g21551.t1,three_way,44.34066666666666,,,,,,,,,,,,,,,,,
OG_03964,1.0428931555198522,FUN_016113-T1,Peve_00013363,Pocillopora_meandrina_HIv1___RNAseq.g21560.t1,three_way,46.34166666666667,,,,,,,,,,,,,,,,,
OG_04001,1.3385290281129747,FUN_016296-T1,Peve_00043168,Pocillopora_meandrina_HIv1___RNAseq.g503.t1,three_way,73.475,FUN_016296-T1,Q99758,ABCA3_HUMAN,,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],Homo sapiens (Human),35.3,1952.0,2.1e-296,1020.8,sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2,GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140,lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019],GO:0003824; GO:0005215; GO:0005615; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; extracellular space; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_04008,1.4530177333032517,FUN_016308-T1,Peve_00032290,Pocillopora_meandrina_HIv1___RNAseq.g10037.t1,three_way,81.12333333333333,,,,,,,,,,,,,,,,,
OG_04056,1.1473542618699966,FUN_016375-T1,Peve_00022921,Pocillopora_meandrina_HIv1___RNAseq.16382_t,three_way,83.09666666666666,FUN_016375-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),65.5,87.0,8.3e-25,115.5,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04072,1.156050462725693,FUN_016393-T1,Peve_00006406,Pocillopora_meandrina_HIv1___RNAseq.g9756.t1,three_way,90.81433333333334,FUN_016393-T1,Q3T087,,,,,81.8,176.0,2.5e-82,306.2,sp|Q3T087|RL11_BOVIN Large ribosomal subunit protein uL5 OS=Bos taurus OX=9913 GN=RPL11 PE=2 SV=3,,,,,,
OG_04096,1.5496243007744583,FUN_016436-T1,Peve_00002886,Pocillopora_meandrina_HIv1___TS.g23399.t2,three_way,66.57249999999999,FUN_016436-T1,P05455,LA_HUMAN,,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),Homo sapiens (Human),46.4,196.0,2.2e-38,160.6,sp|P05455|LA_HUMAN Lupus La protein OS=Homo sapiens OX=9606 GN=SSB PE=1 SV=2,GO:0000049; GO:0000781; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0010494; GO:0042780; GO:0045727; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904,histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; positive regulation of translation [GO:0045727]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]",mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005829; GO:0006399; GO:0006913; GO:0016071; GO:0043226,RNA binding; nucleus; cytosol; tRNA metabolic process; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_04112,1.326485226114218,FUN_016487-T1,Peve_00001328,Pocillopora_meandrina_HIv1___RNAseq.g9628.t1,three_way,64.712,FUN_016487-T1,Q28ET4,VENT1_XENTR,,Homeobox protein vent1 (Vent-1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),35.8,137.0,9.6e-12,72.0,sp|Q28ET4|VENT1_XENTR Homeobox protein vent1 OS=Xenopus tropicalis OX=8364 GN=vent1 PE=2 SV=1,GO:0000122; GO:0000981; GO:0001707; GO:0005634; GO:0030509; GO:0043565; GO:0045892; GO:0048264,BMP signaling pathway [GO:0030509]; determination of ventral identity [GO:0048264]; mesoderm formation [GO:0001707]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04122,1.0834537719834836,FUN_016503-T1,Peve_00016813,Pocillopora_meandrina_HIv1___RNAseq.g9722.t1,three_way,69.429,FUN_016503-T1,Q32LQ4,,,,,58.3,336.0,3.3e-117,422.9,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_04129,1.230626342609086,FUN_016578-T1,Peve_00002516,Pocillopora_meandrina_HIv1___RNAseq.g9694.t1,three_way,71.17683333333333,FUN_016578-T1,Q8K4Q6,NEIL1_MOUSE,,Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (Nei homolog 1) (NEH1) (Nei-like protein 1),Mus musculus (Mouse),49.5,307.0,1.9000000000000002e-80,301.2,sp|Q8K4Q6|NEIL1_MOUSE Endonuclease 8-like 1 OS=Mus musculus OX=10090 GN=Neil1 PE=2 SV=3,GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0006281; GO:0006284; GO:0006979; GO:0008270; GO:0016829; GO:0019104; GO:0140078,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; lyase activity [GO:0016829]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; microtubule organizing center; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_04193,1.123519208277379,FUN_016717-T1,Peve_00014667,Pocillopora_meandrina_HIv1___RNAseq.g226.t1,three_way,70.61533333333334,,,,,,,,,,,,,,,,,
OG_04204,1.4293342964282734,FUN_016759-T1,Peve_00003676,Pocillopora_meandrina_HIv1___RNAseq.g14956.t1,three_way,68.49566666666666,FUN_016759-T1,Q2QUN2,,,,,25.6,629.0,2.7e-41,172.6,sp|Q2QUN2|LAC24_ORYSJ Laccase-24 OS=Oryza sativa subsp. japonica OX=39947 GN=LAC24 PE=2 SV=1,,,,,,
OG_04213,1.480021938310785,FUN_016850-T1,Peve_00018595,Pocillopora_meandrina_HIv1___RNAseq.g15658.t1,three_way,64.21766666666667,,,,,,,,,,,,,,,,,
OG_04219,1.828747679733529,FUN_016970-T1,Peve_00025293,Pocillopora_meandrina_HIv1___RNAseq.g9903.t2,three_way,56.20816666666666,,,,,,,,,,,,,,,,,
OG_04223,1.0472023073405454,FUN_016984-T1,Peve_00025278,Pocillopora_meandrina_HIv1___TS.g23429.t1,three_way,66.937,FUN_016984-T1,Q96GW7,,,,,31.6,133.0,2.6e-11,71.6,sp|Q96GW7|PGCB_HUMAN Brevican core protein OS=Homo sapiens OX=9606 GN=BCAN PE=1 SV=2,,,,,,
OG_04224,1.1765426633387297,FUN_016988-T1,Peve_00025276,Pocillopora_meandrina_HIv1___RNAseq.g9895.t1,three_way,70.32283333333334,FUN_016988-T1,Q8CJ69,BMPER_MOUSE,,BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (mCV2),Mus musculus (Mouse),37.7,446.0,2.6e-92,340.9,sp|Q8CJ69|BMPER_MOUSE BMP-binding endothelial regulator protein OS=Mus musculus OX=10090 GN=Bmper PE=1 SV=1,GO:0001657; GO:0002043; GO:0005576; GO:0005615; GO:0010594; GO:0030509; GO:0030514; GO:0032880; GO:0042118; GO:0048839; GO:0060391; GO:0060395; GO:0062023; GO:0070374; GO:1903672,blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization [GO:0032880]; SMAD protein signal transduction [GO:0060395]; ureteric bud development [GO:0001657],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615],,GO:0005576; GO:0005615; GO:0048856,extracellular region; extracellular space; anatomical structure development
OG_04230,1.125924114878426,FUN_017693-T1,Peve_00030752,Pocillopora_meandrina_HIv1___RNAseq.g23495.t1,three_way,47.43216666666667,,,,,,,,,,,,,,,,,
OG_04239,1.0443380735905832,FUN_017760-T1,Peve_00037315,Pocillopora_meandrina_HIv1___RNAseq.g439.t1,three_way,80.33866666666667,,,,,,,,,,,,,,,,,
OG_04264,1.2424051281924051,FUN_017814-T1,Peve_00006860,Pocillopora_meandrina_HIv1___RNAseq.g9542.t1,three_way,84.417,FUN_017814-T1,Q91029,WNT1_CHICK,,Protein Wnt-1,Gallus gallus (Chicken),51.2,283.0,2.4e-87,323.6,sp|Q91029|WNT1_CHICK Protein Wnt-1 OS=Gallus gallus OX=9031 GN=WNT1 PE=1 SV=3,GO:0005102; GO:0005576; GO:0006915; GO:0009953; GO:0016055; GO:0030509; GO:0031334; GO:0048263,apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of protein-containing complex assembly [GO:0031334]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],signaling receptor binding [GO:0005102],GO:0005576; GO:0012501,extracellular region; programmed cell death
OG_04266,1.8366862263586257,FUN_017816-T1,Peve_00006857,Pocillopora_meandrina_HIv1___RNAseq.g9540.t1,three_way,72.20233333333334,FUN_017816-T1,Q2LMP1,WNT3A_CHICK,,Protein Wnt-3a,Gallus gallus (Chicken),41.7,314.0,2.3000000000000002e-71,270.8,sp|Q2LMP1|WNT3A_CHICK Protein Wnt-3a OS=Gallus gallus OX=9031 GN=WNT3A PE=1 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0005640; GO:0005783; GO:0005829; GO:0005886; GO:0009953; GO:0010628; GO:0010831; GO:0030182; GO:0030509; GO:0035108; GO:0040036; GO:0042472; GO:0045165; GO:0045663; GO:0045743; GO:0045944; GO:0048263; GO:0050679; GO:0060070; GO:0060173; GO:0060828; GO:0061303; GO:0090263,BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cornea development in camera-type eye [GO:0061303]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; endoplasmic reticulum; cytosol; plasma membrane; regulation of DNA-templated transcription; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_04272,1.1595380344435149,FUN_017831-T1,Peve_00029496,Pocillopora_meandrina_HIv1___TS.g23177.t1,three_way,86.089,,,,,,,,,,,,,,,,,
OG_04282,1.063617109865173,FUN_017845-T1,Peve_00018633,Pocillopora_meandrina_HIv1___RNAseq.g9586.t1,three_way,63.23116666666667,,,,,,,,,,,,,,,,,
OG_04305,1.093924708721539,FUN_017890-T1,Peve_00019164,Pocillopora_meandrina_HIv1___RNAseq.g9666.t1,three_way,81.693,FUN_017890-T1,Q5EAB6,PMGT1_BOVIN,,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)",Bos taurus (Bovine),52.1,657.0,1.9e-201,703.7,"sp|Q5EAB6|PMGT1_BOVIN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Bos taurus OX=9913 GN=POMGNT1 PE=2 SV=1",GO:0000139; GO:0006493; GO:0008375; GO:0016020; GO:0016266; GO:0030145; GO:0030246; GO:0047223,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139]; membrane [GO:0016020],"acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]",GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04311,1.266680277599357,FUN_017899-T1,Peve_00000241,Pocillopora_meandrina_HIv1___RNAseq.g341.t1,three_way,85.13083333333333,FUN_017899-T1,Q8ND07,,,,,40.7,477.0,4.6e-76,287.0,sp|Q8ND07|BBOF1_HUMAN Basal body-orientation factor 1 OS=Homo sapiens OX=9606 GN=BBOF1 PE=1 SV=3,,,,,,
OG_04331,1.0011330035840575,FUN_017939-T1,Peve_00001588,Pocillopora_meandrina_HIv1___RNAseq.g219.t1,three_way,53.27133333333334,FUN_017939-T1,Q6P0D7,,,,,42.1,449.0,7.2e-89,330.1,sp|Q6P0D7|MPP7_DANRE MAGUK p55 subfamily member 7 OS=Danio rerio OX=7955 GN=mpp7 PE=1 SV=1,,,,,,
OG_04333,1.0828189675473472,FUN_017941-T1,Peve_00001585,Pocillopora_meandrina_HIv1___RNAseq.g221.t1,three_way,68.06433333333334,FUN_017941-T1,Q5R5J7,,,,,35.6,331.0,2.4e-51,204.1,sp|Q5R5J7|TBCC_PONAB Tubulin-specific chaperone C OS=Pongo abelii OX=9601 GN=TBCC PE=2 SV=1,,,,,,
OG_04338,1.416676817212498,FUN_017952-T1,Peve_00001586,Pocillopora_meandrina_HIv1___RNAseq.g224.t1,three_way,96.399,FUN_017952-T1,Q7T1R4,,,,,91.5,117.0,8.8e-61,235.3,sp|Q7T1R4|FOXA2_XENTR Forkhead box protein A2 OS=Xenopus tropicalis OX=8364 GN=foxa2 PE=2 SV=1,,,,,,
OG_04348,1.0985074803039083,FUN_017974-T1,Peve_00027236,Pocillopora_meandrina_HIv1___RNAseq.g25289.t1,three_way,57.09133333333333,,,,,,,,,,,,,,,,,
OG_04434,1.068852925743035,FUN_018790-T1,Peve_00013151,Pocillopora_meandrina_HIv1___RNAseq.g14712.t1,three_way,68.35233333333333,,,,,,,,,,,,,,,,,
OG_04447,1.7480878687469044,FUN_018948-T1,Peve_00035804,Pocillopora_meandrina_HIv1___RNAseq.g366.t1,three_way,49.209500000000006,FUN_018948-T1,P51954,NEK1_MOUSE,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1),Mus musculus (Mouse),41.7,266.0,6.8e-57,223.8,sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2,GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007283; GO:0010212; GO:0030030; GO:0035264; GO:0046872; GO:0051301; GO:0071889; GO:0106310; GO:2000001,cell division [GO:0051301]; cell projection organization [GO:0030030]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04469,1.1531952103675744,FUN_020835-T1,Peve_00010927,Pocillopora_meandrina_HIv1___RNAseq.g20757.t2,three_way,70.56066666666666,,,,,,,,,,,,,,,,,
OG_04476,1.5331866895786554,FUN_020920-T1,Peve_00017285,Pocillopora_meandrina_HIv1___RNAseq.g15907.t1a,three_way,47.4085,FUN_020920-T1,O95450,,,,,28.7,905.0,8.1e-97,356.7,sp|O95450|ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens OX=9606 GN=ADAMTS2 PE=1 SV=2,,,,,,
OG_04504,1.0351665421699714,FUN_022016-T1,Peve_00042666,Pocillopora_meandrina_HIv1___RNAseq.g3182.t2,three_way,75.399,FUN_022016-T1,P07228,,,,,38.2,808.0,2.6e-144,514.2,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_04508,1.7137358789680015,FUN_022036-T1,Peve_00019003,Pocillopora_meandrina_HIv1___RNAseq.g9285.t1,three_way,61.077333333333335,,,,,,,,,,,,,,,,,
OG_04512,1.168669193199773,FUN_022044-T1,Peve_00007834,Pocillopora_meandrina_HIv1___RNAseq.g9290.t1,three_way,72.45516666666667,FUN_022044-T1,Q5T2R2,DPS1_HUMAN,,All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1),Homo sapiens (Human),57.9,323.0,3e-102,373.6,sp|Q5T2R2|DPS1_HUMAN All trans-polyprenyl-diphosphate synthase PDSS1 OS=Homo sapiens OX=9606 GN=PDSS1 PE=1 SV=1,GO:0004659; GO:0005739; GO:0005759; GO:0006744; GO:0008299; GO:0032476; GO:0032478; GO:0046872; GO:0046982; GO:0052923; GO:0097269; GO:0110142,isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; polyprenyl diphosphate synthase complex [GO:0032476]; ubiquinone biosynthesis complex [GO:0110142],all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_04515,1.2837773935311303,FUN_022048-T1,Peve_00017132,Pocillopora_meandrina_HIv1___RNAseq.g4598.t1,three_way,56.047666666666665,FUN_022048-T1,Q7TN88,,,,,27.8,1834.0,3.2e-182,642.5,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_04536,1.113834824231995,FUN_022092-T1,Peve_00038684,Pocillopora_meandrina_HIv1___RNAseq.g4111.t1,three_way,48.881,,,,,,,,,,,,,,,,,
OG_04538,2.5441575822264624,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_04544,1.307258171109065,FUN_022106-T1,Peve_00025701,Pocillopora_meandrina_HIv1___RNAseq.g9229.t1,three_way,68.26433333333333,FUN_022106-T1,Q5E9J9,,,,,39.2,375.0,1.3e-70,268.5,sp|Q5E9J9|STRAA_BOVIN STE20-related kinase adapter protein alpha OS=Bos taurus OX=9913 GN=STRADA PE=2 SV=1,,,,,,
OG_04559,1.6953363332971538,FUN_022198-T1,Peve_00038010,Pocillopora_meandrina_HIv1___RNAseq.g4797.t1,three_way,68.02633333333333,,,,,,,,,,,,,,,,,
OG_04571,1.097685906646968,FUN_022218-T1,Peve_00028321,Pocillopora_meandrina_HIv1___RNAseq.g4733.t1c,three_way,83.12133333333334,FUN_022218-T1,Q6QN10,,,,,66.3,181.0,2.9999999999999997e-47,189.9,sp|Q6QN10|NACA_CHILA Nascent polypeptide-associated complex subunit alpha OS=Chinchilla lanigera OX=34839 PE=2 SV=1,,,,,,
OG_04592,1.0829926057081765,FUN_022267-T1,Peve_00043987,Pocillopora_meandrina_HIv1___RNAseq.g4714.t2,three_way,76.18966666666667,FUN_022267-T1,Q63357,MYO1D_RAT,,Unconventional myosin-Id (Myosin heavy chain myr 4),Rattus norvegicus (Rat),52.1,637.0,3e-186,653.3,sp|Q63357|MYO1D_RAT Unconventional myosin-Id OS=Rattus norvegicus OX=10116 GN=Myo1d PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030048; GO:0030424; GO:0030673; GO:0030900; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0044853; GO:0048306; GO:0051015; GO:0061502; GO:0097440,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; early endosome to recycling endosome transport [GO:0061502]; endocytosis [GO:0006897]; forebrain development [GO:0030900]; protein transport [GO:0015031],actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904],GO:0003774; GO:0003824; GO:0005768; GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_04600,1.0968536972870426,FUN_022285-T1,Peve_00003591,Pocillopora_meandrina_HIv1___RNAseq.g4696.t1,three_way,62.73716666666667,FUN_022285-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),69.0,58.0,3.8e-17,90.1,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04609,2.2567409958760107,FUN_022305-T1,Peve_00003816,Pocillopora_meandrina_HIv1___RNAseq.g3971.t1,three_way,36.00233333333333,,,,,,,,,,,,,,,,,
OG_04610,1.335151986271985,FUN_022307-T1,Peve_00021671,Pocillopora_meandrina_HIv1___RNAseq.g4623.t1,three_way,86.57633333333334,FUN_022307-T1,Q8VEE0,,,,,65.1,212.0,1e-75,284.6,sp|Q8VEE0|RPE_MOUSE Ribulose-phosphate 3-epimerase OS=Mus musculus OX=10090 GN=Rpe PE=1 SV=1,,,,,,
OG_04617,1.1374230089302348,FUN_022316-T1,Peve_00021693,Pocillopora_meandrina_HIv1___RNAseq.g4633.t1,three_way,36.72766666666666,,,,,,,,,,,,,,,,,
OG_04618,2.3848095349562004,FUN_022319-T1,Peve_00021701,Pocillopora_meandrina_HIv1___TS.g22054.t1,three_way,56.806333333333335,,,,,,,,,,,,,,,,,
OG_04621,1.227067040683653,FUN_022323-T1,Peve_00021645,Pocillopora_meandrina_HIv1___RNAseq.g4644.t1,three_way,86.14483333333334,,,,,,,,,,,,,,,,,
OG_04627,1.0288063917869013,FUN_022340-T1,Peve_00028608,Pocillopora_meandrina_HIv1___RNAseq.g4654.t1,three_way,62.08733333333333,FUN_022340-T1,Q63258,ITA7_RAT,,Integrin alpha-7 (H36-alpha7) [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],Rattus norvegicus (Rat),27.7,1149.0,3.1e-87,325.1,sp|Q63258|ITA7_RAT Integrin alpha-7 OS=Rattus norvegicus OX=10116 GN=Itga7 PE=1 SV=2,GO:0005178; GO:0005737; GO:0005927; GO:0007155; GO:0007229; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016477; GO:0031594; GO:0033627; GO:0034113; GO:0034677; GO:0035987; GO:0042383; GO:0043236; GO:0044877; GO:0046872; GO:0048514; GO:0050839; GO:0050900; GO:0098609,blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519],cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integrin alpha7-beta1 complex [GO:0034677]; integrin complex [GO:0008305]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383],cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0002376; GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0048870,immune system process; plasma membrane; cell adhesion; cell differentiation; anatomical structure development; cell motility
OG_04630,1.0748354838134946,FUN_022343-T1,Peve_00028597,Pocillopora_meandrina_HIv1___RNAseq.g4657.t1,three_way,58.79733333333333,,,,,,,,,,,,,,,,,
OG_04638,1.189438198616103,FUN_022364-T3,Peve_00021992,Pocillopora_meandrina_HIv1___RNAseq.g4595.t2,three_way,67.867,FUN_022364-T3,P18461,,,,,32.1,808.0,7.1e-87,323.6,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_04651,2.191108025103835,FUN_022386-T3,Peve_00037603,Pocillopora_meandrina_HIv1___RNAseq.g9310.t1,three_way,63.92666666666666,FUN_022386-T3,B8V7S0,,,,,48.6,251.0,2.8e-62,241.5,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_04675,1.0899811578561447,FUN_022437-T1,Peve_00017892,Pocillopora_meandrina_HIv1___RNAseq.g4335.t1,three_way,81.93833333333333,FUN_022437-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),42.7,450.0,4.5e-92,340.1,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_04677,1.711578431090981,FUN_022446-T1,Peve_00037587,Pocillopora_meandrina_HIv1___RNAseq.g4330.t1,three_way,71.33800000000001,FUN_022446-T1,Q29496,CP3AO_SHEEP,,Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24),Ovis aries (Sheep),38.8,485.0,1.4999999999999999e-92,341.7,sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1,GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0016712; GO:0020037; GO:0050649; GO:0070989,oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; testosterone 6-beta-hydroxylase activity [GO:0050649]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_04693,1.6230031378808465,FUN_022485-T1,Peve_00002925,Pocillopora_meandrina_HIv1___RNAseq.g4293.t1,three_way,88.12733333333333,,,,,,,,,,,,,,,,,
OG_04737,1.7152835432630833,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_04739,1.2670206528234804,FUN_022615-T1,Peve_00012268,Pocillopora_meandrina_HIv1___RNAseq.g4395.t1,three_way,62.804,FUN_022615-T1,P79691,SHH_CARAU,,Sonic hedgehog protein (SHHA) (EC 3.1.-.-) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) [Cleaved into: Sonic hedgehog protein A N-product (Shh N-terminal processed signaling domains) (ShhNp) (Sonic hedgehog protein N-product) (ShhN)],Carassius auratus (Goldfish),44.2,398.0,9.4e-82,305.4,sp|P79691|SHH_CARAU Sonic hedgehog protein OS=Carassius auratus OX=7957 GN=shha PE=3 SV=3,GO:0000139; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005789; GO:0005886; GO:0007224; GO:0007267; GO:0007389; GO:0008233; GO:0009888; GO:0010468; GO:0016539; GO:0016540; GO:0030182; GO:0035295; GO:0042127; GO:0045880; GO:0048468; GO:0048513; GO:0048709; GO:0050793; GO:0097264; GO:0140853,animal organ development [GO:0048513]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; pattern specification process [GO:0007389]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of cell population proliferation [GO:0042127]; regulation of developmental process [GO:0050793]; regulation of gene expression [GO:0010468]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888]; tube development [GO:0035295],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233],GO:0003824; GO:0005615; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0030154; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; transferase activity; hydrolase activity; signaling; cell differentiation; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_04747,1.2274649975952403,FUN_022630-T1,Peve_00012283,Pocillopora_meandrina_HIv1___RNAseq.g2910.t1,three_way,68.43933333333334,FUN_022630-T1,P07228,,,,,38.2,815.0,1.2e-144,515.4,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_04783,1.1804242891457226,FUN_022694-T1,Peve_00045101,Pocillopora_meandrina_HIv1___RNAseq.g4831.t1,three_way,58.6035,,,,,,,,,,,,,,,,,
OG_04796,1.3878575937871156,FUN_022715-T1,Peve_00016563,Pocillopora_meandrina_HIv1___RNAseq.g3160.t1,three_way,74.70833333333333,FUN_022715-T1,O88794,,,,,52.1,234.0,1.4e-65,251.1,sp|O88794|PNPO_RAT Pyridoxine-5'-phosphate oxidase OS=Rattus norvegicus OX=10116 GN=Pnpo PE=1 SV=1,,,,,,
OG_04801,1.3570974513381036,FUN_022758-T1,Peve_00027945,Pocillopora_meandrina_HIv1___RNAseq.g3153.t1,three_way,64.09166666666667,,,,,,,,,,,,,,,,,
OG_04825,1.1308715804440392,FUN_022817-T1,Peve_00014997,Pocillopora_meandrina_HIv1___TS.g9632.t1,three_way,48.804,,,,,,,,,,,,,,,,,
OG_04833,1.4291033663650845,FUN_022827-T1,Peve_00028898,Pocillopora_meandrina_HIv1___RNAseq.g3431.t1,three_way,84.11833333333334,FUN_022827-T1,Q0IJ33,,,,,54.4,362.0,6.2e-117,422.2,sp|Q0IJ33|TM129_XENTR E3 ubiquitin-protein ligase TM129 OS=Xenopus tropicalis OX=8364 GN=tmem129 PE=2 SV=1,,,,,,
OG_04843,1.1304847766243042,FUN_022852-T1,Peve_00028878,Pocillopora_meandrina_HIv1___RNAseq.g3393.t1,three_way,64.0195,FUN_022852-T1,Q5ZJS6,,,,,34.9,129.0,1.5e-07,57.4,sp|Q5ZJS6|PAIP2_CHICK Polyadenylate-binding protein-interacting protein 2 OS=Gallus gallus OX=9031 GN=PAIP2 PE=2 SV=1,,,,,,
OG_04862,1.479960475722694,FUN_022879-T1,Peve_00012290,Pocillopora_meandrina_HIv1___RNAseq.g3622.t1,three_way,61.50833333333333,,,,,,,,,,,,,,,,,
OG_04870,1.1544859693971323,FUN_022897-T1,Peve_00001717,Pocillopora_meandrina_HIv1___RNAseq.g3698.t1,three_way,60.53266666666666,FUN_022897-T1,Q0VCR4,PPR3C_BOVIN,,Protein phosphatase 1 regulatory subunit 3C (Protein phosphatase 1 regulatory subunit 5) (PP1 subunit R5) (Protein targeting to glycogen) (PTG),Bos taurus (Bovine),35.8,176.0,3e-26,120.2,sp|Q0VCR4|PPR3C_BOVIN Protein phosphatase 1 regulatory subunit 3C OS=Bos taurus OX=9913 GN=PPP1R3C PE=2 SV=1,GO:0000164; GO:0005829; GO:0005977; GO:0005978; GO:0005979; GO:0008157; GO:0019903; GO:0060090; GO:2001069,glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979],cytosol [GO:0005829]; protein phosphatase type 1 complex [GO:0000164],glycogen binding [GO:2001069]; molecular adaptor activity [GO:0060090]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903],GO:0005829; GO:0005975; GO:0006091; GO:0060090,cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; molecular adaptor activity
OG_04890,1.6374856336029138,FUN_022933-T1,Peve_00016029,Pocillopora_meandrina_HIv1___RNAseq.g3734.t1,three_way,55.45366666666667,,,,,,,,,,,,,,,,,
OG_04932,1.0581282759582422,FUN_023000-T1,Peve_00024659,Pocillopora_meandrina_HIv1___RNAseq.g3813.t1,three_way,53.00183333333333,FUN_023000-T1,Q90Z00,FGR1A_DANRE,,Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,804.0,7.2e-136,486.5,sp|Q90Z00|FGR1A_DANRE Fibroblast growth factor receptor 1-A OS=Danio rerio OX=7955 GN=fgfr1a PE=1 SV=2,GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043410; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699,anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04964,1.225935020279778,FUN_023063-T1,Peve_00024670,Pocillopora_meandrina_HIv1___RNAseq.g3882.t1,three_way,80.55416666666666,FUN_023063-T1,Q66L33,,,,,68.8,192.0,2e-75,283.9,sp|Q66L33|MK16A_XENLA Protein MAK16 homolog A OS=Xenopus laevis OX=8355 GN=mak16-a PE=2 SV=1,,,,,,
OG_04979,1.2596379095402923,FUN_023099-T1,Peve_00006979,Pocillopora_meandrina_HIv1___TS.g4182.t1,three_way,64.4485,FUN_023099-T1,P55115,,,,,34.9,278.0,7e-41,171.0,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_04985,1.0093116179285355,FUN_023112-T1,Peve_00045022,Pocillopora_meandrina_HIv1___RNAseq.g1699.t1,three_way,49.251,,,,,,,,,,,,,,,,,
OG_04997,1.6369650535624125,FUN_023132-T1,Peve_00008526,Pocillopora_meandrina_HIv1___RNAseq.g1755.t1,three_way,43.72866666666667,FUN_023132-T1,O16264,,,,,38.7,75.0,4.9e-09,62.4,sp|O16264|PEBPH_CAEEL Phosphatidylethanolamine-binding protein homolog F40A3.3 OS=Caenorhabditis elegans OX=6239 GN=F40A3.3 PE=3 SV=1,,,,,,
OG_04999,2.05829831576302,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05025,1.0131634175711732,FUN_023188-T1,Peve_00009990,Pocillopora_meandrina_HIv1___RNAseq.g670.t1,three_way,70.7675,,,,,,,,,,,,,,,,,
OG_05031,1.0012691562511675,FUN_023205-T1,Peve_00010002,Pocillopora_meandrina_HIv1___RNAseq.g681.t2,three_way,61.8175,FUN_023205-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),41.3,150.0,3.5e-26,119.8,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_05071,1.6369127066940434,FUN_023293-T1,Peve_00003652,Pocillopora_meandrina_HIv1___RNAseq.g23035.t1,three_way,68.382,,,,,,,,,,,,,,,,,
OG_05072,1.3593991998150807,FUN_023298-T1,Peve_00041305,Pocillopora_meandrina_HIv1___RNAseq.g17780.t1,three_way,76.65966666666667,FUN_023298-T1,Q5XIH9,HPDL_RAT,,4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) (EC 1.13.11.46) (Glyoxalase domain-containing protein 1),Rattus norvegicus (Rat),32.8,390.0,1.4e-48,195.3,sp|Q5XIH9|HPDL_RAT 4-hydroxyphenylpyruvate dioxygenase-like protein OS=Rattus norvegicus OX=10116 GN=Hpdl PE=2 SV=1,GO:0003868; GO:0005739; GO:0009072; GO:0046872; GO:0050585,aromatic amino acid metabolic process [GO:0009072],mitochondrion [GO:0005739],4-hydroxymandelate synthase activity [GO:0050585]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; organelle
OG_05073,1.000691751804492,FUN_023299-T2,Peve_00041307,Pocillopora_meandrina_HIv1___RNAseq.g17779.t1,three_way,85.93666666666667,FUN_023299-T2,Q5E9M8,,,,,70.0,210.0,2.5e-82,306.6,sp|Q5E9M8|SFXN1_BOVIN Sideroflexin-1 OS=Bos taurus OX=9913 GN=SFXN1 PE=2 SV=3,,,,,,
OG_05082,1.0336504392895347,FUN_023314-T1,Peve_00017882,Pocillopora_meandrina_HIv1___RNAseq.g17767.t1,three_way,79.65150000000001,FUN_023314-T1,P47870,GBRB2_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Homo sapiens (Human),40.5,321.0,5.9e-61,236.5,sp|P47870|GBRB2_HUMAN Gamma-aminobutyric acid receptor subunit beta-2 OS=Homo sapiens OX=9606 GN=GABRB2 PE=1 SV=2,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0022851; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0051932; GO:0060119; GO:0060384; GO:0070062; GO:0071420; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05100,1.037831858942338,FUN_023352-T1,Peve_00035608,Pocillopora_meandrina_HIv1___RNAseq.g17431.t1,three_way,88.21533333333333,FUN_023352-T1,Q8R367,,,,,42.9,161.0,3.8999999999999995e-28,126.7,sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1,,,,,,
OG_05105,1.4480655582993067,FUN_023363-T1,Peve_00005341,Pocillopora_meandrina_HIv1___RNAseq.g17541.t1,three_way,60.940666666666665,FUN_023363-T1,Q24207,BOULE_DROME,,Protein boule,Drosophila melanogaster (Fruit fly),35.0,163.0,3.5e-13,76.6,sp|Q24207|BOULE_DROME Protein boule OS=Drosophila melanogaster OX=7227 GN=bol PE=1 SV=1,GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0006417; GO:0008315; GO:0008494; GO:0030154; GO:0043204; GO:0045924; GO:0045948; GO:0048137; GO:0070935,3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perikaryon [GO:0043204],mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],GO:0003723; GO:0005634; GO:0022414; GO:0030154; GO:0043226; GO:0045182,RNA binding; nucleus; reproductive process; cell differentiation; organelle; translation regulator activity
OG_05129,1.003616956152245,FUN_023394-T2,Peve_00038661,Pocillopora_meandrina_HIv1___RNAseq.g17627.t1,three_way,62.523,FUN_023394-T2,P10746,HEM4_HUMAN,,Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase),Homo sapiens (Human),36.3,262.0,2.3e-39,164.1,sp|P10746|HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens OX=9606 GN=Mgu PE=1 SV=1,GO:0004852; GO:0005542; GO:0005739; GO:0005829; GO:0006780; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0048034; GO:0070541; GO:0071243; GO:0071418,cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780],cytosol [GO:0005829]; mitochondrion [GO:0005739],folic acid binding [GO:0005542]; uroporphyrinogen-III synthase activity [GO:0004852],GO:0003824; GO:0005739; GO:0005829; GO:0016829; GO:0043226,catalytic activity; mitochondrion; cytosol; lyase activity; organelle
OG_05183,1.442344458906699,FUN_023529-T1,Peve_00044316,Pocillopora_meandrina_HIv1___TS.g7657.t1,three_way,73.594,,,,,,,,,,,,,,,,,
OG_05192,2.0198691331177656,FUN_023558-T1,Peve_00037258,Pocillopora_meandrina_HIv1___RNAseq.g519.t1,three_way,71.653,FUN_023558-T1,P29419,,,,,46.3,67.0,8.1e-07,53.9,"sp|P29419|ATP5I_RAT ATP synthase F(0) complex subunit e, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5me PE=1 SV=3",,,,,,
OG_05198,1.5027738008374532,FUN_023578-T1,Peve_00035142,Pocillopora_meandrina_HIv1___RNAseq.g3534.t2,three_way,64.644,FUN_023578-T1,O95786,RIGI_HUMAN,,Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),Homo sapiens (Human),35.5,716.0,2.1e-106,388.7,sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2,GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005829; GO:0005856; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; cytosol; cytoskeleton; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; molecular transducer activity; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05226,2.0903841286062925,FUN_023639-T1,Peve_00027828,Pocillopora_meandrina_HIv1___RNAseq.g17814.t1c,three_way,45.796,,,,,,,,,,,,,,,,,
OG_05248,1.039001475670605,FUN_023694-T1,Peve_00017435,Pocillopora_meandrina_HIv1___RNAseq.g17612.t1,three_way,85.42266666666667,FUN_023694-T1,Q28G26,P4K2B_XENTR,,Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),61.3,434.0,4.4e-152,539.3,sp|Q28G26|P4K2B_XENTR Phosphatidylinositol 4-kinase type 2-beta OS=Xenopus tropicalis OX=8364 GN=pi4k2b PE=2 SV=1,GO:0000139; GO:0004430; GO:0005524; GO:0005789; GO:0005829; GO:0005886; GO:0031901; GO:0046854,phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016740,catalytic activity; cytosol; plasma membrane; lipid metabolic process; transferase activity
OG_05259,1.760651748361302,FUN_023765-T1,Peve_00030839,Pocillopora_meandrina_HIv1___TS.g9692.t1a,three_way,65.00833333333333,FUN_023765-T1,P17453,,,,,32.3,473.0,4.500000000000001e-65,250.4,sp|P17453|BPI_BOVIN Bactericidal permeability-increasing protein OS=Bos taurus OX=9913 GN=BPI PE=2 SV=2,,,,,,
OG_05291,1.1100985006366686,FUN_023958-T1,Peve_00017996,Pocillopora_meandrina_HIv1___RNAseq.g18521.t1,three_way,58.741,,,,,,,,,,,,,,,,,
OG_05294,1.4832640770077197,FUN_023962-T1,Peve_00043985,Pocillopora_meandrina_HIv1___RNAseq.g18585.t1,three_way,84.302,,,,,,,,,,,,,,,,,
OG_05304,1.7154054321720995,FUN_023976-T1,Peve_00020879,Pocillopora_meandrina_HIv1___RNAseq.g19436.t1,three_way,62.5495,FUN_023976-T1,Q9HBW9,AGRL4_HUMAN,,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",Homo sapiens (Human),37.6,93.0,1.4e-08,65.1,sp|Q9HBW9|AGRL4_HUMAN Adhesion G protein-coupled receptor L4 OS=Homo sapiens OX=9606 GN=ADGRL4 PE=1 SV=3,GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0031410,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0031410; GO:0043226; GO:0060089,plasma membrane; cytoplasmic vesicle; organelle; molecular transducer activity
OG_05305,2.390224154190836,FUN_023978-T1,Peve_00020874,Pocillopora_meandrina_HIv1___RNAseq.g19435.t1,three_way,47.72816666666667,,,,,,,,,,,,,,,,,
OG_05341,1.0124724353293333,FUN_024067-T1,Peve_00000150,Pocillopora_meandrina_HIv1___RNAseq.g19254.t1,three_way,69.05799999999999,FUN_024067-T1,Q54RA4,,,,,34.9,352.0,9.9e-50,198.7,sp|Q54RA4|Y3291_DICDI Probable iron/ascorbate oxidoreductase DDB_G0283291 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0283291 PE=3 SV=1,,,,,,
OG_05351,2.005048656689185,FUN_024121-T1,Peve_00000177,Pocillopora_meandrina_HIv1___RNAseq.g19176.t1,three_way,46.95433333333333,,,,,,,,,,,,,,,,,
OG_05359,1.0578153800755623,FUN_024133-T1,Peve_00010980,Pocillopora_meandrina_HIv1___RNAseq.g19881.t1,three_way,63.13883333333333,FUN_024133-T1,Q14108,,,,,33.2,476.0,2.600000000000001e-71,271.2,sp|Q14108|SCRB2_HUMAN Lysosome membrane protein 2 OS=Homo sapiens OX=9606 GN=SCARB2 PE=1 SV=2,,,,,,
OG_05363,1.001328460737268,FUN_024144-T1,Peve_00036832,Pocillopora_meandrina_HIv1___RNAseq.g19865.t1,three_way,39.884166666666665,,,,,,,,,,,,,,,,,
OG_05370,1.0167035396426016,FUN_024172-T1,Peve_00010868,Pocillopora_meandrina_HIv1___RNAseq.g13458.t1,three_way,63.120666666666665,,,,,,,,,,,,,,,,,
OG_05371,1.346118123680634,FUN_024173-T1,Peve_00010869,Pocillopora_meandrina_HIv1___RNAseq.g13457.t1,three_way,74.04,FUN_024173-T1,Q2UPB1,,,,,24.9,454.0,1.8e-29,132.1,sp|Q2UPB1|ACLC_ASPOR Cytochrome P450 monooxygenase aclC OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) OX=510516 GN=aclC PE=3 SV=1,,,,,,
OG_05375,1.145055663406684,FUN_024188-T1,Peve_00013618,Pocillopora_meandrina_HIv1___RNAseq.g18884.t1,three_way,43.766,,,,,,,,,,,,,,,,,
OG_05395,1.1208542388535865,FUN_024222-T1,Peve_00031895,Pocillopora_meandrina_HIv1___RNAseq.g18914.t1,three_way,77.07900000000001,FUN_024222-T1,Q13887,KLF5_HUMAN,,Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2),Homo sapiens (Human),38.6,166.0,5.3e-19,96.7,sp|Q13887|KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens OX=9606 GN=KLF5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008270; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0060576; GO:0061586; GO:1901653; GO:1990830; GO:1990837,angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816],chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005654; GO:0005794; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleoplasm; Golgi apparatus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05407,1.050335476673666,FUN_024339-T1,Peve_00016804,Pocillopora_meandrina_HIv1___RNAseq.g18936.t1,three_way,66.383,FUN_024339-T1,Q96H96,COQ2_HUMAN,,"4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)",Homo sapiens (Human),66.2,305.0,3.4e-116,419.9,"sp|Q96H96|COQ2_HUMAN 4-hydroxybenzoate polyprenyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=COQ2 PE=1 SV=2",GO:0004659; GO:0005739; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0031314,glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],4-hydroxybenzoate polyprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659],GO:0003824; GO:0005739; GO:0005975; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lipid metabolic process; transferase activity; organelle
OG_05417,1.3827742932891394,FUN_024355-T1,Peve_00024184,Pocillopora_meandrina_HIv1___RNAseq.g18691.t1,three_way,67.9895,,,,,,,,,,,,,,,,,
OG_05418,1.479084997787361,FUN_024357-T1,Peve_00024183,Pocillopora_meandrina_HIv1___RNAseq.g18694.t1,three_way,60.891,,,,,,,,,,,,,,,,,
OG_05432,1.17471846889632,FUN_024378-T1,Peve_00020233,Pocillopora_meandrina_HIv1___RNAseq.g18603.t1,three_way,84.493,FUN_024378-T1,P94598,,,,,60.0,440.0,7.3e-161,568.5,sp|P94598|DHE3_BACTN Glutamate dehydrogenase OS=Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50) OX=226186 GN=gdhA PE=3 SV=2,,,,,,
OG_05440,1.1879339363038626,FUN_024393-T1,Peve_00005016,Pocillopora_meandrina_HIv1___RNAseq.g18624.t1,three_way,66.556,FUN_024393-T1,P42674,,,,,48.3,201.0,1.4e-44,182.2,sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1,,,,,,
OG_05446,1.2038666553886697,FUN_024402-T1,Peve_00007147,Pocillopora_meandrina_HIv1___RNAseq.g18634.t1,three_way,78.25166666666667,FUN_024402-T1,O54865,,,,,51.5,532.0,1.4e-146,521.2,sp|O54865|GCYB1_MOUSE Guanylate cyclase soluble subunit beta-1 OS=Mus musculus OX=10090 GN=Gucy1b1 PE=1 SV=1,,,,,,
OG_05457,1.349392989160197,FUN_024418-T1,Peve_00029260,Pocillopora_meandrina_HIv1___RNAseq.g18720.t1,three_way,74.32566666666666,FUN_024418-T1,Q98SN7,,,,,55.1,345.0,5e-110,399.4,sp|Q98SN7|WNT2B_CHICK Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1,,,,,,
OG_05474,1.0510595763953003,FUN_024457-T1,Peve_00010311,Pocillopora_meandrina_HIv1___TS.g27964.t1,three_way,63.876,FUN_024457-T1,Q9H8H3,TMT1A_HUMAN,,Thiol S-methyltransferase TMT1A (EC 2.1.1.9) (Methyltransferase-like protein 7A) (N6-adenosine-methyltransferase TMT1A) (EC 2.1.1.348) (Protein AAM-B) (Thiol methyltransferase 1A),Homo sapiens (Human),40.7,216.0,1.1e-40,168.3,sp|Q9H8H3|TMT1A_HUMAN Thiol S-methyltransferase TMT1A OS=Homo sapiens OX=9606 GN=TMT1A PE=1 SV=1,GO:0001649; GO:0001734; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0008168; GO:0008173; GO:0016020; GO:0018708; GO:0032259; GO:0042476; GO:0180035; GO:1904724,lncRNA processing [GO:0180035]; methylation [GO:0032259]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724],methyltransferase activity [GO:0008168]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA methyltransferase activity [GO:0008173]; thiol S-methyltransferase activity [GO:0018708],GO:0003824; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0016740; GO:0030154; GO:0043226; GO:0140098,"catalytic activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; transferase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_05478,1.3961279251781682,FUN_024472-T1,Peve_00041386,Pocillopora_meandrina_HIv1___RNAseq.g29213.t1,three_way,48.294,,,,,,,,,,,,,,,,,
OG_05485,1.0340607247379014,FUN_024482-T1,Peve_00010582,Pocillopora_meandrina_HIv1___RNAseq.g19067.t1,three_way,60.68966666666667,,,,,,,,,,,,,,,,,
OG_05506,1.8545773584842664,FUN_024587-T1,Peve_00037917,Pocillopora_meandrina_HIv1___RNAseq.2717_t,three_way,63.268,,,,,,,,,,,,,,,,,
OG_05507,1.565181851722539,FUN_024588-T1,Peve_00007644,Pocillopora_meandrina_HIv1___RNAseq.g19109.t1,three_way,76.148,FUN_024588-T1,P42785,PCP_HUMAN,,Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP),Homo sapiens (Human),59.5,444.0,2.2e-157,557.0,sp|P42785|PCP_HUMAN Lysosomal Pro-X carboxypeptidase OS=Homo sapiens OX=9606 GN=PRCP PE=1 SV=1,GO:0002003; GO:0002155; GO:0002353; GO:0003085; GO:0004181; GO:0004185; GO:0005886; GO:0008239; GO:0035577; GO:0042593; GO:0043231; GO:0043535; GO:0045178; GO:0060055; GO:0070062; GO:0097009; GO:0101003; GO:2000377,angiogenesis involved in wound healing [GO:0060055]; angiotensin maturation [GO:0002003]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone receptor signaling pathway [GO:0002155],azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],dipeptidyl-peptidase activity [GO:0008239]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185],GO:0003824; GO:0005886; GO:0006954; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; inflammatory response; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_05531,1.328564873075576,FUN_024682-T1,Peve_00012723,Pocillopora_meandrina_HIv1___RNAseq.g18950.t1,three_way,76.55683333333333,FUN_024682-T1,Q17QB7,RAB30_BOVIN,,Ras-related protein Rab-30 (EC 3.6.5.2),Bos taurus (Bovine),53.8,184.0,3.0999999999999996e-55,216.5,sp|Q17QB7|RAB30_BOVIN Ras-related protein Rab-30 OS=Bos taurus OX=9913 GN=RAB30 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016020; GO:0016192; GO:0031985; GO:0032482,Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; vesicle-mediated transport; hydrolase activity; organelle
OG_05563,1.2451969638839129,FUN_024783-T1,Peve_00007043,Pocillopora_meandrina_HIv1___TS.g28188.t1,three_way,49.95166666666667,FUN_024783-T1,Q3U481,MFS12_MOUSE,,Major facilitator superfamily domain-containing protein 12 (Protein grizzled),Mus musculus (Mouse),32.5,206.0,9e-19,96.7,sp|Q3U481|MFS12_MOUSE Major facilitator superfamily domain-containing protein 12 OS=Mus musculus OX=10090 GN=Mfsd12 PE=1 SV=1,GO:0005764; GO:0005765; GO:0005770; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; cytoplasmic vesicle; organelle; transmembrane transport
OG_05565,1.1699716208397437,FUN_024794-T1,Peve_00007040,Pocillopora_meandrina_HIv1___RNAseq.2280_t,three_way,39.91566666666667,FUN_024794-T1,P79121,,,,,26.6,177.0,1.8e-13,77.8,sp|P79121|TIMP3_BOVIN Metalloproteinase inhibitor 3 OS=Bos taurus OX=9913 GN=TIMP3 PE=2 SV=1,,,,,,
OG_05573,1.8344467083889653,FUN_024861-T1,Peve_00026074,Pocillopora_meandrina_HIv1___RNAseq.g18770.t1,three_way,57.13,FUN_024861-T1,Q8NEG2,,,,,29.7,182.0,2.8e-08,60.8,sp|Q8NEG2|CG057_HUMAN Uncharacterized protein C7orf57 OS=Homo sapiens OX=9606 GN=C7orf57 PE=1 SV=3,,,,,,
OG_05609,1.0481569876206382,FUN_025294-T1,Peve_00040955,Pocillopora_meandrina_HIv1___RNAseq.g13469.t1,three_way,53.38583333333333,,,,,,,,,,,,,,,,,
OG_05610,1.579129032897943,FUN_025295-T1,Peve_00040954,Pocillopora_meandrina_HIv1___RNAseq.g13468.t1,three_way,62.326,,,,,,,,,,,,,,,,,
OG_05611,1.1745774140337215,FUN_025296-T1,Peve_00001926,Pocillopora_meandrina_HIv1___RNAseq.g11490.t1,three_way,45.81016666666667,,,,,,,,,,,,,,,,,
OG_05617,1.2869641695139895,FUN_025306-T1,Peve_00027097,Pocillopora_meandrina_HIv1___RNAseq.g13454.t1,three_way,78.10933333333332,FUN_025306-T1,Q95R48,,,,,28.5,396.0,5.8e-38,159.8,sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2,,,,,,
OG_05626,1.1799923787400766,FUN_025321-T1,Peve_00027089,Pocillopora_meandrina_HIv1___RNAseq.g13423.t1,three_way,58.5,,,,,,,,,,,,,,,,,
OG_05637,1.403199085307594,FUN_025338-T2,Peve_00000776,Pocillopora_meandrina_HIv1___RNAseq.g24106.t1,three_way,62.506,,,,,,,,,,,,,,,,,
OG_05654,2.3016272757117444,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_05655,1.3165948122350524,FUN_025410-T1,Peve_00017348,Pocillopora_meandrina_HIv1___RNAseq.14602_t,three_way,53.36533333333333,,,,,,,,,,,,,,,,,
OG_05674,1.937922709699578,FUN_025504-T1,Peve_00040926,Pocillopora_meandrina_HIv1___RNAseq.g13217.t1,three_way,54.756166666666665,FUN_025504-T1,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),42.3,196.0,3.5e-33,144.8,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_05678,1.1287814118532418,FUN_025511-T1,Peve_00002249,Pocillopora_meandrina_HIv1___RNAseq.g13212.t1,three_way,56.655,FUN_025511-T1,Q8TCQ1,MARH1_HUMAN,,E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCHF1),Homo sapiens (Human),28.2,206.0,7.7e-14,79.7,sp|Q8TCQ1|MARH1_HUMAN E3 ubiquitin-protein ligase MARCHF1 OS=Homo sapiens OX=9606 GN=MARCHF1 PE=1 SV=1,GO:0000209; GO:0002495; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0043231; GO:0061630,antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"immune system process; catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05680,1.1651013698070172,FUN_025517-T1,Peve_00020632,Pocillopora_meandrina_HIv1___RNAseq.14497_t,three_way,51.73233333333334,,,,,,,,,,,,,,,,,
OG_05717,1.3374014486758783,FUN_025607-T1,Peve_00033139,Pocillopora_meandrina_HIv1___RNAseq.g23132.t1,three_way,41.1535,FUN_025607-T1,P29319,,,,,33.2,386.0,5.0000000000000005e-48,194.1,sp|P29319|EPHA3_MOUSE Ephrin type-A receptor 3 OS=Mus musculus OX=10090 GN=Epha3 PE=1 SV=1,,,,,,
OG_05718,1.269409755124081,FUN_025610-T1,Peve_00009537,Pocillopora_meandrina_HIv1___RNAseq.g23128.t1,three_way,58.688833333333335,FUN_025610-T1,Q07497,,,,,34.9,935.0,3.6999999999999996e-147,523.9,sp|Q07497|EPHB5_CHICK Ephrin type-B receptor 5 OS=Gallus gallus OX=9031 GN=EPHB5 PE=2 SV=1,,,,,,
OG_05743,1.179979968340196,FUN_025670-T1,Peve_00042194,Pocillopora_meandrina_HIv1___TS.g15944.t1,three_way,81.551,FUN_025670-T1,O09012,PEX5_MOUSE,,Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (PXR1P) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1),Mus musculus (Mouse),47.9,645.0,2.2e-117,424.5,sp|O09012|PEX5_MOUSE Peroxisomal targeting signal 1 receptor OS=Mus musculus OX=10090 GN=Pex5 PE=1 SV=2,GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005739; GO:0005777; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006629; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0016020; GO:0016558; GO:0016560; GO:0016562; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0034614; GO:0040018; GO:0044721; GO:0045046; GO:0048468; GO:0050905; GO:0140597,"cell development [GO:0048468]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome membrane targeting sequence binding [GO:0033328]; peroxisome targeting sequence binding [GO:0000268]; protein carrier chaperone [GO:0140597]; small GTPase binding [GO:0031267],GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0006629; GO:0006886; GO:0006914; GO:0007005; GO:0007031; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0061024; GO:0140104,mitochondrion; peroxisome; Golgi apparatus; cytosol; lipid metabolic process; intracellular protein transport; autophagy; mitochondrion organization; peroxisome organization; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; membrane organization; molecular carrier activity
OG_05749,1.5310799309026444,FUN_025681-T1,Peve_00000455,Pocillopora_meandrina_HIv1___RNAseq.g13115.t1,three_way,68.22683333333333,FUN_025681-T1,P98064,,,,,39.3,690.0,1.5999999999999999e-137,491.5,sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2,,,,,,
OG_05764,1.8051321428268168,FUN_025722-T1,Peve_00014085,Pocillopora_meandrina_HIv1___RNAseq.g10452.t1,three_way,58.814,FUN_025722-T1,A8MY62,,,,,29.3,447.0,1.5e-46,188.7,sp|A8MY62|BLML_HUMAN Putative beta-lactamase-like 1 OS=Homo sapiens OX=9606 GN=LACTBL1 PE=1 SV=2,,,,,,
OG_05809,1.8149569450284269,FUN_025809-T2,Peve_00017944,Pocillopora_meandrina_HIv1___TS.g19642.t2,three_way,56.2395,FUN_025809-T2,Q08EN7,,,,,29.7,286.0,1.6e-26,122.5,sp|Q08EN7|ZCPW2_MOUSE Zinc finger CW-type PWWP domain protein 2 homolog OS=Mus musculus OX=10090 GN=Zcwpw2 PE=2 SV=2,,,,,,
OG_05813,1.759540215334153,FUN_025815-T1,Peve_00002524,Pocillopora_meandrina_HIv1___RNAseq.g9337.t1,three_way,46.56366666666667,FUN_025815-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),32.5,126.0,2e-11,71.2,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05819,1.3895991641988874,FUN_025826-T1,Peve_00036290,Pocillopora_meandrina_HIv1___RNAseq.g9346.t1,three_way,60.5495,FUN_025826-T1,B8V7Q1,,,,,39.9,3257.0,0.0,2112.0,sp|B8V7Q1|PCDL_ACRMI Protocadherin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05826,2.0941160232924623,FUN_025843-T1,Peve_00028316,Pocillopora_meandrina_HIv1___RNAseq.g10339.t1,three_way,66.52566666666667,,,,,,,,,,,,,,,,,
OG_05882,1.1000435120754817,FUN_026035-T1,Peve_00022186,Pocillopora_meandrina_HIv1___TS.g13968.t3,three_way,87.66533333333334,FUN_026035-T1,Q5ZKI4,,,,,58.3,604.0,6.5000000000000004e-186,652.1,sp|Q5ZKI4|CCD93_CHICK Coiled-coil domain-containing protein 93 OS=Gallus gallus OX=9031 GN=CCDC93 PE=2 SV=1,,,,,,
OG_05895,1.254529380696958,FUN_026071-T1,Peve_00010393,Pocillopora_meandrina_HIv1___TS.g13984.t1,three_way,67.47733333333333,FUN_026071-T1,O82333,,,,,27.7,573.0,9e-47,189.9,sp|O82333|GH31_ARATH Probable indole-3-acetic acid-amido synthetase GH3.1 OS=Arabidopsis thaliana OX=3702 GN=GH3.1 PE=2 SV=1,,,,,,
OG_05926,1.0141567090015184,FUN_026150-T1,Peve_00020731,Pocillopora_meandrina_HIv1___RNAseq.g3216.t1,three_way,83.78333333333333,FUN_026150-T1,Q9UJ83,HACL1_HUMAN,,2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2),Homo sapiens (Human),60.0,578.0,2.3e-206,719.9,sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2,GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:0106359; GO:0106376; GO:1903512,fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0005654; GO:0005777; GO:0005829; GO:0006629; GO:0016829; GO:0043226,catalytic activity; nucleoplasm; peroxisome; cytosol; lipid metabolic process; lyase activity; organelle
OG_05933,1.0700548119392914,FUN_026161-T1,Peve_00006892,Pocillopora_meandrina_HIv1___RNAseq.g3202.t1,three_way,65.80033333333333,FUN_026161-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),33.2,564.0,2.7999999999999997e-82,307.8,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05947,1.4558360184189036,FUN_026194-T1,Peve_00016690,Pocillopora_meandrina_HIv1___TS.g18158.t1,three_way,54.12983333333333,,,,,,,,,,,,,,,,,
OG_06005,1.0174896095962245,FUN_026501-T1,Peve_00004184,Pocillopora_meandrina_HIv1___TS.g21607.t1,three_way,44.153333333333336,FUN_026501-T1,Q9VTT0,SEM5C_DROME,,Semaphorin 5c,Drosophila melanogaster (Fruit fly),27.1,630.0,1.7e-51,206.1,sp|Q9VTT0|SEM5C_DROME Semaphorin 5c OS=Drosophila melanogaster OX=7227 GN=Sema5c PE=1 SV=3,GO:0001700; GO:0005768; GO:0005886; GO:0007411; GO:0016324; GO:0016328; GO:0030215; GO:0030335; GO:0042048; GO:0045499; GO:0048036; GO:0071526,axon guidance [GO:0007411]; central complex development [GO:0048036]; embryonic development via the syncytial blastoderm [GO:0001700]; olfactory behavior [GO:0042048]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0048018; GO:0048856; GO:0098772,endosome; plasma membrane; cytoplasmic vesicle; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06007,1.3693412816834194,FUN_026527-T1,Peve_00021565,Pocillopora_meandrina_HIv1___RNAseq.g4205.t1,three_way,58.59633333333333,,,,,,,,,,,,,,,,,
OG_06016,1.741786206554604,FUN_026543-T1,Peve_00020319,Pocillopora_meandrina_HIv1___RNAseq.g4238.t1,three_way,56.20633333333333,,,,,,,,,,,,,,,,,
OG_06022,1.1605778388413603,FUN_026564-T1,Peve_00043274,Pocillopora_meandrina_HIv1___RNAseq.g4519.t1,three_way,45.92583333333333,FUN_026564-T1,Q9DD78,,,,,32.7,107.0,3.3e-12,75.1,sp|Q9DD78|TLR21_CHICK Toll-like receptor 2 type-1 OS=Gallus gallus OX=9031 GN=TLR2-1 PE=2 SV=1,,,,,,
OG_06046,2.293473424919317,FUN_026714-T1,Peve_00018519,Pocillopora_meandrina_HIv1___RNAseq.g9373.t1,three_way,56.48,FUN_026714-T1,Q96EW2,,,,,42.0,138.0,4.4e-20,99.4,sp|Q96EW2|HBAP1_HUMAN HSPB1-associated protein 1 OS=Homo sapiens OX=9606 GN=HSPBAP1 PE=1 SV=1,,,,,,
OG_06057,1.0291656374186569,FUN_026741-T2,Peve_00006716,Pocillopora_meandrina_HIv1___RNAseq.g9416.t1,three_way,57.72766666666666,FUN_026741-T2,Q8BKN6,,,,,53.6,261.0,1.3000000000000001e-71,271.6,sp|Q8BKN6|HS3SA_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 OS=Mus musculus OX=10090 GN=Hs3st3a1 PE=2 SV=1,,,,,,
OG_06105,1.1837261586758898,FUN_027806-T1,Peve_00036481,Pocillopora_meandrina_HIv1___RNAseq.g13895.t1,three_way,70.82966666666667,,,,,,,,,,,,,,,,,
OG_06125,1.245666030501503,FUN_027903-T1,Peve_00020107,Pocillopora_meandrina_HIv1___RNAseq.g13881.t1,three_way,48.315666666666665,FUN_027903-T1,O75487,GPC4_HUMAN,,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],Homo sapiens (Human),33.5,507.0,6.5e-73,276.6,sp|O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens OX=9606 GN=GPC4 PE=1 SV=4,GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0015026; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1905606,cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],coreceptor activity [GO:0015026],GO:0005634; GO:0005886; GO:0007155; GO:0043226; GO:0048870; GO:0060089,nucleus; plasma membrane; cell adhesion; organelle; cell motility; molecular transducer activity
OG_06131,1.0292872785956677,FUN_027935-T1,Peve_00023144,Pocillopora_meandrina_HIv1___RNAseq.g14027.t1,three_way,83.12183333333333,,,,,,,,,,,,,,,,,
OG_06132,1.856076409176227,FUN_027938-T2,Peve_00032459,Pocillopora_meandrina_HIv1___RNAseq.g14030.t1,three_way,71.97066666666667,,,,,,,,,,,,,,,,,
OG_06154,3.63428195278557,FUN_027987-T1,Peve_00023127,Pocillopora_meandrina_HIv1___RNAseq.g14022.t1,three_way,64.95433333333334,,,,,,,,,,,,,,,,,
OG_06173,1.0168174682051054,FUN_028028-T1,Peve_00044200,Pocillopora_meandrina_HIv1___RNAseq.g13931.t1,three_way,54.44433333333333,,,,,,,,,,,,,,,,,
OG_06174,2.6971112803838886,FUN_028030-T1,Peve_00044201,Pocillopora_meandrina_HIv1___RNAseq.g13933.t1,three_way,44.60566666666666,,,,,,,,,,,,,,,,,
OG_06199,1.074207381813816,FUN_028133-T1,Peve_00004264,Pocillopora_meandrina_HIv1___RNAseq.g15555.t1,three_way,47.007000000000005,FUN_028133-T1,A2AJ76,HMCN2_MOUSE,,Hemicentin-2,Mus musculus (Mouse),22.6,495.0,5.8e-18,94.4,sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0030054; GO:0032154; GO:0062023,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],calcium ion binding [GO:0005509],GO:0005576; GO:0030312; GO:0031012,extracellular region; external encapsulating structure; extracellular matrix
OG_06215,1.3405623594379794,FUN_028156-T1,Peve_00027512,Pocillopora_meandrina_HIv1___RNAseq.g16461.t1,three_way,34.681666666666665,,,,,,,,,,,,,,,,,
OG_06218,2.256092630270753,FUN_028160-T1,Peve_00000617,Pocillopora_meandrina_HIv1___RNAseq.g29828.t1,three_way,77.55183333333333,,,,,,,,,,,,,,,,,
OG_06222,1.8989609051603336,FUN_028166-T1,Peve_00044585,Pocillopora_meandrina_HIv1___RNAseq.g16474.t1,three_way,55.586666666666666,FUN_028166-T1,Q6AI12,,,,,49.2,59.0,3.6e-10,67.0,sp|Q6AI12|ANR40_HUMAN Ankyrin repeat domain-containing protein 40 OS=Homo sapiens OX=9606 GN=ANKRD40 PE=1 SV=2,,,,,,
OG_06262,1.0181497938876685,FUN_028287-T1,Peve_00003672,Pocillopora_meandrina_HIv1___RNAseq.g15495.t1,three_way,73.47366666666667,FUN_028287-T1,Q8K1K9,HINFP_MOUSE,,Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein),Mus musculus (Mouse),50.1,413.0,4.2e-106,386.7,sp|Q8K1K9|HINFP_MOUSE Histone H4 transcription factor OS=Mus musculus OX=10090 GN=Hinfp PE=2 SV=3,GO:0000077; GO:0000082; GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0008270; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044843; GO:0045184; GO:0045445; GO:0045892; GO:0045893,cell cycle G1/S phase transition [GO:0044843]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355],Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; anatomical structure development; transcription regulator activity
OG_06280,1.3271969261794814,FUN_028449-T1,Peve_00031080,Pocillopora_meandrina_HIv1___TS.g11207.t1,three_way,39.0405,FUN_028449-T1,Q62718,NTRI_RAT,,Neurotrimin (GP65),Rattus norvegicus (Rat),31.4,204.0,2.4e-18,95.9,sp|Q62718|NTRI_RAT Neurotrimin OS=Rattus norvegicus OX=10116 GN=Ntm PE=1 SV=1,GO:0005615; GO:0007155; GO:0009986; GO:0010976; GO:0010977; GO:0021549; GO:0030424; GO:0032355; GO:0042802; GO:0048471; GO:0048787; GO:0060076; GO:0060253; GO:0071392; GO:0098552; GO:0098686; GO:0098839; GO:1900149,cell adhesion [GO:0007155]; cellular response to estradiol stimulus [GO:0071392]; cerebellum development [GO:0021549]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron projection development [GO:0010977]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Schwann cell migration [GO:1900149]; response to estradiol [GO:0032355],axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; side of membrane [GO:0098552],identical protein binding [GO:0042802],GO:0005615; GO:0007155; GO:0048856,extracellular space; cell adhesion; anatomical structure development
OG_06291,1.03764841754827,FUN_028486-T1,Peve_00039740,Pocillopora_meandrina_HIv1___TS.g11105.t3a,three_way,50.81666666666667,FUN_028486-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),33.2,368.0,2.2e-41,172.6,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06307,1.1454609110783287,FUN_028513-T1,Peve_00008089,Pocillopora_meandrina_HIv1___TS.g11902.t2,three_way,40.3635,,,,,,,,,,,,,,,,,
OG_06312,1.035331510122272,FUN_028552-T1,Peve_00000749,Pocillopora_meandrina_HIv1___RNAseq.g9164.t1,three_way,47.18,,,,,,,,,,,,,,,,,
OG_06323,1.3603544066236768,FUN_028831-T1,Peve_00024573,Pocillopora_meandrina_HIv1___RNAseq.g20708.t1,three_way,60.382666666666665,FUN_028831-T1,Q9NVH0,EXD2_HUMAN,,Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2),Homo sapiens (Human),34.2,669.0,3.8e-100,367.5,sp|Q9NVH0|EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2,GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090304; GO:0090734,DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],GO:0003824; GO:0005634; GO:0005739; GO:0005856; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; mitochondrion; cytoskeleton; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_06336,1.201145172915053,FUN_028894-T1,Peve_00044594,Pocillopora_meandrina_HIv1___RNAseq.g25693.t1,three_way,71.78116666666666,FUN_028894-T1,Q58DA6,S35A2_BOVIN,,UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT),Bos taurus (Bovine),52.1,286.0,8.9e-69,261.9,sp|Q58DA6|S35A2_BOVIN UDP-galactose translocator OS=Bos taurus OX=9913 GN=SLC35A2 PE=2 SV=1,GO:0000139; GO:0005459; GO:0015297; GO:0072334,UDP-galactose transmembrane transport [GO:0072334],Golgi membrane [GO:0000139],antiporter activity [GO:0015297]; UDP-galactose transmembrane transporter activity [GO:0005459],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_06344,1.01955143561416,FUN_028909-T1,Peve_00041428,Pocillopora_meandrina_HIv1___RNAseq.g20758.t1,three_way,59.083,,,,,,,,,,,,,,,,,
OG_06353,1.263800047548243,FUN_028946-T1,Peve_00026868,Pocillopora_meandrina_HIv1___RNAseq.g25583.t1,three_way,40.32216666666666,,,,,,,,,,,,,,,,,
OG_06360,1.9096824361289768,FUN_028963-T1,Peve_00025110,Pocillopora_meandrina_HIv1___RNAseq.g25566.t1,three_way,55.882666666666665,,,,,,,,,,,,,,,,,
OG_06373,1.2242220570053934,FUN_028978-T1,Peve_00029291,Pocillopora_meandrina_HIv1___RNAseq.g25600.t1,three_way,57.49583333333333,FUN_028978-T1,P35331,,,,,29.0,978.0,1.4e-95,352.8,sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06376,1.5252061379266328,FUN_028981-T1,Peve_00014491,Pocillopora_meandrina_HIv1___RNAseq.g25619.t1,three_way,69.54766666666667,FUN_028981-T1,A7WM73,HEXO1_ARATH,,Beta-hexosaminidase 1 (EC 3.2.1.52) (Beta-GlcNAcase 1) (Beta-N-acetylhexosaminidase 1) (Beta-hexosaminidase 2) (AtHEX2) (N-acetyl-beta-glucosaminidase 1),Arabidopsis thaliana (Mouse-ear cress),27.5,534.0,4.1e-45,184.1,sp|A7WM73|HEXO1_ARATH Beta-hexosaminidase 1 OS=Arabidopsis thaliana OX=3702 GN=HEXO1 PE=1 SV=1,GO:0000325; GO:0004563; GO:0005773; GO:0005975; GO:0015929; GO:0099503,carbohydrate metabolic process [GO:0005975],plant-type vacuole [GO:0000325]; secretory vesicle [GO:0099503]; vacuole [GO:0005773],beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929],GO:0003824; GO:0005773; GO:0005975; GO:0016787; GO:0031410; GO:0043226,catalytic activity; vacuole; carbohydrate metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_06382,1.261876317509265,FUN_028994-T1,Peve_00034531,Pocillopora_meandrina_HIv1___RNAseq.g25641.t1,three_way,71.23533333333333,FUN_028994-T1,Q9UI42,CBPA4_HUMAN,,Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3),Homo sapiens (Human),39.8,402.0,5.9000000000000005e-87,322.8,sp|Q9UI42|CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens OX=9606 GN=CPA4 PE=1 SV=2,GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0042447; GO:0043171,hormone catabolic process [GO:0042447]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_06384,1.0591896019323013,FUN_029014-T1,Peve_00003118,Pocillopora_meandrina_HIv1___TS.g9087.t1,three_way,52.617,FUN_029014-T1,B8VIW9,,,,,40.2,1040.0,3.2999999999999996e-188,660.6,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_06403,1.8775823561341616,FUN_029065-T1,Peve_00043255,Pocillopora_meandrina_HIv1___RNAseq.g25804.t1,three_way,71.726,,,,,,,,,,,,,,,,,
OG_06417,1.2309189865157384,FUN_029104-T1,Peve_00038072,Pocillopora_meandrina_HIv1___TS.g8929.t1,three_way,65.834,FUN_029104-T1,P41970,ELK3_HUMAN,,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),Homo sapiens (Human),60.0,85.0,1.5000000000000002e-22,107.8,sp|P41970|ELK3_HUMAN ETS domain-containing protein Elk-3 OS=Homo sapiens OX=9606 GN=ELK3 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0030154; GO:0042060; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; cell differentiation; wound healing; organelle; transcription regulator activity
OG_06434,1.4849762990824704,FUN_029128-T1,Peve_00004674,Pocillopora_meandrina_HIv1___RNAseq.g25780.t1,three_way,76.54333333333334,FUN_029128-T1,I6V1W0,,,,,40.1,409.0,1.2e-79,298.9,sp|I6V1W0|BMBL_DANRE Protein brambleberry OS=Danio rerio OX=7955 GN=bmb PE=2 SV=1,,,,,,
OG_06436,1.2216805737708398,FUN_029130-T1,Peve_00033155,Pocillopora_meandrina_HIv1___RNAseq.g25785.t1,three_way,48.33016666666666,,,,,,,,,,,,,,,,,
OG_06443,1.0138258390987027,FUN_029154-T1,Peve_00041026,Pocillopora_meandrina_HIv1___RNAseq.g25735.t1,three_way,90.00566666666667,FUN_029154-T1,Q86XH1,,,,,57.3,820.0,1.7000000000000002e-218,760.8,sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1,,,,,,
OG_06447,1.2659297904533937,FUN_029166-T1,Peve_00027805,Pocillopora_meandrina_HIv1___RNAseq.g25481.t1,three_way,75.72866666666667,FUN_029166-T1,P50395,GDIB_HUMAN,,Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2),Homo sapiens (Human),62.2,442.0,6.8e-166,585.1,sp|P50395|GDIB_HUMAN Rab GDP dissociation inhibitor beta OS=Homo sapiens OX=9606 GN=GDI2 PE=1 SV=2,GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0031267; GO:0031982; GO:0034774; GO:0035578; GO:0045202; GO:0070062; GO:1902018; GO:1903565,negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0003723; GO:0005576; GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,RNA binding; extracellular region; Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_06462,1.0135687652208003,FUN_029193-T1,Peve_00032838,Pocillopora_meandrina_HIv1___RNAseq.g25517.t1,three_way,55.414,FUN_029193-T1,Q1RMZ1,SAMTR_HUMAN,,S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog) (EC 2.1.1.-),Homo sapiens (Human),38.7,411.0,3.7e-70,266.9,sp|Q1RMZ1|SAMTR_HUMAN S-adenosylmethionine sensor upstream of mTORC1 OS=Homo sapiens OX=9606 GN=SAMTOR PE=1 SV=1,GO:0005829; GO:0008168; GO:0032259; GO:0034198; GO:0044877; GO:0061431; GO:1903432; GO:1904047; GO:1904262; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to methionine [GO:0061431]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263]; regulation of TORC1 signaling [GO:1903432],cytosol [GO:0005829],methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0005829; GO:0016740,catalytic activity; cytosol; transferase activity
OG_06500,1.4257158093993252,FUN_029291-T1,Peve_00036559,Pocillopora_meandrina_HIv1___RNAseq.g11686.t1,three_way,61.11266666666666,FUN_029291-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),44.3,300.0,2.0999999999999997e-68,263.1,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_06507,1.3187079678947269,FUN_029301-T1,Peve_00040808,Pocillopora_meandrina_HIv1___RNAseq.g12585.t1,three_way,51.386,FUN_029301-T1,Q01974,ROR2_HUMAN,,"Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)",Homo sapiens (Human),27.3,264.0,1.5e-16,90.5,sp|Q01974|ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens OX=9606 GN=ROR2 PE=1 SV=2,GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0015026; GO:0016055; GO:0017147; GO:0030335; GO:0030424; GO:0030669; GO:0031435; GO:0043235; GO:0046872,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; positive regulation of cell migration [GO:0030335]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; clathrin-coated endocytic vesicle membrane [GO:0030669]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0016740; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; transferase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_06508,1.1874481508454775,FUN_029305-T1,Peve_00040807,Pocillopora_meandrina_HIv1___RNAseq.g12584.t1,three_way,70.46983333333334,FUN_029305-T1,P51049,,,,,27.9,315.0,5.7e-28,126.7,sp|P51049|MR1BB_DANRE Melatonin receptor type 1B-B OS=Danio rerio OX=7955 GN=mtnr1bb PE=2 SV=2,,,,,,
OG_06528,1.2226362170525136,FUN_029357-T1,Peve_00023328,Pocillopora_meandrina_HIv1___RNAseq.g17291.t1,three_way,87.65433333333334,FUN_029357-T1,Q9UIJ7,KAD3_HUMAN,,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)",Homo sapiens (Human),57.9,209.0,2.1e-67,256.9,"sp|Q9UIJ7|KAD3_HUMAN GTP:AMP phosphotransferase AK3, mitochondrial OS=Homo sapiens OX=9606 GN=AK3 PE=1 SV=4",GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0016874; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899,ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; ligase activity [GO:0016874]; nucleoside triphosphate adenylate kinase activity [GO:0046899],GO:0003824; GO:0005739; GO:0016740; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; transferase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_06541,1.2181079588454116,FUN_029405-T1,Peve_00035059,Pocillopora_meandrina_HIv1___RNAseq.g17144.t1,three_way,85.84700000000001,FUN_029405-T1,Q3MHG1,SPTC1_BOVIN,,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),Bos taurus (Bovine),57.5,463.0,4.2e-156,552.7,sp|Q3MHG1|SPTC1_BOVIN Serine palmitoyltransferase 1 OS=Bos taurus OX=9913 GN=SPTLC1 PE=2 SV=1,GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0017059; GO:0030170; GO:0046512; GO:0046513; GO:1904649,ceramide biosynthetic process [GO:0046513]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_06553,1.4984656419481264,FUN_029428-T1,Peve_00039462,Pocillopora_meandrina_HIv1___RNAseq.g17173.t1,three_way,68.539,,,,,,,,,,,,,,,,,
OG_06554,1.8056974031201545,FUN_029431-T1,Peve_00039461,Pocillopora_meandrina_HIv1___RNAseq.g17172.t1,three_way,70.55433333333333,,,,,,,,,,,,,,,,,
OG_06556,1.0228400440229266,FUN_029438-T1,Peve_00028188,Pocillopora_meandrina_HIv1___RNAseq.g17152.t1,three_way,76.8055,FUN_029438-T1,Q8IZF0,NALCN_HUMAN,,Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1),Homo sapiens (Human),41.8,1604.0,0.0,1137.9,sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1,GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805,"calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]",monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06569,1.1284677356529718,FUN_029476-T1,Peve_00028204,Pocillopora_meandrina_HIv1___RNAseq.g17150.t1,three_way,62.744166666666665,,,,,,,,,,,,,,,,,
OG_06616,1.693348375597021,FUN_029772-T1,Peve_00013611,Pocillopora_meandrina_HIv1___RNAseq.g17328.t1a,three_way,49.64566666666666,FUN_029772-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),21.8,458.0,5e-18,94.7,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06642,1.1087268860363506,FUN_030643-T1,Peve_00006240,Pocillopora_meandrina_HIv1___RNAseq.g21086.t1,three_way,75.03066666666666,FUN_030643-T1,P52493,,,,,33.6,143.0,3.3e-19,96.3,sp|P52493|UBC2_NEUCR Ubiquitin-conjugating enzyme E2 2 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=mus-8 PE=3 SV=4,,,,,,
OG_06663,2.0384334958661547,FUN_031054-T1,Peve_00028185,Pocillopora_meandrina_HIv1___RNAseq.g30322.t1,three_way,84.973,FUN_031054-T1,Q8CIB5,FERM2_MOUSE,,Fermitin family homolog 2 (Kindlin-2) (Pleckstrin homology domain-containing family C member 1),Mus musculus (Mouse),47.4,694.0,4.1000000000000004e-170,599.7,sp|Q8CIB5|FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus OX=10090 GN=Fermt2 PE=1 SV=1,GO:0001725; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0005938; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009898; GO:0009986; GO:0010718; GO:0016055; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035025; GO:0043116; GO:0043539; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0070374; GO:0072657; GO:0120283; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691,"adherens junction maintenance [GO:0034334]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]",adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725],"actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]",GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0007155; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,circulatory system process; nucleus; nucleoplasm; cytosol; cell adhesion; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_06670,1.7704166671116954,FUN_031070-T1,Peve_00025081,Pocillopora_meandrina_HIv1___RNAseq.g6195.t1,three_way,68.65666666666667,FUN_031070-T1,Q93VC9,,,,,40.9,320.0,1.6e-60,234.6,sp|Q93VC9|CATB2_ARATH Cathepsin B-like protease 2 OS=Arabidopsis thaliana OX=3702 GN=CATHB2 PE=2 SV=1,,,,,,
OG_06685,1.2358938479923651,FUN_031206-T1,Peve_00041864,Pocillopora_meandrina_HIv1___RNAseq.g5212.t1,three_way,67.21766666666666,,,,,,,,,,,,,,,,,
OG_06699,1.856309197192737,FUN_031265-T1,Peve_00001471,Pocillopora_meandrina_HIv1___RNAseq.g5186.t1,three_way,80.76033333333334,FUN_031265-T1,Q4I963,,,,,34.0,150.0,3.9e-17,89.4,sp|Q4I963|COFI_GIBZE Cofilin OS=Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) OX=229533 GN=COF1 PE=3 SV=2,,,,,,
OG_06712,1.0741451831073905,FUN_031304-T1,Peve_00026516,Pocillopora_meandrina_HIv1___TS.g23876.t1,three_way,80.76050000000001,FUN_031304-T1,Q2XVR6,SC4AB_TAKRU,,Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b),Takifugu rubripes (Japanese pufferfish) (Fugu rubripes),36.0,1773.0,3.2e-262,907.1,sp|Q2XVR6|SC4AB_TAKRU Sodium channel protein type 4 subunit alpha B OS=Takifugu rubripes OX=31033 GN=scn4ab PE=3 SV=1,GO:0001518; GO:0005248; GO:0019228; GO:0086010,membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228],voltage-gated sodium channel complex [GO:0001518],voltage-gated sodium channel activity [GO:0005248],GO:0005215,transporter activity
OG_06713,1.08830908298523,FUN_031306-T1,Peve_00026515,Pocillopora_meandrina_HIv1___RNAseq.11376_t,three_way,53.790333333333336,,,,,,,,,,,,,,,,,
OG_06733,1.5114492425101935,FUN_031517-T2,Peve_00045249,Pocillopora_meandrina_HIv1___TS.g23839.t1,three_way,57.293,FUN_031517-T2,Q8NBJ9,SIDT2_HUMAN,,SID1 transmembrane family member 2,Homo sapiens (Human),23.9,440.0,5.2e-15,84.7,sp|Q8NBJ9|SIDT2_HUMAN SID1 transmembrane family member 2 OS=Homo sapiens OX=9606 GN=SIDT2 PE=1 SV=2,GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0051033; GO:0061178,cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032]; RNA transmembrane transporter activity [GO:0051033],GO:0003677; GO:0003723; GO:0005215; GO:0005764; GO:0005773; GO:0005886; GO:0043226; GO:0048856,DNA binding; RNA binding; transporter activity; lysosome; vacuole; plasma membrane; organelle; anatomical structure development
OG_06757,2.398813835278648,FUN_031570-T1,Peve_00021507,Pocillopora_meandrina_HIv1___RNAseq.g5065.t1,three_way,57.521,FUN_031570-T1,D4A218,,,,,32.0,303.0,1.1e-26,122.5,sp|D4A218|DMRT3_RAT Doublesex and mab-3 related transcription factor 3 OS=Rattus norvegicus OX=10116 GN=Dmrt3 PE=3 SV=1,,,,,,
OG_06778,1.0290232816575322,FUN_031644-T1,Peve_00043582,Pocillopora_meandrina_HIv1___RNAseq.g5685.t1,three_way,76.86,FUN_031644-T1,Q3EBF7,SLD2_ARATH,,Delta(8)-fatty-acid desaturase 2 (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase 2) (Sphingoid long-chain base desaturase 2) (Sphingoid LCB desaturase 2) (Sphingolipid 8-(E/Z)-desaturase 2),Arabidopsis thaliana (Mouse-ear cress),41.9,451.0,8.5e-100,365.5,sp|Q3EBF7|SLD2_ARATH Delta(8)-fatty-acid desaturase 2 OS=Arabidopsis thaliana OX=3702 GN=SLD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0030148; GO:0046872; GO:0052631; GO:0070417,cellular response to cold [GO:0070417]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; sphingolipid 8-(E/Z)-desaturase activity [GO:0052631],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_06799,1.208506164826353,FUN_031687-T1,Peve_00021456,Pocillopora_meandrina_HIv1___RNAseq.g5769.t1,three_way,58.85433333333334,FUN_031687-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),28.0,440.0,4.8e-42,173.7,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_06800,1.0416542323393303,FUN_031688-T1,Peve_00008190,Pocillopora_meandrina_HIv1___RNAseq.g5768.t1,three_way,65.605,FUN_031688-T1,Q15582,BGH3_HUMAN,,Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP),Homo sapiens (Human),27.7,629.0,1.4999999999999999e-53,212.6,sp|Q15582|BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens OX=9606 GN=TGFBI PE=1 SV=1,GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0062023; GO:0070062,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; visual perception [GO:0007601],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178],GO:0005198; GO:0005576; GO:0005615; GO:0005886; GO:0007155; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; extracellular region; extracellular space; plasma membrane; cell adhesion; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_06801,1.0307670923042025,FUN_031696-T1,Peve_00008196,Pocillopora_meandrina_HIv1___RNAseq.g5767.t1,three_way,78.851,,,,,,,,,,,,,,,,,
OG_06842,1.891466607156579,FUN_031782-T1,Peve_00010427,Pocillopora_meandrina_HIv1___RNAseq.g5565.t1,three_way,65.31783333333333,FUN_031782-T1,P29176,,,,,44.2,77.0,1.2e-06,55.1,sp|P29176|FOSX_MSVFR Transforming protein v-Fos/v-Fox OS=FBR murine osteosarcoma virus OX=353765 GN=FOS-FOX PE=3 SV=1,,,,,,
OG_06850,1.1489796896999949,FUN_031791-T1,Peve_00019321,Pocillopora_meandrina_HIv1___RNAseq.g5572.t1,three_way,73.44166666666666,FUN_031791-T1,K7VCB9,,,,,43.1,232.0,1e-38,161.8,sp|K7VCB9|THIM_MAIZE Hydroxyethylthiazole kinase OS=Zea mays OX=4577 GN=THIM PE=1 SV=1,,,,,,
OG_06877,1.3605761144638349,FUN_031894-T1,Peve_00031826,Pocillopora_meandrina_HIv1___RNAseq.g6060.t1,three_way,53.31966666666666,,,,,,,,,,,,,,,,,
OG_06895,1.012538156508814,FUN_031937-T1,Peve_00024805,Pocillopora_meandrina_HIv1___RNAseq.g18211.t1,three_way,52.65616666666666,,,,,,,,,,,,,,,,,
OG_06900,1.283476230933314,FUN_031943-T1,Peve_00031842,Pocillopora_meandrina_HIv1___RNAseq.g18205.t1,three_way,68.272,,,,,,,,,,,,,,,,,
OG_06903,1.033292682382079,FUN_031949-T1,Peve_00031822,Pocillopora_meandrina_HIv1___RNAseq.g6063.t2,three_way,64.09533333333334,FUN_031949-T1,P81439,,,,,40.1,187.0,5.8e-32,141.7,sp|P81439|EQSTC_ACTEQ Equistatin OS=Actinia equina OX=6106 PE=1 SV=2,,,,,,
OG_06909,1.5252663645978368,FUN_031967-T1,Peve_00013260,Pocillopora_meandrina_HIv1___RNAseq.g17806.t1,three_way,83.551,FUN_031967-T1,Q95M17,CHIA_BOVIN,,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04),Bos taurus (Bovine),46.4,390.0,4.3999999999999996e-91,336.7,sp|Q95M17|CHIA_BOVIN Acidic mammalian chitinase OS=Bos taurus OX=9913 GN=CHIA PE=1 SV=1,GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0008843; GO:0032722,apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005975; GO:0012501; GO:0016787; GO:1901135,immune system process; catalytic activity; extracellular region; extracellular space; carbohydrate metabolic process; programmed cell death; hydrolase activity; carbohydrate derivative metabolic process
OG_06911,1.19779275352727,FUN_031971-T1,Peve_00043665,Pocillopora_meandrina_HIv1___RNAseq.g30205.t1,three_way,62.97566666666667,,,,,,,,,,,,,,,,,
OG_06913,1.0795950136502652,FUN_031974-T2,Peve_00043636,Pocillopora_meandrina_HIv1___TS.g22504.t1,three_way,69.29716666666667,FUN_031974-T2,Q866F4,,,,,31.2,818.0,1.2e-97,360.5,sp|Q866F4|ADCYA_RABIT Adenylate cyclase type 10 OS=Oryctolagus cuniculus OX=9986 GN=ADCY10 PE=2 SV=1,,,,,,
OG_06922,1.674144361655505,FUN_032012-T1,Peve_00028791,Pocillopora_meandrina_HIv1___RNAseq.g30267.t1,three_way,74.29599999999999,FUN_032012-T1,Q20191,,,,,44.3,228.0,1.5e-45,185.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_06956,1.71554824197583,FUN_032081-T1,Peve_00039910,Pocillopora_meandrina_HIv1___RNAseq.g5227.t1,three_way,79.99466666666666,FUN_032081-T1,Q5RE98,AOFB_PONAB,,Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.7,486.0,1.1000000000000001e-130,468.4,sp|Q5RE98|AOFB_PONAB Amine oxidase [flavin-containing] B OS=Pongo abelii OX=9601 GN=MAOB PE=2 SV=3,GO:0005739; GO:0005741; GO:0008131; GO:0050660; GO:0097621,,mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_06957,1.5065873377465386,FUN_032082-T1,Peve_00039909,Pocillopora_meandrina_HIv1___RNAseq.g5228.t1,three_way,70.91216666666666,FUN_032082-T1,Q6UWX4,,,,,47.1,605.0,4.7e-163,576.2,sp|Q6UWX4|HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens OX=9606 GN=HHIPL2 PE=1 SV=1,,,,,,
OG_06960,1.458477113984441,FUN_032089-T1,Peve_00012817,Pocillopora_meandrina_HIv1___RNAseq.g2588.t1,three_way,67.0965,,,,,,,,,,,,,,,,,
OG_06998,1.58061129183105,FUN_032147-T1,Peve_00007908,Pocillopora_meandrina_HIv1___RNAseq.g5342.t1,three_way,65.17866666666666,FUN_032147-T1,Q3U435,MMP25_MOUSE,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-),Mus musculus (Mouse),37.3,566.0,7.6e-77,289.7,sp|Q3U435|MMP25_MOUSE Matrix metalloproteinase-25 OS=Mus musculus OX=10090 GN=Mmp25 PE=2 SV=1,GO:0004222; GO:0005886; GO:0006508; GO:0008270; GO:0009986; GO:0016504; GO:0031012; GO:0060022; GO:0098552,hard palate development [GO:0060022]; proteolysis [GO:0006508],cell surface [GO:0009986]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],metalloendopeptidase activity [GO:0004222]; peptidase activator activity [GO:0016504]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030312; GO:0031012; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; external encapsulating structure; extracellular matrix; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07000,1.1795600281681295,FUN_032151-T1,Peve_00003236,Pocillopora_meandrina_HIv1___RNAseq.g5328.t1,three_way,63.626333333333335,FUN_032151-T1,Q9NPA2,MMP25_HUMAN,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP),Homo sapiens (Human),36.2,384.0,6.7e-56,219.9,sp|Q9NPA2|MMP25_HUMAN Matrix metalloproteinase-25 OS=Homo sapiens OX=9606 GN=MMP25 PE=1 SV=1,GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0035579; GO:0060022; GO:0098552,collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; specific granule membrane [GO:0035579],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0006954; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular space; plasma membrane; inflammatory response; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_07002,1.111458190947179,FUN_032154-T1,Peve_00003238,Pocillopora_meandrina_HIv1___RNAseq.g5326.t1,three_way,41.39083333333333,,,,,,,,,,,,,,,,,
OG_07035,1.117011715729068,FUN_032229-T1,Peve_00027503,Pocillopora_meandrina_HIv1___RNAseq.g24831.t1,three_way,71.70400000000001,FUN_032229-T1,Q66GV0,,,,,49.1,175.0,1.7e-41,170.6,sp|Q66GV0|MPV17_XENLA Mitochondrial inner membrane protein Mpv17 OS=Xenopus laevis OX=8355 GN=mpv17 PE=2 SV=2,,,,,,
OG_07037,1.167924985536814,FUN_032232-T1,Peve_00043437,Pocillopora_meandrina_HIv1___RNAseq.g24836.t1,three_way,68.60266666666666,FUN_032232-T1,Q6DG22,ADA_DANRE,,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),Danio rerio (Zebrafish) (Brachydanio rerio),48.0,350.0,3.3e-91,336.7,sp|Q6DG22|ADA_DANRE Adenosine deaminase OS=Danio rerio OX=7955 GN=ada PE=2 SV=2,GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0042110; GO:0043103; GO:0046103; GO:0046936; GO:0060169; GO:0060205; GO:0070161,adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110],anchoring junction [GO:0070161]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764],2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07051,1.1743501344893796,FUN_032271-T1,Peve_00030007,Pocillopora_meandrina_HIv1___RNAseq.g24973.t1,three_way,77.01566666666666,FUN_032271-T1,A5PJJ7,,,,,49.8,301.0,1.8999999999999998e-82,307.8,sp|A5PJJ7|S16C6_BOVIN Short-chain dehydrogenase/reductase family 16C member 6 OS=Bos taurus OX=9913 GN=SDR16C6 PE=2 SV=1,,,,,,
OG_07074,1.0140037981722043,FUN_032310-T1,Peve_00001530,Pocillopora_meandrina_HIv1___RNAseq.g24765.t1,three_way,78.05033333333333,FUN_032310-T1,Q6GPV5,,,,,48.7,156.0,3.2e-35,149.4,sp|Q6GPV5|RN181_XENLA E3 ubiquitin-protein ligase RNF181 OS=Xenopus laevis OX=8355 GN=rnf181 PE=2 SV=1,,,,,,
OG_07077,1.287781463454364,FUN_032314-T1,Peve_00031926,Pocillopora_meandrina_HIv1___RNAseq.g24787.t1,three_way,73.028,FUN_032314-T1,P83205,CATB_SHEEP,,Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain],Ovis aries (Sheep),56.0,336.0,2.5e-107,390.2,sp|P83205|CATB_SHEEP Cathepsin B OS=Ovis aries OX=9940 GN=CTSB PE=1 SV=2,GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090,cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471],collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0006575; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; modified amino acid metabolic process; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07103,2.0496328829287918,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_07105,1.1369328009873745,FUN_032372-T1,Peve_00036459,Pocillopora_meandrina_HIv1___TS.g12198.t1,three_way,80.77066666666667,FUN_032372-T1,Q04786,,,,,38.7,863.0,5.8e-153,543.1,sp|Q04786|HEX_VIBVL Beta-hexosaminidase OS=Vibrio vulnificus OX=672 GN=hex PE=3 SV=1,,,,,,
OG_07118,1.873546731148595,FUN_032395-T1,Peve_00036447,Pocillopora_meandrina_HIv1___RNAseq.g29833.t1,three_way,64.09349999999999,FUN_032395-T1,Q76LC6,RBM24_DANRE,,RNA-binding protein 24 (RNA-binding motif protein 24) (RNA-binding protein SEB-4),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,89.0,7.2e-27,122.5,sp|Q76LC6|RBM24_DANRE RNA-binding protein 24 OS=Danio rerio OX=7955 GN=rbm24 PE=2 SV=1,GO:0000381; GO:0001654; GO:0001756; GO:0001947; GO:0003228; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006974; GO:0007519; GO:0008380; GO:0010830; GO:0010831; GO:0035315; GO:0035925; GO:0043488; GO:0045663; GO:0048255; GO:0048702; GO:0060297; GO:0060298; GO:0061157; GO:0061158; GO:0071599; GO:0072359; GO:0097157; GO:1902811; GO:1905870; GO:1990715; GO:1990825; GO:2000738; GO:2000766,"3'-UTR-mediated mRNA destabilization [GO:0061158]; atrial cardiac muscle tissue development [GO:0003228]; circulatory system development [GO:0072359]; DNA damage response [GO:0006974]; embryonic neurocranium morphogenesis [GO:0048702]; eye development [GO:0001654]; hair cell differentiation [GO:0035315]; heart looping [GO:0001947]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; otic vesicle development [GO:0071599]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; regulation of sarcomere organization [GO:0060297]; RNA splicing [GO:0008380]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0030154; GO:0043226; GO:0048856,RNA binding; nucleus; cytosol; mRNA metabolic process; cell differentiation; organelle; anatomical structure development
OG_07123,1.1608709533242452,FUN_032422-T1,Peve_00009161,Pocillopora_meandrina_HIv1___RNAseq.g21126.t1,three_way,56.91133333333333,,,,,,,,,,,,,,,,,
OG_07129,1.5180347921248458,FUN_032429-T1,Peve_00027369,Pocillopora_meandrina_HIv1___RNAseq.g24121.t1,three_way,86.55766666666666,FUN_032429-T1,O95847,UCP4_HUMAN,,Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27),Homo sapiens (Human),60.4,303.0,4.3e-103,375.9,sp|O95847|UCP4_HUMAN Mitochondrial uncoupling protein 4 OS=Homo sapiens OX=9606 GN=SLC25A27 PE=1 SV=1,GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0015078; GO:0015108; GO:0022857; GO:0031966; GO:0035356; GO:0042803; GO:0043025; GO:0043524; GO:0045177; GO:0046324; GO:0048839; GO:0051562,inner ear development [GO:0048839]; intracellular triglyceride homeostasis [GO:0035356]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; regulation of D-glucose import [GO:0046324]; response to cold [GO:0009409],apical part of cell [GO:0045177]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025],chloride transmembrane transporter activity [GO:0015108]; protein homodimerization activity [GO:0042803]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005739; GO:0043226; GO:0048856,transporter activity; mitochondrion; organelle; anatomical structure development
OG_07134,1.006009858519674,FUN_032459-T1,Peve_00009149,Pocillopora_meandrina_HIv1___RNAseq.g24151.t1,three_way,75.24633333333333,,,,,,,,,,,,,,,,,
OG_07144,3.250374980191449,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_07150,1.5079495611816278,FUN_032503-T1,Peve_00042404,Pocillopora_meandrina_HIv1___TS.g12263.t1,three_way,58.67733333333334,FUN_032503-T1,Q20191,,,,,47.1,204.0,5.400000000000001e-44,181.0,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_07161,1.0580061261330436,FUN_032573-T1,Peve_00020057,Pocillopora_meandrina_HIv1___RNAseq.g24657.t1,three_way,46.22766666666666,FUN_032573-T1,Q90876,,,,,34.0,153.0,5.600000000000001e-23,109.4,sp|Q90876|IRF1_CHICK Interferon regulatory factor 1 OS=Gallus gallus OX=9031 GN=IRF1 PE=2 SV=1,,,,,,
OG_07168,1.0510929942262692,FUN_032603-T1,Peve_00001522,Pocillopora_meandrina_HIv1___RNAseq.g24627.t1,three_way,61.717666666666666,FUN_032603-T1,Q8NFZ3,,,,,34.2,588.0,2.8e-77,291.2,"sp|Q8NFZ3|NLGNY_HUMAN Neuroligin-4, Y-linked OS=Homo sapiens OX=9606 GN=NLGN4Y PE=1 SV=1",,,,,,
OG_07188,1.601912489583032,FUN_032679-T1,Peve_00015963,Pocillopora_meandrina_HIv1___RNAseq.g24109.t1,three_way,79.57666666666667,FUN_032679-T1,A4L9J0,MIP_RABIT,,Lens fiber major intrinsic protein (Aquaporin-0),Oryctolagus cuniculus (Rabbit),39.3,229.0,3.4e-33,143.7,sp|A4L9J0|MIP_RABIT Lens fiber major intrinsic protein OS=Oryctolagus cuniculus OX=9986 GN=MIP PE=2 SV=1,GO:0002088; GO:0005212; GO:0005516; GO:0005886; GO:0006833; GO:0007601; GO:0015250; GO:0016324; GO:0034109; GO:0036438; GO:0070161; GO:0098631; GO:1990349,gap junction-mediated intercellular transport [GO:1990349]; homotypic cell-cell adhesion [GO:0034109]; lens development in camera-type eye [GO:0002088]; maintenance of lens transparency [GO:0036438]; visual perception [GO:0007601]; water transport [GO:0006833],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; cell adhesion mediator activity [GO:0098631]; structural constituent of eye lens [GO:0005212]; water channel activity [GO:0015250],GO:0005198; GO:0005215; GO:0005886; GO:0007155; GO:0048856; GO:0050877; GO:0098631,structural molecule activity; transporter activity; plasma membrane; cell adhesion; anatomical structure development; nervous system process; cell adhesion mediator activity
OG_07192,1.0990356404621129,FUN_032690-T1,Peve_00006289,Pocillopora_meandrina_HIv1___RNAseq.g24100.t1,three_way,67.0185,FUN_032690-T1,Q9CPZ8,,,,,53.3,90.0,3.8e-21,102.4,sp|Q9CPZ8|COXM1_MOUSE COX assembly mitochondrial protein homolog OS=Mus musculus OX=10090 GN=Cmc1 PE=1 SV=1,,,,,,
OG_07200,1.1317103819498806,FUN_032709-T2,Peve_00029921,Pocillopora_meandrina_HIv1___RNAseq.g29873.t1,three_way,77.85433333333333,FUN_032709-T2,F1QB54,PABPA_DANRE,,Polyadenylate-binding protein 1A (PABP-1A) (Poly(A)-binding protein 1A),Danio rerio (Zebrafish) (Brachydanio rerio),58.9,628.0,1.0999999999999999e-187,657.9,sp|F1QB54|PABPA_DANRE Polyadenylate-binding protein 1A OS=Danio rerio OX=7955 GN=pabpc1a PE=1 SV=1,GO:0003730; GO:0005634; GO:0005829; GO:0006397; GO:0006412; GO:0006417; GO:0007507; GO:0008143; GO:0008266; GO:0010494; GO:1990904,heart development [GO:0007507]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; translation [GO:0006412],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0048856,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; anatomical structure development
OG_07218,1.1796994704060844,FUN_032790-T1,Peve_00010373,Pocillopora_meandrina_HIv1___RNAseq.g29721.t1,three_way,55.391333333333336,FUN_032790-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),38.8,456.0,1.5999999999999999e-83,312.8,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07220,1.1577639190662297,FUN_032813-T1,Peve_00010364,Pocillopora_meandrina_HIv1___TS.g24962.t1,three_way,46.85066666666666,FUN_032813-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),40.7,327.0,6.7e-59,230.7,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_07224,1.0227928074339714,FUN_032825-T1,Peve_00014525,Pocillopora_meandrina_HIv1___TS.g24937.t1a,three_way,59.772,FUN_032825-T1,A1ZAY1,DLISH_DROME,,SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains),Drosophila melanogaster (Fruit fly),55.6,63.0,2.3e-14,81.6,sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1,GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219,establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251],apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219],cadherin binding [GO:0045296],GO:0005929; GO:0007163; GO:0043226,cilium; establishment or maintenance of cell polarity; organelle
OG_07229,2.121840243895948,FUN_032885-T1,Peve_00001722,Pocillopora_meandrina_HIv1___RNAseq.g29858.t1,three_way,52.5095,,,,,,,,,,,,,,,,,
OG_07250,1.0908229860330976,FUN_032992-T1,Peve_00014540,Pocillopora_meandrina_HIv1___RNAseq.g24473.t1,three_way,73.003,FUN_032992-T1,Q8RCT3,,,,,57.0,302.0,2.5e-88,328.2,sp|Q8RCT3|PSUG_CALS4 Pseudouridine-5'-phosphate glycosidase OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=psuG PE=3 SV=1,,,,,,
OG_07251,1.7748823817374324,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_07253,1.1261419115092737,FUN_033016-T1,Peve_00015569,Pocillopora_meandrina_HIv1___RNAseq.g24465.t1,three_way,50.23716666666667,FUN_033016-T1,Q20911,,,,,32.7,107.0,1.5e-06,56.6,sp|Q20911|CUBN_CAEEL Cubilin homolog OS=Caenorhabditis elegans OX=6239 GN=cubn-1 PE=1 SV=4,,,,,,
OG_07262,1.0869374333188444,FUN_033039-T1,Peve_00017500,Pocillopora_meandrina_HIv1___RNAseq.g24445.t1,three_way,64.32033333333334,FUN_033039-T1,O94766,,,,,45.2,303.0,1.9e-65,251.1,sp|O94766|B3GA3_HUMAN Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Homo sapiens OX=9606 GN=B3GAT3 PE=1 SV=2,,,,,,
OG_07281,1.704421482012506,FUN_033488-T1,Peve_00033737,Pocillopora_meandrina_HIv1___RNAseq.g12099.t1,three_way,71.806,FUN_033488-T1,Q60848,HELLS_MOUSE,,Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein),Mus musculus (Mouse),50.1,807.0,3.8e-200,699.9,sp|Q60848|HELLS_MOUSE Lymphocyte-specific helicase OS=Mus musculus OX=10090 GN=Hells PE=1 SV=2,GO:0000775; GO:0001655; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006338; GO:0006346; GO:0006915; GO:0016787; GO:0030098; GO:0031507; GO:0031508; GO:0043066; GO:0044027; GO:0046651; GO:0051301; GO:0141119; GO:1990830; GO:2001243,apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; heterochromatin formation [GO:0031507]; kidney development [GO:0001822]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin formation [GO:0031508]; urogenital system development [GO:0001655],"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]",ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787],GO:0002376; GO:0003824; GO:0005634; GO:0006325; GO:0012501; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0048856; GO:0140657,immune system process; catalytic activity; nucleus; chromatin organization; programmed cell death; hydrolase activity; isomerase activity; cell differentiation; organelle; anatomical structure development; ATP-dependent activity
OG_07282,1.1512939590169902,FUN_033509-T1,Peve_00009172,Pocillopora_meandrina_HIv1___RNAseq.g24179.t1,three_way,62.28966666666666,FUN_033509-T1,P14942,GSTA4_RAT,,Glutathione S-transferase alpha-4 (EC 2.5.1.18) (GST 8-8) (GST A4-4) (GST K) (Glutathione S-transferase Yk) (GST Yk),Rattus norvegicus (Rat),30.8,211.0,1.5e-17,91.3,sp|P14942|GSTA4_RAT Glutathione S-transferase alpha-4 OS=Rattus norvegicus OX=10116 GN=Gsta4 PE=1 SV=2,GO:0004364; GO:0005739; GO:0005829; GO:0006749; GO:0006805; GO:0009635; GO:0010043; GO:0015643; GO:0035094; GO:0042802; GO:0042803; GO:0071285,cellular response to lithium ion [GO:0071285]; glutathione metabolic process [GO:0006749]; response to herbicide [GO:0009635]; response to nicotine [GO:0035094]; response to zinc ion [GO:0010043]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; mitochondrion [GO:0005739],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643],GO:0003824; GO:0005739; GO:0005829; GO:0006575; GO:0006790; GO:0016740; GO:0043226,catalytic activity; mitochondrion; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle
OG_07318,1.0278694162878566,FUN_033711-T1,Peve_00014636,Pocillopora_meandrina_HIv1___RNAseq.g28838.t1,three_way,71.58500000000001,FUN_033711-T1,O00418,EF2K_HUMAN,,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),Homo sapiens (Human),45.3,695.0,2.2e-155,550.8,sp|O00418|EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2,GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637,cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]",GO:0003824; GO:0005829; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07351,1.570186471945166,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_07360,1.1552233951642965,FUN_033771-T1,Peve_00006491,Pocillopora_meandrina_HIv1___RNAseq.g26660.t1,three_way,47.66133333333333,FUN_033771-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),34.7,340.0,7.799999999999999e-49,196.1,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_07373,1.768782449859141,FUN_033793-T2,Peve_00029690,Pocillopora_meandrina_HIv1___RNAseq.g26316.t1,three_way,63.531666666666666,,,,,,,,,,,,,,,,,
OG_07400,2.6304816644316698,FUN_033839-T1,Peve_00016490,Pocillopora_meandrina_HIv1___RNAseq.g26367.t1,three_way,53.79466666666666,,,,,,,,,,,,,,,,,
OG_07405,1.0364172875379818,FUN_033856-T2,Peve_00043300,Pocillopora_meandrina_HIv1___TS.g8205.t2,three_way,77.4,FUN_033856-T2,Q96KP4,CNDP2_HUMAN,,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase),Homo sapiens (Human),65.4,474.0,6.799999999999999e-188,658.3,sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2,GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573,proteolysis [GO:0006508],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07409,1.2209560708854,FUN_033862-T1,Peve_00043295,Pocillopora_meandrina_HIv1___RNAseq.g28416.t1,three_way,77.74766666666666,,,,,,,,,,,,,,,,,
OG_07414,1.8804788041537044,FUN_033872-T1,Peve_00043319,Pocillopora_meandrina_HIv1___RNAseq.g28409.t1,three_way,53.156,,,,,,,,,,,,,,,,,
OG_07418,1.0680205203953328,FUN_033878-T1,Peve_00043310,Pocillopora_meandrina_HIv1___RNAseq.g28402.t1,three_way,78.19333333333333,FUN_033878-T1,Q5U4K5,,,,,58.3,252.0,7.9e-75,282.0,sp|Q5U4K5|TM41B_XENLA Transmembrane protein 41B OS=Xenopus laevis OX=8355 GN=tmem41b PE=2 SV=1,,,,,,
OG_07426,1.007188810827837,FUN_033906-T1,Peve_00039887,Pocillopora_meandrina_HIv1___TS.g8165.t1a,three_way,38.5305,FUN_033906-T1,Q704V6,TLR6_BOVIN,,Toll-like receptor 6 (CD antigen CD286),Bos taurus (Bovine),37.8,111.0,1.4e-16,89.0,sp|Q704V6|TLR6_BOVIN Toll-like receptor 6 OS=Bos taurus OX=9913 GN=TLR6 PE=2 SV=1,GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227,cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355],"identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_07430,1.1528511286037546,FUN_033917-T1,Peve_00022631,Pocillopora_meandrina_HIv1___TS.g19347.t2a,three_way,44.82383333333333,,,,,,,,,,,,,,,,,
OG_07455,4.038110379879174,FUN_033951-T1,Peve_00032117,Pocillopora_meandrina_HIv1___RNAseq.g28360.t1,three_way,65.717,,,,,,,,,,,,,,,,,
OG_07470,1.9015970095674617,FUN_033980-T1,Peve_00004847,Pocillopora_meandrina_HIv1___RNAseq.g26110.t1,three_way,64.06066666666666,FUN_033980-T1,Q1EHB4,SC5AC_HUMAN,,Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12),Homo sapiens (Human),34.5,560.0,3.3e-86,320.9,sp|Q1EHB4|SC5AC_HUMAN Sodium-coupled monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC5A12 PE=1 SV=2,GO:0005343; GO:0005654; GO:0005886; GO:0006811; GO:0006814; GO:0015129; GO:0015293; GO:0015718; GO:0016324; GO:0070062; GO:0140161,monoatomic ion transport [GO:0006811]; monocarboxylic acid transport [GO:0015718]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; symporter activity [GO:0015293],GO:0005215; GO:0005654; GO:0005886; GO:0043226,transporter activity; nucleoplasm; plasma membrane; organelle
OG_07518,1.1587300490459758,FUN_034086-T1,Peve_00037076,Pocillopora_meandrina_HIv1___RNAseq.g26057.t1,three_way,75.915,FUN_034086-T1,Q2S1V4,,,,,52.2,469.0,6e-134,479.2,sp|Q2S1V4|TNAA_SALRD Tryptophanase OS=Salinibacter ruber (strain DSM 13855 / M31) OX=309807 GN=tnaA PE=3 SV=1,,,,,,
OG_07535,1.0826141211266973,FUN_034111-T1,Peve_00034867,Pocillopora_meandrina_HIv1___TS.g18705.t1a,three_way,76.7515,FUN_034111-T1,Q0P5H9,TTC5_BOVIN,,Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Protein Strap),Bos taurus (Bovine),50.7,302.0,4.8e-81,302.8,sp|Q0P5H9|TTC5_BOVIN Tetratricopeptide repeat protein 5 OS=Bos taurus OX=9913 GN=TTC5 PE=2 SV=1,GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006281; GO:0006974; GO:0009267; GO:0031410,cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; DNA repair [GO:0006281],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634],,GO:0005634; GO:0005739; GO:0005829; GO:0006281; GO:0031410; GO:0043226,nucleus; mitochondrion; cytosol; DNA repair; cytoplasmic vesicle; organelle
OG_07537,1.0730717526958409,FUN_034113-T1,Peve_00034855,Pocillopora_meandrina_HIv1___RNAseq.g25956.t1,three_way,76.55533333333334,FUN_034113-T1,Q178L7,,,,,58.6,116.0,4.899999999999999e-31,135.6,"sp|Q178L7|SDHF2_AEDAE Succinate dehydrogenase assembly factor 2, mitochondrial OS=Aedes aegypti OX=7159 GN=AAEL005866 PE=3 SV=1",,,,,,
OG_07550,1.1363453766892877,FUN_034132-T1,Peve_00006384,Pocillopora_meandrina_HIv1___RNAseq.g7012.t1,three_way,59.236666666666665,FUN_034132-T1,A0A2B4RP11,,,,,53.8,372.0,1.1e-103,378.3,sp|A0A2B4RP11|CGLR1_STYPI Cyclic GMP-AMP synthase-like receptor 1 OS=Stylophora pistillata OX=50429 GN=cGLR1 PE=1 SV=1,,,,,,
OG_07623,1.013225136720816,FUN_034368-T1,Peve_00036157,Pocillopora_meandrina_HIv1___RNAseq.g26131.t2,three_way,72.677,FUN_034368-T1,Q9TW28,,,,,31.6,269.0,1.9e-30,135.6,sp|Q9TW28|MYOM_DICDI Myosin-M heavy chain OS=Dictyostelium discoideum OX=44689 GN=myoM PE=1 SV=1,,,,,,
OG_07628,1.1913824145163778,FUN_034376-T1,Peve_00027168,Pocillopora_meandrina_HIv1___RNAseq.g26154.t1,three_way,68.84483333333333,FUN_034376-T1,E7FAG6,AMR1A_DANRE,,Activating molecule in BECN1-regulated autophagy protein 1A,Danio rerio (Zebrafish) (Brachydanio rerio),26.3,954.0,1.9e-61,238.8,sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2,GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0006914; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0043231; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; chordate embryonic development [GO:0043009]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741],autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634],protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005856; GO:0006914; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; mitochondrion; vacuole; endoplasmic reticulum; cytosol; cytoskeleton; autophagy; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_07645,1.0204834078054974,FUN_034460-T1,Peve_00025955,Pocillopora_meandrina_HIv1___RNAseq.g25842.t2,three_way,66.28216666666667,FUN_034460-T1,Q8QGX4,PRKDC_CHICK,,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1),Gallus gallus (Chicken),40.0,1500.0,3.2e-308,1059.7,sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1,GO:0000723; GO:0000724; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0008630; GO:0031571; GO:0033152; GO:0035979; GO:0042254; GO:0070419; GO:0106310,double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; ribosome biogenesis [GO:0042254]; telomere maintenance [GO:0000723],nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016740; GO:0032200; GO:0042254; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; transferase activity; telomere organization; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_07648,1.3331184594744672,FUN_034480-T1,Peve_00008656,Pocillopora_meandrina_HIv1___RNAseq.g25905.t1,three_way,72.97983333333333,,,,,,,,,,,,,,,,,
OG_07652,1.1864915024573233,FUN_034486-T1,Peve_00043236,Pocillopora_meandrina_HIv1___RNAseq.g28569.t1,three_way,78.29433333333334,FUN_034486-T1,Q13613,,,,,45.0,387.0,6.2e-98,360.5,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_07659,1.0800278455694017,FUN_034604-T1,Peve_00037084,Pocillopora_meandrina_HIv1___TS.g18635.t1,three_way,65.48566666666666,FUN_034604-T1,Q90XE6,KLF1_DANRE,,Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d),Danio rerio (Zebrafish) (Brachydanio rerio),80.0,80.0,5.7e-08,59.7,sp|Q90XE6|KLF1_DANRE Kruppel-like factor 1 OS=Danio rerio OX=7955 GN=klf1 PE=2 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0008270; GO:0010628; GO:0010725; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0055007; GO:0060038; GO:0060319,animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07677,1.1430374388219002,FUN_034795-T1,Peve_00007519,Pocillopora_meandrina_HIv1___RNAseq.g12295.t1,three_way,68.32300000000001,FUN_034795-T1,Q5RFU0,,,,,42.2,500.0,3.2999999999999996e-114,413.7,sp|Q5RFU0|SIAE_PONAB Sialate O-acetylesterase OS=Pongo abelii OX=9601 GN=SIAE PE=2 SV=1,,,,,,
OG_07716,1.2188939714331688,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_07731,1.652997122637146,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_07732,1.4328132382506316,FUN_034893-T1,Peve_00037337,Pocillopora_meandrina_HIv1___RNAseq.g27805.t1,three_way,60.900333333333336,FUN_034893-T1,Q8R4E9,CDT1_MOUSE,,DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein),Mus musculus (Mouse),32.5,449.0,1.2e-50,203.0,sp|Q8R4E9|CDT1_MOUSE DNA replication factor Cdt1 OS=Mus musculus OX=10090 GN=Cdt1 PE=1 SV=1,GO:0000076; GO:0000776; GO:0003677; GO:0003682; GO:0005634; GO:0016604; GO:0030174; GO:0033262; GO:0051315; GO:0071163; GO:0072708; GO:2000104; GO:2000105,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; DNA replication checkpoint signaling [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of DNA-templated DNA replication [GO:2000104]; positive regulation of DNA-templated DNA replication [GO:2000105]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708],kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0043226; GO:0065003,DNA binding; nucleus; organelle; protein-containing complex assembly
OG_07749,1.0112040872157375,FUN_034938-T1,Peve_00036685,Pocillopora_meandrina_HIv1___RNAseq.g27832.t1,three_way,69.10716666666667,FUN_034938-T1,Q7Z614,SNX20_HUMAN,,Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1),Homo sapiens (Human),35.0,246.0,3.5000000000000005e-22,107.1,sp|Q7Z614|SNX20_HUMAN Sorting nexin-20 OS=Homo sapiens OX=9606 GN=SNX20 PE=1 SV=1,GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981,protein transport [GO:0015031],early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005654; GO:0005886; GO:0008289,nucleoplasm; plasma membrane; lipid binding
OG_07762,1.1112390670068448,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_07777,1.0410725648854424,FUN_034993-T1,Peve_00024607,Pocillopora_meandrina_HIv1___RNAseq.g12122.t1,three_way,65.4765,FUN_034993-T1,Q90WY6,ADA2C_DANRE,,Alpha-2C adrenergic receptor (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR),Danio rerio (Zebrafish) (Brachydanio rerio),29.2,233.0,3.5e-14,80.9,sp|Q90WY6|ADA2C_DANRE Alpha-2C adrenergic receptor OS=Danio rerio OX=7955 GN=adra2c PE=3 SV=1,GO:0004938; GO:0005886; GO:0006940; GO:0007186; GO:0019229; GO:0030168; GO:0051379; GO:0071881,adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; G protein-coupled receptor signaling pathway [GO:0007186]; platelet activation [GO:0030168]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229],plasma membrane [GO:0005886],alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379],GO:0003013; GO:0005886; GO:0060089,circulatory system process; plasma membrane; molecular transducer activity
OG_07787,1.1092355203609217,FUN_035008-T1,Peve_00024587,Pocillopora_meandrina_HIv1___RNAseq.g12134.t1,three_way,76.40066666666667,FUN_035008-T1,Q9VCA2,,,,,32.9,538.0,3.9e-72,273.9,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_07807,1.8110064192806112,FUN_035052-T1,Peve_00011121,Pocillopora_meandrina_HIv1___RNAseq.g27741.t1,three_way,68.56233333333333,FUN_035052-T1,Q9C2L8,,,,,29.8,168.0,2.7e-14,80.5,sp|Q9C2L8|RAB7_NEUCR Ypt/Rab-type GTPase Rab7 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=gtp-14 PE=3 SV=1,,,,,,
OG_07835,1.604170096996798,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_07836,3.025300710001094,FUN_035166-T1,Peve_00036194,Pocillopora_meandrina_HIv1___RNAseq.g27915.t1,three_way,52.95516666666667,FUN_035166-T1,Q29477,TRFL_CAPHI,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-),Capra hircus (Goat),35.5,366.0,2.5e-42,174.5,sp|Q29477|TRFL_CAPHI Lactotransferrin OS=Capra hircus OX=9925 GN=LTF PE=1 SV=1,GO:0001503; GO:0001817; GO:0002227; GO:0005615; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0008236; GO:0019731; GO:0019732; GO:0031665; GO:0032680; GO:0033690; GO:0042581; GO:0043066; GO:0045669; GO:0046872; GO:0055037; GO:0060349; GO:1900159; GO:1900229; GO:1902732; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; bone morphogenesis [GO:0060349]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule [GO:0042581],metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236],GO:0002376; GO:0003824; GO:0005615; GO:0005768; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; endosome; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_07872,1.9225787334710664,FUN_035231-T1,Peve_00044486,Pocillopora_meandrina_HIv1___RNAseq.g27905.t1,three_way,73.57433333333333,,,,,,,,,,,,,,,,,
OG_07907,1.032427462276723,FUN_035351-T1,Peve_00016239,Pocillopora_meandrina_HIv1___RNAseq.g12260.t1,three_way,72.70233333333333,FUN_035351-T1,Q6XPZ3,PAG15_CANLF,,Lysosomal phospholipase A and acyltransferase (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (EC 3.1.1.5) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2) (Phospholipase A2 group XV),Canis lupus familiaris (Dog) (Canis familiaris),40.4,394.0,2.3999999999999998e-82,307.4,sp|Q6XPZ3|PAG15_CANLF Lysosomal phospholipase A and acyltransferase OS=Canis lupus familiaris OX=9615 GN=PLA2G15 PE=1 SV=1,GO:0004622; GO:0005615; GO:0005654; GO:0005764; GO:0006631; GO:0006650; GO:0006651; GO:0006658; GO:0006672; GO:0008270; GO:0008374; GO:0008970; GO:0016020; GO:0016411; GO:0034638; GO:0046338; GO:0046470; GO:0046471; GO:0047499,ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658],extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654],acylglycerol O-acyltransferase activity [GO:0016411]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipase A1 activity [GO:0008970]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005654; GO:0005764; GO:0005773; GO:0006575; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; extracellular space; nucleoplasm; lysosome; vacuole; modified amino acid metabolic process; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_07910,1.015336847381347,FUN_035368-T1,Peve_00016220,Pocillopora_meandrina_HIv1___TS.g3560.t1,three_way,68.399,FUN_035368-T1,P10611,,,,,35.0,451.0,5.5e-78,293.1,sp|P10611|CP4A4_RABIT Cytochrome P450 4A4 OS=Oryctolagus cuniculus OX=9986 GN=CYP4A4 PE=1 SV=3,,,,,,
OG_07911,1.6941757157119384,FUN_035369-T1,Peve_00016219,Pocillopora_meandrina_HIv1___TS.g3559.t1,three_way,73.006,FUN_035369-T1,Q5ZIJ9,,,,,36.0,100.0,7e-11,70.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_07916,1.108473665891888,FUN_035397-T1,Peve_00005178,Pocillopora_meandrina_HIv1___RNAseq.g12210.t1,three_way,59.64666666666667,,,,,,,,,,,,,,,,,
OG_07929,1.5344326015115148,FUN_035418-T1,Peve_00039851,Pocillopora_meandrina_HIv1___RNAseq.g27566.t1,three_way,69.55066666666667,FUN_035418-T1,B8AJ09,,,,,28.2,312.0,1.7e-16,88.6,"sp|B8AJ09|BASS4_ORYSI Probable sodium/metabolite cotransporter BASS4, chloroplastic OS=Oryza sativa subsp. indica OX=39946 GN=BASS4 PE=3 SV=1",,,,,,
OG_07933,1.8114889362123263,FUN_035426-T1,Peve_00007639,Pocillopora_meandrina_HIv1___RNAseq.g27573.t1,three_way,42.896,,,,,,,,,,,,,,,,,
OG_07947,1.0555892774414914,FUN_035468-T1,Peve_00012132,Pocillopora_meandrina_HIv1___TS.g14397.t1,three_way,83.6845,FUN_035468-T1,Q8BH04,PCKGM_MOUSE,,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",Mus musculus (Mouse),65.5,611.0,6.100000000000001e-248,858.2,"sp|Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Mus musculus OX=10090 GN=Pck2 PE=1 SV=1",GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0030145; GO:0032024; GO:0032496; GO:0071333; GO:0071356; GO:0071548,cellular response to glucose stimulus [GO:0071333]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; pyruvate metabolic process [GO:0006090]; response to dexamethasone [GO:0071548]; response to lipopolysaccharide [GO:0032496],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],GO:0003824; GO:0005739; GO:0005975; GO:0016829; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lyase activity; organelle
OG_07956,1.5547790853209231,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_07961,1.773191938205085,FUN_035519-T1,Peve_00007927,Pocillopora_meandrina_HIv1___RNAseq.g26966.t1,three_way,53.88283333333334,FUN_035519-T1,A3KMR8,MAFA_DANRE,,Transcription factor MafAa (Somite Maf1) (SMaf1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,97.0,4.2e-09,63.2,sp|A3KMR8|MAFA_DANRE Transcription factor MafAa OS=Danio rerio OX=7955 GN=mafaa PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07963,1.189303549751535,FUN_035524-T1,Peve_00020842,Pocillopora_meandrina_HIv1___RNAseq.g26954.t1,three_way,73.49983333333333,FUN_035524-T1,O54975,XPP1_RAT,,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",Rattus norvegicus (Rat),44.4,626.0,4.6e-150,533.1,sp|O54975|XPP1_RAT Xaa-Pro aminopeptidase 1 OS=Rattus norvegicus OX=10116 GN=Xpnpep1 PE=1 SV=1,GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016787; GO:0140096,"catalytic activity; cytosol; hydrolase activity; catalytic activity, acting on a protein"
OG_07972,1.7456821182649225,FUN_035547-T1,Peve_00036924,Pocillopora_meandrina_HIv1___RNAseq.11135_t,three_way,45.327,,,,,,,,,,,,,,,,,
OG_07996,1.6201736730761678,FUN_035637-T1,Peve_00029721,Pocillopora_meandrina_HIv1___RNAseq.g28085.t1,three_way,59.298,,,,,,,,,,,,,,,,,
OG_08002,1.1039471558638556,FUN_035648-T1,Peve_00022818,Pocillopora_meandrina_HIv1___RNAseq.g28098.t1,three_way,65.012,FUN_035648-T1,P53668,LIMK1_MOUSE,,LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (KIZ-1),Mus musculus (Mouse),32.9,210.0,5.1e-23,110.2,sp|P53668|LIMK1_MOUSE LIM domain kinase 1 OS=Mus musculus OX=10090 GN=Limk1 PE=1 SV=1,GO:0001673; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0016020; GO:0016607; GO:0030027; GO:0031072; GO:0031625; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051496; GO:0098794; GO:0098978; GO:0106310; GO:1990948,axon extension [GO:0048675]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; stress fiber assembly [GO:0043149],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08004,1.1744290502472994,FUN_035653-T1,Peve_00028212,Pocillopora_meandrina_HIv1___RNAseq.g28108.t1,three_way,78.766,FUN_035653-T1,Q568Z7,CIB2_RAT,,Calcium and integrin-binding family member 2,Rattus norvegicus (Rat),52.7,188.0,6.2e-54,213.0,sp|Q568Z7|CIB2_RAT Calcium and integrin-binding family member 2 OS=Rattus norvegicus OX=10116 GN=Cib2 PE=1 SV=1,GO:0000287; GO:0001750; GO:0001917; GO:0005178; GO:0005509; GO:0005737; GO:0005829; GO:0005927; GO:0007204; GO:0031594; GO:0032420; GO:0032437; GO:0042383; GO:0042803; GO:0044877; GO:0045494; GO:0055074; GO:0071318; GO:0071944,calcium ion homeostasis [GO:0055074]; cellular response to ATP [GO:0071318]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cytosolic calcium ion concentration [GO:0007204],cell periphery [GO:0071944]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; sarcolemma [GO:0042383]; stereocilium [GO:0032420],calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0005829; GO:0005886,cytosol; plasma membrane
OG_08008,1.3292049286914087,FUN_035660-T1,Peve_00020774,Pocillopora_meandrina_HIv1___RNAseq.g28116.t1,three_way,60.16833333333333,,,,,,,,,,,,,,,,,
OG_08056,1.3932282349087346,FUN_035751-T1,Peve_00044197,Pocillopora_meandrina_HIv1___RNAseq.g11877.t1,three_way,71.535,FUN_035751-T1,P54802,ANAG_HUMAN,,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form],Homo sapiens (Human),50.3,708.0,3.1000000000000005e-214,746.5,sp|P54802|ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2,GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016020; GO:0016042; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030202; GO:0030203; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0097696; GO:0099022; GO:1904389; GO:1904390,adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; lipid catabolic process [GO:0016042]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020],alpha-N-acetylglucosaminidase activity [GO:0004561],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0006629; GO:0006914; GO:0007040; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0051604; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; lipid metabolic process; autophagy; lysosome organization; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; protein maturation; carbohydrate derivative metabolic process
OG_08061,1.110031868200045,FUN_035758-T1,Peve_00033436,Pocillopora_meandrina_HIv1___RNAseq.g11888.t1,three_way,71.446,FUN_035758-T1,Q9PVY8,,,,,68.4,155.0,1.1e-52,209.1,sp|Q9PVY8|FXC2B_XENLA Forkhead box protein C2-B OS=Xenopus laevis OX=8355 GN=foxc2-b PE=2 SV=2,,,,,,
OG_08092,1.15270382450366,FUN_035825-T1,Peve_00037803,Pocillopora_meandrina_HIv1___RNAseq.g11934.t1,three_way,85.167,FUN_035825-T1,Q80VY9,DHX33_MOUSE,,ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33),Mus musculus (Mouse),58.4,630.0,1.3e-219,764.2,sp|Q80VY9|DHX33_MOUSE ATP-dependent RNA helicase DHX33 OS=Mus musculus OX=10090 GN=Dhx33 PE=1 SV=1,GO:0000182; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0016887; GO:0032481; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:0140297; GO:1900227,positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08094,1.688056732403034,FUN_035829-T1,Peve_00002595,Pocillopora_meandrina_HIv1___RNAseq.g11938.t1,three_way,39.348333333333336,,,,,,,,,,,,,,,,,
OG_08095,1.4785374059112368,FUN_035833-T1,Peve_00002593,Pocillopora_meandrina_HIv1___RNAseq.g11963.t1,three_way,82.79166666666667,FUN_035833-T1,O74212,,,,,49.9,443.0,1.9999999999999999e-128,460.7,sp|O74212|D5FAD_MORAP Acyl-lipid (8-3)-desaturase OS=Mortierella alpina OX=64518 GN=DES1 PE=1 SV=1,,,,,,
OG_08097,1.7162789526730835,FUN_035839-T1,Peve_00032500,Pocillopora_meandrina_HIv1___RNAseq.g11958.t2,three_way,68.27866666666667,,,,,,,,,,,,,,,,,
OG_08098,1.5570855582532588,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_08140,1.2603033717796488,FUN_035902-T1,Peve_00006711,Pocillopora_meandrina_HIv1___TS.g3367.t1,three_way,85.12433333333334,FUN_035902-T1,Q9JJ94,SSNA1_MOUSE,,Microtubule nucleation factor SSNA1 (Sjoegren syndrome nuclear autoantigen 1 homolog),Mus musculus (Mouse),44.7,114.0,9e-12,71.2,sp|Q9JJ94|SSNA1_MOUSE Microtubule nucleation factor SSNA1 OS=Mus musculus OX=10090 GN=Ssna1 PE=1 SV=1,GO:0000226; GO:0005634; GO:0005813; GO:0005814; GO:0005886; GO:0005930; GO:0007020; GO:0007409; GO:0008017; GO:0030424; GO:0030496; GO:0031514; GO:0036064; GO:0042073; GO:0042802; GO:0043113; GO:0048675; GO:0051301; GO:0099512; GO:0140060,axon arborization [GO:0140060]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell division [GO:0051301]; intraciliary transport [GO:0042073]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; receptor clustering [GO:0043113],axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; midbody [GO:0030496]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; supramolecular fiber [GO:0099512],identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005634; GO:0005815; GO:0005886; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0043226,nucleus; microtubule organizing center; plasma membrane; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; organelle
OG_08151,1.719510594824235,FUN_035923-T1,Peve_00006710,Pocillopora_meandrina_HIv1___RNAseq.g12052.t1,three_way,56.369166666666665,,,,,,,,,,,,,,,,,
OG_08163,1.204524781390947,FUN_035945-T1,Peve_00036633,Pocillopora_meandrina_HIv1___RNAseq.g12353.t1,three_way,72.697,FUN_035945-T1,Q5RJV0,,,,,44.9,243.0,8.8e-55,215.3,"sp|Q5RJV0|COQ9_XENTR Ubiquinone biosynthesis protein COQ9, mitochondrial OS=Xenopus tropicalis OX=8364 GN=coq9 PE=2 SV=1",,,,,,
OG_08189,1.0262208393391106,FUN_036029-T1,Peve_00011105,Pocillopora_meandrina_HIv1___RNAseq.g27239.t1,three_way,87.85733333333333,FUN_036029-T1,P37879,,,,,74.4,426.0,4e-195,682.2,sp|P37879|SYK_CRIGR Lysine--tRNA ligase OS=Cricetulus griseus OX=10029 GN=KARS1 PE=1 SV=1,,,,,,
OG_08202,1.508453868984358,FUN_036047-T1,Peve_00029867,Pocillopora_meandrina_HIv1___RNAseq.g27387.t1,three_way,71.29666666666667,FUN_036047-T1,Q2HJ57,,,,,48.2,137.0,3.2999999999999997e-29,129.4,sp|Q2HJ57|COTL1_BOVIN Coactosin-like protein OS=Bos taurus OX=9913 GN=COTL1 PE=2 SV=3,,,,,,
OG_08217,2.605267267276145,FUN_036077-T1,Peve_00018989,Pocillopora_meandrina_HIv1___RNAseq.g27413.t1,three_way,66.047,,,,,,,,,,,,,,,,,
OG_08222,1.154377003760885,FUN_036093-T1,Peve_00032189,Pocillopora_meandrina_HIv1___RNAseq.g27441.t1,three_way,76.63133333333333,FUN_036093-T1,Q68DA7,FMN1_HUMAN,,Formin-1 (Limb deformity protein homolog),Homo sapiens (Human),33.3,471.0,1.5e-63,246.1,sp|Q68DA7|FMN1_HUMAN Formin-1 OS=Homo sapiens OX=9606 GN=FMN1 PE=1 SV=3,GO:0003779; GO:0005634; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0030036; GO:0045010,actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010],actin filament [GO:0005884]; adherens junction [GO:0005912]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0005634; GO:0005886; GO:0007010; GO:0008092; GO:0043226,nucleus; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08226,1.0134074026883817,FUN_036097-T2,Peve_00032194,Pocillopora_meandrina_HIv1___RNAseq.g27437.t1,three_way,61.02516666666666,FUN_036097-T2,Q801E2,ANLN_XENLA,,Anillin,Xenopus laevis (African clawed frog),34.7,432.0,4.6e-56,221.5,sp|Q801E2|ANLN_XENLA Anillin OS=Xenopus laevis OX=8355 GN=anln PE=1 SV=1,GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005826; GO:0005938; GO:0031106; GO:0032059; GO:1904172,actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; septin ring organization [GO:0031106],actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; nucleus [GO:0005634],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0007010; GO:0008092; GO:0043226,cytokinesis; nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08228,2.102082011952473,FUN_036100-T1,Peve_00032196,Pocillopora_meandrina_HIv1___RNAseq.g27435.t1,three_way,77.412,FUN_036100-T1,Q0P8I7,GMHD_CAMJE,,GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-),Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168),41.3,310.0,2.6e-64,247.3,sp|Q0P8I7|GMHD_CAMJE GDP-D-glycero-alpha-D-manno-heptose dehydrogenase OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) OX=192222 GN=Cj1427c PE=1 SV=1,GO:0003978; GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404,capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289],,GDP binding [GO:0019003]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491]; UDP-glucose 4-epimerase activity [GO:0003978],GO:0003824; GO:0005975; GO:0016491; GO:0016853; GO:0065003,catalytic activity; carbohydrate metabolic process; oxidoreductase activity; isomerase activity; protein-containing complex assembly
OG_08229,2.1989159808564165,FUN_036101-T1,Peve_00032197,Pocillopora_meandrina_HIv1___RNAseq.g10817.t1,three_way,53.59666666666666,,,,,,,,,,,,,,,,,
OG_08233,1.1100125822149214,FUN_036109-T1,Peve_00003699,Pocillopora_meandrina_HIv1___RNAseq.g27427.t1,three_way,71.93266666666666,FUN_036109-T1,Q330K2,NDUF6_HUMAN,,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (Putative phytoene synthase)",Homo sapiens (Human),51.8,301.0,2.4e-85,317.0,"sp|Q330K2|NDUF6_HUMAN NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 OS=Homo sapiens OX=9606 GN=NDUFAF6 PE=1 SV=2",GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0009058; GO:0032981,biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634],,GO:0005634; GO:0005739; GO:0043226; GO:0065003,nucleus; mitochondrion; organelle; protein-containing complex assembly
OG_08237,1.4770097106502451,FUN_036116-T1,Peve_00000283,Pocillopora_meandrina_HIv1___RNAseq.g27423.t1,three_way,63.0515,FUN_036116-T1,O34313,NTPES_BACSU,,"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]",Bacillus subtilis (strain 168),27.1,510.0,4.6e-36,154.8,sp|O34313|NTPES_BACSU Trifunctional nucleotide phosphoesterase protein YfkN OS=Bacillus subtilis (strain 168) OX=224308 GN=yfkN PE=1 SV=1,GO:0000166; GO:0005576; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872,nucleotide catabolic process [GO:0009166],extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288],"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]",GO:0003824; GO:0005576; GO:0016787; GO:0055086,catalytic activity; extracellular region; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_08249,1.003746698703505,FUN_036158-T1,Peve_00039218,Pocillopora_meandrina_HIv1___RNAseq.g27493.t1,three_way,85.587,FUN_036158-T1,Q5PQY6,,,,,58.8,838.0,6.9e-268,924.9,"sp|Q5PQY6|LONP2_DANRE Lon protease homolog 2, peroxisomal OS=Danio rerio OX=7955 GN=lonp2 PE=2 SV=1",,,,,,
OG_08274,1.0961137088470112,FUN_036189-T1,Peve_00038735,Pocillopora_meandrina_HIv1___RNAseq.g27372.t1,three_way,67.0075,FUN_036189-T1,P42674,,,,,42.8,208.0,8.1e-39,164.1,sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1,,,,,,
OG_08337,1.1334946953252645,FUN_036850-T1,Peve_00036530,Pocillopora_meandrina_HIv1___RNAseq.g10652.t1,three_way,46.763666666666666,,,,,,,,,,,,,,,,,
OG_08340,1.160955033870043,FUN_036857-T1,Peve_00001064,Pocillopora_meandrina_HIv1___RNAseq.g27062.t1,three_way,73.51566666666666,FUN_036857-T1,Q8BTI7,,,,,29.1,158.0,2.6e-07,58.9,sp|Q8BTI7|ANR52_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Mus musculus OX=10090 GN=Ankrd52 PE=1 SV=1,,,,,,
OG_08341,2.279858892200385,FUN_036858-T1,Peve_00001065,Pocillopora_meandrina_HIv1___RNAseq.g27061.t1,three_way,76.1845,FUN_036858-T1,P22412,,,,,50.9,369.0,1.1e-104,381.7,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_08342,1.3046394938049977,FUN_036865-T1,Peve_00044052,Pocillopora_meandrina_HIv1___RNAseq.g28988.t1,three_way,35.233666666666664,,,,,,,,,,,,,,,,,
OG_08355,1.1089520601666731,FUN_036899-T1,Peve_00018371,Pocillopora_meandrina_HIv1___RNAseq.g26703.t1,three_way,78.23133333333332,FUN_036899-T1,Q8VZ42,,,,,40.3,129.0,1.3e-25,117.5,sp|Q8VZ42|SAP11_ARATH Zinc finger AN1 and C2H2 domain-containing stress-associated protein 11 OS=Arabidopsis thaliana OX=3702 GN=SAP11 PE=2 SV=1,,,,,,
OG_08362,1.5309029175565507,FUN_036911-T1,Peve_00018411,Pocillopora_meandrina_HIv1___RNAseq.g10816.t1,three_way,73.75933333333333,FUN_036911-T1,P51614,,,,,32.5,292.0,1.1e-35,152.5,sp|P51614|CHIT3_VITVI Acidic endochitinase OS=Vitis vinifera OX=29760 GN=CHIT3 PE=2 SV=1,,,,,,
OG_08380,1.0704725344377193,FUN_036957-T1,Peve_00040027,Pocillopora_meandrina_HIv1___RNAseq.g10871.t1,three_way,78.528,FUN_036957-T1,Q68F72,S15A4_XENLA,,Solute carrier family 15 member 4,Xenopus laevis (African clawed frog),36.0,483.0,8.700000000000001e-78,292.7,sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_08391,1.4458824355170865,FUN_037001-T1,Peve_00002157,Pocillopora_meandrina_HIv1___RNAseq.g26679.t1,three_way,50.65266666666667,,,,,,,,,,,,,,,,,
OG_08392,1.3420992947827208,FUN_037004-T1,Peve_00002158,Pocillopora_meandrina_HIv1___RNAseq.g26681.t1,three_way,58.53766666666667,FUN_037004-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),35.2,267.0,1.5999999999999998e-41,172.9,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08427,1.2102554608653593,FUN_037089-T1,Peve_00004758,Pocillopora_meandrina_HIv1___RNAseq.g11095.t1,three_way,84.80416666666667,FUN_037089-T1,Q9NQ94,,,,,49.9,583.0,6.8e-140,499.2,sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1,,,,,,
OG_08452,1.091720686574185,FUN_037217-T2,Peve_00006683,Pocillopora_meandrina_HIv1___RNAseq.g11057.t1,three_way,61.09466666666667,FUN_037217-T2,Q8BFR2,,,,,25.6,789.0,5.4e-64,247.3,sp|Q8BFR2|FSTL5_MOUSE Follistatin-related protein 5 OS=Mus musculus OX=10090 GN=Fstl5 PE=2 SV=1,,,,,,
OG_08490,1.0570739206086293,FUN_037327-T1,Peve_00006233,Pocillopora_meandrina_HIv1___RNAseq.g10694.t1,three_way,65.693,FUN_037327-T1,Q90YK3,,,,,49.0,437.0,2.1e-133,477.2,sp|Q90YK3|GGLO_SCYTO L-gulonolactone oxidase OS=Scyliorhinus torazame OX=75743 GN=GULO PE=2 SV=1,,,,,,
OG_08508,1.041787737593756,FUN_037416-T2,Peve_00028857,Pocillopora_meandrina_HIv1___RNAseq.g10945.t1,three_way,60.57983333333333,FUN_037416-T2,Q569T7,,,,,33.2,400.0,7.700000000000001e-48,193.0,sp|Q569T7|MFS4B_XENLA Sodium-dependent glucose transporter 1 OS=Xenopus laevis OX=8355 GN=mfsd4b PE=2 SV=1,,,,,,
OG_08540,1.2798065939384942,FUN_037491-T1,Peve_00028570,Pocillopora_meandrina_HIv1___RNAseq.g1307.t1,three_way,88.51766666666667,FUN_037491-T1,P31153,METK2_HUMAN,,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),Homo sapiens (Human),79.0,381.0,3.6e-177,622.5,sp|P31153|METK2_HUMAN S-adenosylmethionine synthase isoform type-2 OS=Homo sapiens OX=9606 GN=MAT2A PE=1 SV=1,GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0036094; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0061431; GO:1904263; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to methionine [GO:0061431]; one-carbon metabolic process [GO:0006730]; positive regulation of TORC1 signaling [GO:1904263]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556],cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; small molecule binding [GO:0036094],GO:0003824; GO:0005829; GO:0006790; GO:0016740; GO:0065003,catalytic activity; cytosol; sulfur compound metabolic process; transferase activity; protein-containing complex assembly
OG_08546,1.6796384555615125,FUN_037508-T1,Peve_00028562,Pocillopora_meandrina_HIv1___RNAseq.g1315.t1,three_way,65.59033333333333,,,,,,,,,,,,,,,,,
OG_08551,1.1016869101512916,FUN_037526-T1,Peve_00044841,Pocillopora_meandrina_HIv1___RNAseq.g10605.t1,three_way,68.244,,,,,,,,,,,,,,,,,
OG_08557,1.048354429194813,FUN_037545-T1,Peve_00032229,Pocillopora_meandrina_HIv1___RNAseq.g1633.t2,three_way,65.51433333333333,FUN_037545-T1,P60483,,,,,47.9,382.0,1.2e-98,361.7,"sp|P60483|PTEN_CANLF Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Canis lupus familiaris OX=9615 GN=PTEN PE=2 SV=1",,,,,,
OG_08572,1.0741233179090326,FUN_037574-T1,Peve_00035297,Pocillopora_meandrina_HIv1___RNAseq.g1591.t2,three_way,50.35733333333334,,,,,,,,,,,,,,,,,
OG_08611,1.1514895485773502,FUN_037758-T1,Peve_00014340,Pocillopora_meandrina_HIv1___RNAseq.g1498.t1,three_way,47.662333333333336,,,,,,,,,,,,,,,,,
OG_08616,1.2489693138928724,FUN_037765-T1,Peve_00014329,Pocillopora_meandrina_HIv1___RNAseq.g1491.t1,three_way,56.507,,,,,,,,,,,,,,,,,
OG_08621,1.084078300858468,FUN_037776-T1,Peve_00040706,Pocillopora_meandrina_HIv1___RNAseq.g1509.t1,three_way,81.93966666666667,,,,,,,,,,,,,,,,,
OG_08635,1.5085214231116917,FUN_037806-T1,Peve_00003980,Pocillopora_meandrina_HIv1___RNAseq.g1566.t1,three_way,45.65533333333333,,,,,,,,,,,,,,,,,
OG_08638,1.0629411709278231,FUN_037810-T1,Peve_00028101,Pocillopora_meandrina_HIv1___RNAseq.g1572.t1,three_way,58.22133333333333,,,,,,,,,,,,,,,,,
OG_08639,1.0442766008607962,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08653,1.4711412123649548,FUN_037849-T1,Peve_00002752,Pocillopora_meandrina_HIv1___RNAseq.g1438.t1,three_way,68.4055,,,,,,,,,,,,,,,,,
OG_08663,1.277516942571724,FUN_037896-T1,Peve_00028733,Pocillopora_meandrina_HIv1___TS.g8473.t1,three_way,53.025666666666666,FUN_037896-T1,Q7TN88,,,,,25.8,1720.0,6.2e-137,491.9,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08685,1.2648715543680904,FUN_037926-T1,Peve_00005837,Pocillopora_meandrina_HIv1___RNAseq.g26224.t1,three_way,74.24433333333334,FUN_037926-T1,A0A0G2K1Q8,ABCA3_RAT,,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],Rattus norvegicus (Rat),46.9,1760.0,0.0,1404.0,sp|A0A0G2K1Q8|ABCA3_RAT Phospholipid-transporting ATPase ABCA3 OS=Rattus norvegicus OX=10116 GN=Abca3 PE=1 SV=1,GO:0005319; GO:0005524; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032368; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140,lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid transport [GO:0032368]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019],GO:0003824; GO:0005215; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_08693,1.7171515440633531,FUN_037937-T1,Peve_00015638,Pocillopora_meandrina_HIv1___RNAseq.g26202.t1,three_way,78.55583333333333,FUN_037937-T1,Q5M9B1,,,,,51.3,226.0,6.9e-63,242.3,sp|Q5M9B1|SPSB3_XENLA SPRY domain-containing SOCS box protein 3 OS=Xenopus laevis OX=8355 GN=spsb3 PE=2 SV=1,,,,,,
OG_08705,1.071034452023904,FUN_037955-T1,Peve_00040732,Pocillopora_meandrina_HIv1___TS.g19261.t1,three_way,55.23566666666667,FUN_037955-T1,Q9PVY9,,,,,40.6,217.0,5.7000000000000006e-36,153.3,sp|Q9PVY9|FXC2A_XENLA Forkhead box protein C2-A OS=Xenopus laevis OX=8355 GN=foxc2-a PE=2 SV=1,,,,,,
OG_08713,1.2089583344619468,FUN_037965-T1,Peve_00009707,Pocillopora_meandrina_HIv1___RNAseq.g26234.t1,three_way,48.86333333333334,,,,,,,,,,,,,,,,,
OG_08747,1.28574659770859,FUN_038011-T1,Peve_00013509,Pocillopora_meandrina_HIv1___RNAseq.g26524.t1,three_way,63.710166666666666,FUN_038011-T1,Q8CGS5,,,,,36.2,804.0,2e-131,471.5,sp|Q8CGS5|RNZ2_RAT Zinc phosphodiesterase ELAC protein 2 OS=Rattus norvegicus OX=10116 GN=Elac2 PE=1 SV=1,,,,,,
OG_08779,1.487744357288491,FUN_038065-T1,Peve_00010941,Pocillopora_meandrina_HIv1___RNAseq.g789.t1,three_way,67.371,FUN_038065-T1,O66515,,,,,27.3,388.0,2.3e-27,125.9,sp|O66515|AMT_AQUAE Ammonium transporter OS=Aquifex aeolicus (strain VF5) OX=224324 GN=amt PE=1 SV=1,,,,,,
OG_08782,1.0965443488318132,FUN_038068-T1,Peve_00030105,Pocillopora_meandrina_HIv1___RNAseq.g786.t1,three_way,71.34216666666667,FUN_038068-T1,Q5HZH2,TSR3_MOUSE,,18S rRNA aminocarboxypropyltransferase (EC 2.5.1.157) (20S S rRNA accumulation protein 3 homolog),Mus musculus (Mouse),58.3,175.0,4.9e-51,202.2,sp|Q5HZH2|TSR3_MOUSE 18S rRNA aminocarboxypropyltransferase OS=Mus musculus OX=10090 GN=Tsr3 PE=1 SV=1,GO:0000455; GO:0005737; GO:0106388; GO:1904047,enzyme-directed rRNA pseudouridine synthesis [GO:0000455],cytoplasm [GO:0005737],18S rRNA aminocarboxypropyltransferase activity [GO:0106388]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0016740; GO:0140098,"catalytic activity; transferase activity; catalytic activity, acting on RNA"
OG_08799,1.630451237422768,FUN_038101-T2,Peve_00009167,Pocillopora_meandrina_HIv1___RNAseq.g25708.t1,three_way,60.379666666666665,,,,,,,,,,,,,,,,,
OG_08841,1.0524737224381695,FUN_038186-T1,Peve_00006346,Pocillopora_meandrina_HIv1___RNAseq.g946.t1,three_way,45.531666666666666,,,,,,,,,,,,,,,,,
OG_08842,1.81839893635054,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_08849,1.5093964256763606,FUN_038210-T1,Peve_00038842,Pocillopora_meandrina_HIv1___TS.g5429.t1,three_way,51.66433333333333,FUN_038210-T1,Q7TN88,,,,,27.8,967.0,4.1e-93,344.7,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08858,1.0176441313756657,FUN_038244-T2,Peve_00029668,Pocillopora_meandrina_HIv1___TS.g5461.t1,three_way,77.83200000000001,FUN_038244-T2,Q15822,ACHA2_HUMAN,,Neuronal acetylcholine receptor subunit alpha-2 (Nicotinic acetylcholine receptor subunit alpha-2),Homo sapiens (Human),34.7,505.0,3.8e-83,310.5,sp|Q15822|ACHA2_HUMAN Neuronal acetylcholine receptor subunit alpha-2 OS=Homo sapiens OX=9606 GN=CHRNA2 PE=1 SV=2,GO:0005654; GO:0005886; GO:0005892; GO:0006811; GO:0007165; GO:0007271; GO:0007274; GO:0015464; GO:0016020; GO:0022848; GO:0034220; GO:0034703; GO:0035094; GO:0043005; GO:0045171; GO:0045202; GO:0045211; GO:0050997; GO:0051899; GO:0071316; GO:0095500; GO:0098828; GO:0098878; GO:0120111; GO:1901363,"acetylcholine receptor signaling pathway [GO:0095500]; cellular response to nicotine [GO:0071316]; membrane depolarization [GO:0051899]; modulation of inhibitory postsynaptic potential [GO:0098828]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; neuromuscular synaptic transmission [GO:0007274]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; nucleoplasm; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_08898,1.06552323291187,FUN_038311-T1,Peve_00020693,Pocillopora_meandrina_HIv1___RNAseq.g1142.t1,three_way,76.04366666666667,FUN_038311-T1,Q8R5K6,,,,,43.3,217.0,3.7999999999999996e-39,163.3,sp|Q8R5K6|TOB1_RAT Protein Tob1 OS=Rattus norvegicus OX=10116 GN=Tob1 PE=1 SV=1,,,,,,
OG_08903,1.2882408607081526,FUN_038332-T1,Peve_00023107,Pocillopora_meandrina_HIv1___RNAseq.g1118.t1,three_way,64.6005,FUN_038332-T1,Q6ZPJ0,,,,,28.1,720.0,3.7e-42,175.3,sp|Q6ZPJ0|TEX2_MOUSE Testis-expressed protein 2 OS=Mus musculus OX=10090 GN=Tex2 PE=1 SV=2,,,,,,
OG_08923,1.576188561150024,FUN_038380-T1,Peve_00000073,Pocillopora_meandrina_HIv1___RNAseq.g1059.t1,three_way,73.2775,FUN_038380-T1,Q8VCC8,RPGF3_MOUSE,,Rap guanine nucleotide exchange factor 3 (Exchange factor directly activated by cAMP 1) (Exchange protein directly activated by cAMP 1) (EPAC 1) (cAMP-regulated guanine nucleotide exchange factor I) (cAMP-GEFI),Mus musculus (Mouse),32.5,123.0,8.6e-08,60.8,sp|Q8VCC8|RPGF3_MOUSE Rap guanine nucleotide exchange factor 3 OS=Mus musculus OX=10090 GN=Rapgef3 PE=1 SV=2,GO:0001525; GO:0005085; GO:0005886; GO:0005902; GO:0008306; GO:0019904; GO:0030027; GO:0030175; GO:0030552; GO:0030864; GO:0032486; GO:0032956; GO:0034242; GO:0043547; GO:0045766; GO:0046827; GO:0051496; GO:0051896; GO:0060143; GO:0061028; GO:0071320,angiogenesis [GO:0001525]; associative learning [GO:0008306]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of syncytium formation by plasma membrane fusion [GO:0034242]; positive regulation of angiogenesis [GO:0045766]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; Rap protein signal transduction [GO:0032486]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886],cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904],GO:0005856; GO:0005886; GO:0043226; GO:0048856; GO:0050877; GO:0098772,cytoskeleton; plasma membrane; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_08926,1.3169297014478716,FUN_038383-T2,Peve_00000066,Pocillopora_meandrina_HIv1___RNAseq.g28291.t1,three_way,63.75116666666667,FUN_038383-T2,P16065,,,,,37.5,1140.0,3e-191,670.6,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08928,1.534372012584296,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08941,1.2801272426252437,FUN_038410-T1,Peve_00000012,Pocillopora_meandrina_HIv1___RNAseq.g28285.t1,three_way,90.88266666666668,FUN_038410-T1,Q66IZ7,,,,,48.4,287.0,1.4e-49,198.4,sp|Q66IZ7|NDL1B_XENLA Nuclear distribution protein nudE-like 1-B OS=Xenopus laevis OX=8355 GN=ndel1-b PE=2 SV=1,,,,,,
OG_08952,1.4378397800121494,FUN_038426-T1,Peve_00000114,Pocillopora_meandrina_HIv1___RNAseq.g1178.t1,three_way,77.04633333333334,FUN_038426-T1,F1R8Z9,FXJ1B_DANRE,,Forkhead box protein J1-B,Danio rerio (Zebrafish) (Brachydanio rerio),45.4,282.0,2.2e-51,204.5,sp|F1R8Z9|FXJ1B_DANRE Forkhead box protein J1-B OS=Danio rerio OX=7955 GN=foxj1b PE=2 SV=1,GO:0000978; GO:0000981; GO:0001947; GO:0003146; GO:0005634; GO:0006357; GO:0007368; GO:0044458; GO:0060088; GO:0060271,auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0044782; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cilium organization; transcription regulator activity
OG_08967,2.148255466200269,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_08975,1.149425700912716,FUN_038482-T1,Peve_00013523,Pocillopora_meandrina_HIv1___RNAseq.g6991.t1,three_way,43.61266666666667,,,,,,,,,,,,,,,,,
OG_09007,1.9301525485689213,FUN_038557-T1,Peve_00020191,Pocillopora_meandrina_HIv1___RNAseq.g1024.t1,three_way,38.4565,,,,,,,,,,,,,,,,,
OG_09020,1.013846181665014,FUN_038608-T1,Peve_00005403,Pocillopora_meandrina_HIv1___RNAseq.g989.t1,three_way,57.90166666666666,,,,,,,,,,,,,,,,,
OG_09021,1.4703704159880158,FUN_038610-T1,Peve_00002803,Pocillopora_meandrina_HIv1___RNAseq.g988.t1,three_way,58.11266666666667,FUN_038610-T1,Q60437,BAIP2_CRIGR,,BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),31.7,221.0,2.2e-23,111.7,sp|Q60437|BAIP2_CRIGR BAR/IMD domain-containing adapter protein 2 OS=Cricetulus griseus OX=10029 GN=BAIAP2 PE=1 SV=1,GO:0001726; GO:0005654; GO:0005829; GO:0005856; GO:0007009; GO:0008093; GO:0008360; GO:0016020; GO:0030175; GO:0030838; GO:0032956; GO:0051017; GO:0051764; GO:0070064,actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],cytoskeletal anchor activity [GO:0008093]; proline-rich region binding [GO:0070064],GO:0005654; GO:0005829; GO:0005856; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; cytosol; cytoskeleton; organelle; molecular adaptor activity; membrane organization
OG_09036,1.1138769969605422,FUN_038637-T1,Peve_00013493,Pocillopora_meandrina_HIv1___RNAseq.g26491.t1,three_way,71.66766666666666,FUN_038637-T1,P70426,,,,,43.2,183.0,1.3999999999999998e-29,131.7,sp|P70426|RIT1_MOUSE GTP-binding protein Rit1 OS=Mus musculus OX=10090 GN=Rit1 PE=1 SV=1,,,,,,
OG_09075,2.5350924160325743,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_09091,1.4902222520418626,FUN_038889-T1,Peve_00028699,Pocillopora_meandrina_HIv1___RNAseq.g28663.t1,three_way,51.704,,,,,,,,,,,,,,,,,
OG_09120,2.3133130985837886,FUN_039266-T1,Peve_00002772,Pocillopora_meandrina_HIv1___RNAseq.g13577.t1,three_way,76.14266666666667,FUN_039266-T1,P12394,,,,,43.7,462.0,3.8999999999999998e-109,396.7,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_09128,1.293668677755037,FUN_039434-T1,Peve_00012688,Pocillopora_meandrina_HIv1___RNAseq.g15607.t1,three_way,52.38966666666666,FUN_039434-T1,Q27312,NADA_APLKU,,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase),Aplysia kurodai (Kuroda's sea hare),36.9,260.0,1.9e-40,167.9,sp|Q27312|NADA_APLKU ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia kurodai OX=6501 PE=1 SV=1,GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0030890; GO:0031410; GO:0061809,positive regulation of B cell proliferation [GO:0030890]; single fertilization [GO:0007338],cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]",GO:0003824; GO:0005886; GO:0016740; GO:0016787; GO:0016829; GO:0022414; GO:0031410; GO:0043226,catalytic activity; plasma membrane; transferase activity; hydrolase activity; lyase activity; reproductive process; cytoplasmic vesicle; organelle
OG_09130,1.5594530076423463,FUN_039512-T1,Peve_00003617,Pocillopora_meandrina_HIv1___RNAseq.g27137.t1,three_way,55.90733333333333,,,,,,,,,,,,,,,,,
OG_09146,2.2106730836804367,FUN_039798-T1,Peve_00017577,Pocillopora_meandrina_HIv1___RNAseq.g7474.t1,three_way,69.27600000000001,,,,,,,,,,,,,,,,,
OG_09178,2.0794922539163463,FUN_039858-T1,Peve_00020641,Pocillopora_meandrina_HIv1___RNAseq.g7287.t1a,three_way,34.05316666666667,,,,,,,,,,,,,,,,,
OG_09183,1.2194216589995206,FUN_039863-T1,Peve_00020822,Pocillopora_meandrina_HIv1___RNAseq.g7280.t1,three_way,68.19433333333333,FUN_039863-T1,B5XF11,KDM8_SALSA,,Lysine-specific demethylase 8 (EC 1.14.11.27) (JmjC domain-containing protein 5) (Jumonji domain-containing protein 5),Salmo salar (Atlantic salmon),47.1,401.0,1.6e-104,381.3,sp|B5XF11|KDM8_SALSA Lysine-specific demethylase 8 OS=Salmo salar OX=8030 GN=kdm8 PE=2 SV=1,GO:0000086; GO:0003682; GO:0005634; GO:0032922; GO:0045893; GO:0046872; GO:0051864; GO:0140680,circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893],nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0006355; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_09188,1.3199798892148733,FUN_039870-T1,Peve_00006913,Pocillopora_meandrina_HIv1___RNAseq.g7377.t1,three_way,54.30833333333333,,,,,,,,,,,,,,,,,
OG_09197,1.5550628776597115,FUN_039880-T1,Peve_00004942,Pocillopora_meandrina_HIv1___RNAseq.g7353.t1,three_way,56.60916666666667,FUN_039880-T1,Q9NX45,,,,,52.0,75.0,2.7e-12,75.5,sp|Q9NX45|SOLH2_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 OS=Homo sapiens OX=9606 GN=SOHLH2 PE=1 SV=2,,,,,,
OG_09203,1.0783842525828389,FUN_039889-T1,Peve_00021857,Pocillopora_meandrina_HIv1___RNAseq.g7366.t1,three_way,37.58166666666666,,,,,,,,,,,,,,,,,
OG_09204,1.8786094020540232,FUN_039892-T1,Peve_00021860,Pocillopora_meandrina_HIv1___RNAseq.g7364.t1,three_way,45.9685,FUN_039892-T1,Q9JK41,COPT1_RAT,,High affinity copper uptake protein 1 (Copper transporter 1) (rCTR1) (Liver regeneration-related protein LRRGT00200) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form],Rattus norvegicus (Rat),31.9,144.0,2e-09,64.3,sp|Q9JK41|COPT1_RAT High affinity copper uptake protein 1 OS=Rattus norvegicus OX=10116 GN=Slc31a1 PE=2 SV=1,GO:0001525; GO:0005375; GO:0005507; GO:0005770; GO:0005886; GO:0006825; GO:0006878; GO:0014704; GO:0015080; GO:0015677; GO:0015679; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0036324; GO:0042802; GO:0042908; GO:0042910; GO:0043025; GO:0051259; GO:0051649; GO:0055037; GO:0055038; GO:0055085; GO:0072719; GO:0098705; GO:1902601,angiogenesis [GO:0001525]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; transmembrane transport [GO:0055085]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; silver ion transmembrane transporter activity [GO:0015080]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085; GO:0065003,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport; protein-containing complex assembly
OG_09210,1.0428554580257805,FUN_039923-T1,Peve_00010141,Pocillopora_meandrina_HIv1___RNAseq.g7340.t1,three_way,61.899,,,,,,,,,,,,,,,,,
OG_09216,1.3646388274545267,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_09230,1.6872607984028838,FUN_039968-T1,Peve_00039036,Pocillopora_meandrina_HIv1___RNAseq.g7517.t1c,three_way,57.724,,,,,,,,,,,,,,,,,
OG_09233,1.3053334845087057,FUN_039977-T1,Peve_00029897,Pocillopora_meandrina_HIv1___RNAseq.g7542.t1,three_way,56.55166666666666,FUN_039977-T1,Q9ULJ7,,,,,25.1,427.0,1.1e-26,124.8,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_09247,2.010523244026575,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09250,1.2340691938843895,FUN_040040-T1,Peve_00040427,Pocillopora_meandrina_HIv1___RNAseq.g8459.t1,three_way,75.77216666666668,FUN_040040-T1,Q9BRS2,RIOK1_HUMAN,,Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.1.-) (RIO kinase 1),Homo sapiens (Human),55.6,459.0,1.2e-133,478.4,sp|Q9BRS2|RIOK1_HUMAN Serine/threonine-protein kinase RIO1 OS=Homo sapiens OX=9606 GN=RIOK1 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0016787; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:0106310; GO:2000234,maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274],"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]",ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_09262,1.0261993253322594,FUN_040067-T1,Peve_00033898,Pocillopora_meandrina_HIv1___RNAseq.g7701.t2,three_way,60.609,FUN_040067-T1,A8VU90,ANKL1_MOUSE,,Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3),Mus musculus (Mouse),45.4,251.0,4.0999999999999996e-53,210.7,sp|A8VU90|ANKL1_MOUSE Ankyrin repeat and LEM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankle1 PE=2 SV=1,GO:0004519; GO:0005654; GO:0005829; GO:0006611; GO:0045950; GO:1905453; GO:1905456,negative regulation of mitotic recombination [GO:0045950]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453],cytosol [GO:0005829]; nucleoplasm [GO:0005654],endonuclease activity [GO:0004519],GO:0003824; GO:0005654; GO:0005829; GO:0006886; GO:0006913,catalytic activity; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_09269,1.2770375160381284,FUN_040075-T1,Peve_00021003,Pocillopora_meandrina_HIv1___RNAseq.g7690.t1,three_way,38.61383333333333,,,,,,,,,,,,,,,,,
OG_09286,1.0414417704811785,FUN_040107-T1,Peve_00037281,Pocillopora_meandrina_HIv1___RNAseq.g8724.t1,three_way,86.47783333333334,FUN_040107-T1,Q0VCX2,BIP_BOVIN,,Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),Bos taurus (Bovine),83.2,637.0,9.8e-294,1010.4,sp|Q0VCX2|BIP_BOVIN Endoplasmic reticulum chaperone BiP OS=Bos taurus OX=9913 GN=HSPA5 PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006983; GO:0008180; GO:0009986; GO:0016020; GO:0016887; GO:0019904; GO:0021589; GO:0021680; GO:0030291; GO:0030335; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0034663; GO:0035437; GO:0036503; GO:0042026; GO:0042149; GO:0042470; GO:0043022; GO:0043066; GO:0043231; GO:0044183; GO:0051085; GO:0051787; GO:0071353; GO:0140662; GO:1903895; GO:1903898,"cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]",cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; protein serine/threonine kinase inhibitor activity [GO:0030291]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006886; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048856; GO:0055085; GO:0098772; GO:0140657,catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; protein folding; intracellular protein transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; anatomical structure development; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_09295,2.0577594901257763,FUN_040146-T1,Peve_00038108,Pocillopora_meandrina_HIv1___RNAseq.g8511.t1,three_way,40.80866666666667,,,,,,,,,,,,,,,,,
OG_09336,1.0912756570691784,FUN_040299-T1,Peve_00038649,Pocillopora_meandrina_HIv1___TS.g20792.t1,three_way,42.627833333333335,FUN_040299-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),24.5,4769.0,0.0,1096.6,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_09382,1.0107746597458418,FUN_040668-T1,Peve_00015417,Pocillopora_meandrina_HIv1___RNAseq.g6463.t1,three_way,49.15766666666666,,,,,,,,,,,,,,,,,
OG_09384,1.1475774673809098,FUN_040673-T1,Peve_00015420,Pocillopora_meandrina_HIv1___RNAseq.g6458.t1,three_way,49.12566666666667,,,,,,,,,,,,,,,,,
OG_09440,1.0333063391059405,FUN_041426-T1,Peve_00008987,Pocillopora_meandrina_HIv1___RNAseq.g15735.t2,three_way,80.48633333333333,FUN_041426-T1,P97360,ETV6_MOUSE,,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),Mus musculus (Mouse),44.6,65.0,1.7e-11,70.9,sp|P97360|ETV6_MOUSE Transcription factor ETV6 OS=Mus musculus OX=10090 GN=Etv6 PE=1 SV=1,GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005730; GO:0005829; GO:0006355; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152,cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296],cytosol [GO:0005829]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005730; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleolus; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; transcription regulator activity
OG_09443,1.968272019173383,FUN_041432-T2,Peve_00027845,Pocillopora_meandrina_HIv1___RNAseq.g15740.t1,three_way,86.71633333333334,FUN_041432-T2,Q90837,,,,,41.4,459.0,1.8000000000000002e-81,304.7,sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1,,,,,,
OG_09462,1.0814109994259964,FUN_041481-T1,Peve_00015167,Pocillopora_meandrina_HIv1___RNAseq.g15673.t1,three_way,81.04583333333333,FUN_041481-T1,Q6NVN0,SOX2_XENTR,,Transcription factor Sox-2 (SRY (sex determining region Y)-box 2),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.8,271.0,2.8e-42,174.1,sp|Q6NVN0|SOX2_XENTR Transcription factor Sox-2 OS=Xenopus tropicalis OX=8364 GN=sox2 PE=2 SV=1,GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0008283; GO:0021522; GO:0021538; GO:0021982; GO:0031101; GO:0043565; GO:0045893; GO:0045944; GO:0048592; GO:0060119; GO:0071599; GO:1905040; GO:1905812,cell population proliferation [GO:0008283]; epithalamus development [GO:0021538]; eye morphogenesis [GO:0048592]; fin regeneration [GO:0031101]; inner ear receptor cell development [GO:0060119]; nervous system development [GO:0007399]; otic placode development [GO:1905040]; otic vesicle development [GO:0071599]; pineal gland development [GO:0021982]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of motor neuron axon guidance [GO:1905812]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09466,1.0249175608377037,FUN_041490-T1,Peve_00004073,Pocillopora_meandrina_HIv1___RNAseq.g15669.t1,three_way,79.144,FUN_041490-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),33.6,420.0,1.3e-68,262.3,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_09472,1.7694732444280163,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_09490,1.026381430286774,FUN_041526-T1,Peve_00017090,Pocillopora_meandrina_HIv1___RNAseq.g2461.t1,three_way,40.93683333333333,FUN_041526-T1,P78345,RPP38_HUMAN,,Ribonuclease P protein subunit p38 (RNaseP protein p38),Homo sapiens (Human),29.5,251.0,2.5e-13,77.8,sp|P78345|RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens OX=9606 GN=RPP38 PE=1 SV=2,GO:0000172; GO:0001650; GO:0001682; GO:0004526; GO:0005654; GO:0005655; GO:0005730; GO:0006364; GO:0030681; GO:0033204,rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682],fibrillar center [GO:0001650]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172],ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204],GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; nucleolus; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09531,1.9165394654395111,FUN_041609-T1,Peve_00036118,Pocillopora_meandrina_HIv1___RNAseq.g15296.t1,three_way,62.51383333333334,,,,,,,,,,,,,,,,,
OG_09547,1.7016224936124102,FUN_041645-T1,Peve_00000469,Pocillopora_meandrina_HIv1___RNAseq.g14205.t1,three_way,76.259,FUN_041645-T1,Q10751,ACE_CHICK,,Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II),Gallus gallus (Chicken),52.3,583.0,2.7e-176,620.2,sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2,GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573,angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030154; GO:0048856; GO:0050886; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; cell differentiation; anatomical structure development; endocrine process; protein maturation; catalytic activity, acting on a protein"
OG_09559,1.3680808693263955,FUN_041668-T1,Peve_00041077,Pocillopora_meandrina_HIv1___TS.g11779.t1,three_way,59.742,FUN_041668-T1,O88871,GABR2_RAT,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51),Rattus norvegicus (Rat),39.2,745.0,8.899999999999999e-153,542.7,sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2,GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_09579,1.2057959037510322,FUN_041717-T1,Peve_00024455,Pocillopora_meandrina_HIv1___RNAseq.g13945.t1,three_way,63.239333333333335,FUN_041717-T1,O43543,XRCC2_HUMAN,,DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2),Homo sapiens (Human),35.3,252.0,5.1e-35,149.4,sp|O43543|XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens OX=9606 GN=XRCC2 PE=1 SV=1,GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0010165; GO:0010332; GO:0022008; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:0140664; GO:2000269,centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756],centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677],GO:0000278; GO:0003677; GO:0003824; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"mitotic cell cycle; DNA binding; catalytic activity; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_09584,1.675992046813524,FUN_041722-T1,Peve_00014616,Pocillopora_meandrina_HIv1___RNAseq.g15476.t1,three_way,61.13666666666667,,,,,,,,,,,,,,,,,
OG_09585,1.0673233860134013,FUN_041725-T1,Peve_00014618,Pocillopora_meandrina_HIv1___RNAseq.g15480.t2b,three_way,60.04133333333333,,,,,,,,,,,,,,,,,
OG_09611,1.2442972011363451,FUN_041769-T1,Peve_00041575,Pocillopora_meandrina_HIv1___RNAseq.g15246.t1,three_way,89.10266666666666,,,,,,,,,,,,,,,,,
OG_09625,1.391348504249785,FUN_041789-T1,Peve_00038532,Pocillopora_meandrina_HIv1___RNAseq.g15770.t1,three_way,64.701,FUN_041789-T1,O15072,ATS3_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme),Homo sapiens (Human),30.6,992.0,5.3e-119,430.6,sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4,GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748,collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_09627,2.3232984177286538,FUN_041794-T1,Peve_00009375,Pocillopora_meandrina_HIv1___RNAseq.g15767.t1,three_way,43.15016666666666,FUN_041794-T1,Q4VC17,ATS18_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-),Mus musculus (Mouse),27.2,1006.0,3.1e-77,292.0,sp|Q4VC17|ATS18_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Mus musculus OX=10090 GN=Adamts18 PE=2 SV=2,GO:0001654; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0090331,extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]; proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0030198; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; extracellular matrix organization; anatomical structure development; catalytic activity, acting on a protein"
OG_09633,1.2164301395236716,FUN_041820-T1,Peve_00025198,Pocillopora_meandrina_HIv1___RNAseq.g15803.t1,three_way,68.35566666666666,FUN_041820-T1,P47793,WNT4A_DANRE,,Protein Wnt-4a,Danio rerio (Zebrafish) (Brachydanio rerio),43.4,334.0,3.1000000000000003e-76,287.0,sp|P47793|WNT4A_DANRE Protein Wnt-4a OS=Danio rerio OX=7955 GN=wnt4a PE=2 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0007507; GO:0021986; GO:0030182; GO:0042074; GO:0045165; GO:0045893; GO:0048703; GO:0048841; GO:0060070; GO:0070654,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell migration involved in gastrulation [GO:0042074]; embryonic viscerocranium morphogenesis [GO:0048703]; habenula development [GO:0021986]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of axon extension involved in axon guidance [GO:0048841]; sensory epithelium regeneration [GO:0070654],extracellular space [GO:0005615],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0006355; GO:0030154; GO:0048018; GO:0048856; GO:0048870; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell differentiation; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09644,1.1064914835098705,FUN_041839-T1,Peve_00009639,Pocillopora_meandrina_HIv1___RNAseq.g15081.t1,three_way,63.03933333333333,FUN_041839-T1,Q9UKB3,,,,,38.9,144.0,6e-25,115.5,sp|Q9UKB3|DJC12_HUMAN DnaJ homolog subfamily C member 12 OS=Homo sapiens OX=9606 GN=DNAJC12 PE=1 SV=1,,,,,,
OG_09650,1.0841107788941726,FUN_041848-T1,Peve_00010478,Pocillopora_meandrina_HIv1___RNAseq.g15073.t1,three_way,64.9195,FUN_041848-T1,P78543,BTG2_HUMAN,,Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3),Homo sapiens (Human),41.4,116.0,4e-19,96.3,sp|P78543|BTG2_HUMAN Protein BTG2 OS=Homo sapiens OX=9606 GN=BTG2 PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007405; GO:0007406; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0051602; GO:0060213; GO:0070062; GO:1904628,anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuroblast proliferation [GO:0007405]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005829; GO:0006281; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140110,nucleus; cytosol; DNA repair; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; transcription regulator activity
OG_09674,1.2659663126054468,FUN_041896-T1,Peve_00026173,Pocillopora_meandrina_HIv1___RNAseq.6056_t,three_way,57.614666666666665,FUN_041896-T1,Q90WM5,,,,,36.3,292.0,2.0000000000000002e-29,131.7,sp|Q90WM5|DMRT3_TAKRU Doublesex- and mab-3-related transcription factor 3 OS=Takifugu rubripes OX=31033 GN=dmrt3 PE=2 SV=2,,,,,,
OG_09698,1.1877753480599809,FUN_041929-T1,Peve_00022681,Pocillopora_meandrina_HIv1___RNAseq.g15697.t1,three_way,59.108,FUN_041929-T1,Q6AYB8,GO45_RAT,,Golgin-45 (Basic leucine zipper nuclear factor 1),Rattus norvegicus (Rat),29.6,422.0,1.5e-25,119.0,sp|Q6AYB8|GO45_RAT Golgin-45 OS=Rattus norvegicus OX=10116 GN=Blzf1 PE=1 SV=1,GO:0000139; GO:0005634; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001,Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005794; GO:0016192; GO:0043226; GO:0072659,nucleus; Golgi apparatus; vesicle-mediated transport; organelle; protein localization to plasma membrane
OG_09717,1.0499808373662325,FUN_041963-T1,Peve_00043506,Pocillopora_meandrina_HIv1___RNAseq.g15912.t1,three_way,78.311,FUN_041963-T1,O35547,ACSL4_RAT,,Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4),Rattus norvegicus (Rat),53.7,706.0,2.6e-220,766.5,sp|O35547|ACSL4_RAT Long-chain-fatty-acid--CoA ligase 4 OS=Rattus norvegicus OX=10116 GN=Acsl4 PE=1 SV=2,GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0030182; GO:0031957; GO:0031966; GO:0032024; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672,dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886],arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957],GO:0003824; GO:0005739; GO:0005777; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0006790; GO:0016874; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140657,catalytic activity; mitochondrion; peroxisome; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; sulfur compound metabolic process; ligase activity; reproductive process; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; ATP-dependent activity
OG_09720,1.1129127560689125,FUN_041966-T1,Peve_00043494,Pocillopora_meandrina_HIv1___RNAseq.g15916.t1,three_way,81.62733333333334,FUN_041966-T1,P19984,,,,,44.6,130.0,2.5e-20,99.8,sp|P19984|PROF2_ACACA Profilin-2 OS=Acanthamoeba castellanii OX=5755 PE=1 SV=3,,,,,,
OG_09743,1.2408718683656168,FUN_042009-T1,Peve_00031038,Pocillopora_meandrina_HIv1___RNAseq.g15212.t1,three_way,48.658166666666666,,,,,,,,,,,,,,,,,
OG_09769,1.0099530469949152,FUN_042050-T1,Peve_00025417,Pocillopora_meandrina_HIv1___TS.g10177.t1,three_way,70.72583333333334,FUN_042050-T1,P34949,MPI_HUMAN,,Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI),Homo sapiens (Human),48.8,418.0,1.8e-107,391.0,sp|P34949|MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens OX=9606 GN=MPI PE=1 SV=2,GO:0004476; GO:0005829; GO:0008270; GO:0009298; GO:0061611; GO:0061729; GO:0070062,GDP-D-mannose biosynthetic process from fructose-6-phosphate [GO:0061729]; GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate catabolic process [GO:0061611],cytosol [GO:0005829]; extracellular exosome [GO:0070062],mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005975; GO:0016853; GO:0043226; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; isomerase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09783,1.6677394306677036,FUN_042583-T1,Peve_00034294,Pocillopora_meandrina_HIv1___RNAseq.g16882.t1,three_way,83.662,FUN_042583-T1,P09132,SRP19_HUMAN,,Signal recognition particle 19 kDa protein (SRP19),Homo sapiens (Human),47.1,140.0,3.1000000000000002e-27,122.9,sp|P09132|SRP19_HUMAN Signal recognition particle 19 kDa protein OS=Homo sapiens OX=9606 GN=SRP19 PE=1 SV=3,GO:0003723; GO:0005730; GO:0005786; GO:0005829; GO:0006613; GO:0006617; GO:0008312; GO:0016604; GO:0048500,"cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]","cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]",7S RNA binding [GO:0008312]; RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0005829; GO:0043226; GO:0065003,RNA binding; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_09789,1.393708484410086,FUN_042591-T1,Peve_00012673,Pocillopora_meandrina_HIv1___RNAseq.g16869.t1,three_way,79.75733333333334,FUN_042591-T1,Q87PP5,,,,,36.3,535.0,8.499999999999999e-92,339.7,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_09798,1.6474343950214811,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000003e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_09806,1.7005005958831256,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09807,1.7848708449212678,FUN_042628-T1,Peve_00016195,Pocillopora_meandrina_HIv1___RNAseq.g11508.t1,three_way,45.25,FUN_042628-T1,O95390,GDF11_HUMAN,,Growth/differentiation factor 11 (GDF-11) (Bone morphogenetic protein 11) (BMP-11),Homo sapiens (Human),29.0,372.0,2.3000000000000002e-33,144.8,sp|O95390|GDF11_HUMAN Growth/differentiation factor 11 OS=Homo sapiens OX=9606 GN=GDF11 PE=1 SV=1,GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005615; GO:0007399; GO:0007498; GO:0008083; GO:0008283; GO:0008285; GO:0021512; GO:0032924; GO:0032991; GO:0035881; GO:0048593; GO:0060021; GO:0060391; GO:0072560; GO:1902870,activin receptor signaling pathway [GO:0032924]; amacrine cell differentiation [GO:0035881]; camera-type eye morphogenesis [GO:0048593]; cell population proliferation [GO:0008283]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of SMAD protein signal transduction [GO:0060391]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; spinal cord anterior/posterior patterning [GO:0021512]; type B pancreatic cell maturation [GO:0072560]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; protein-containing complex [GO:0032991],cytokine activity [GO:0005125]; growth factor activity [GO:0008083],GO:0005615; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_09826,4.342242741083118,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_09832,1.021543088299893,FUN_042809-T1,Peve_00003078,Pocillopora_meandrina_HIv1___RNAseq.g7426.t1,three_way,69.40266666666666,FUN_042809-T1,P15206,,,,,51.8,342.0,4.4e-84,313.2,sp|P15206|CCNB_MARGL G2/mitotic-specific cyclin-B OS=Marthasterias glacialis OX=7609 PE=2 SV=1,,,,,,
OG_09834,1.1447556671875132,FUN_042811-T1,Peve_00028976,Pocillopora_meandrina_HIv1___RNAseq.g7428.t1,three_way,73.61033333333333,FUN_042811-T1,Q4R8R3,,,,,51.1,444.0,2.9e-53,211.1,sp|Q4R8R3|CC112_MACFA Coiled-coil domain-containing protein 112 OS=Macaca fascicularis OX=9541 GN=CCDC112 PE=2 SV=1,,,,,,
OG_09852,1.5420529058120191,FUN_042843-T1,Peve_00023281,Pocillopora_meandrina_HIv1___RNAseq.g7256.t1,three_way,66.93900000000001,FUN_042843-T1,Q6ZZY0,,,,,56.5,483.0,1.4e-176,620.9,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_09894,2.5826373238298124,FUN_042988-T1,Peve_00036062,Pocillopora_meandrina_HIv1___RNAseq.g7093.t1,three_way,53.70933333333333,,,,,,,,,,,,,,,,,
OG_09895,1.3492600892236832,FUN_042989-T1,Peve_00031072,Pocillopora_meandrina_HIv1___RNAseq.g7089.t1,three_way,80.24966666666667,FUN_042989-T1,Q8BS35,,,,,54.4,397.0,1.2e-125,451.4,sp|Q8BS35|ALKMO_MOUSE Alkylglycerol monooxygenase OS=Mus musculus OX=10090 GN=Agmo PE=1 SV=1,,,,,,
OG_09910,1.095023400057885,FUN_043008-T1,Peve_00017770,Pocillopora_meandrina_HIv1___RNAseq.g7032.t1,three_way,89.62533333333333,FUN_043008-T1,Q9JKK1,STX6_MOUSE,,Syntaxin-6,Mus musculus (Mouse),50.4,232.0,1.3e-55,218.0,sp|Q9JKK1|STX6_MOUSE Syntaxin-6 OS=Mus musculus OX=10090 GN=Stx6 PE=1 SV=1,GO:0000139; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0016020; GO:0019905; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048471; GO:0055037; GO:0055038,"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]",cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905],GO:0005654; GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; endosome; Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization
OG_09916,1.3918222484769711,FUN_043025-T1,Peve_00041863,Pocillopora_meandrina_HIv1___TS.g23978.t1,three_way,79.40066666666667,,,,,,,,,,,,,,,,,
OG_09920,1.23394912001756,FUN_043031-T1,Peve_00026965,Pocillopora_meandrina_HIv1___TS.g793.t1,three_way,52.451,FUN_043031-T1,Q9FN03,,,,,28.7,334.0,5.500000000000001e-28,129.0,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_09936,1.2852586223850535,FUN_043096-T1,Peve_00033763,Pocillopora_meandrina_HIv1___RNAseq.g7008.t1,three_way,52.39533333333333,,,,,,,,,,,,,,,,,
OG_09963,1.4102144144929951,FUN_043144-T1,Peve_00034957,Pocillopora_meandrina_HIv1___RNAseq.g6886.t1,three_way,84.25150000000001,FUN_043144-T1,Q26481,,,,,73.1,279.0,2e-116,420.2,sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3,,,,,,
OG_09984,1.0994233938216815,FUN_043176-T1,Peve_00025845,Pocillopora_meandrina_HIv1___RNAseq.g6801.t1,three_way,80.18466666666667,FUN_043176-T1,Q6YP21,KAT3_HUMAN,,Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III),Homo sapiens (Human),55.5,411.0,1.1999999999999999e-132,474.6,sp|Q6YP21|KAT3_HUMAN Kynurenine--oxoglutarate transaminase 3 OS=Homo sapiens OX=9606 GN=KYAT3 PE=1 SV=1,GO:0003723; GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189; GO:0097053,2-oxoglutarate metabolic process [GO:0006103]; amino acid metabolic process [GO:0006520]; biosynthetic process [GO:0009058]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0016829; GO:0043226,RNA binding; catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; lyase activity; organelle
OG_09986,1.326331104925334,FUN_043179-T1,Peve_00025843,Pocillopora_meandrina_HIv1___TS.g546.t1,three_way,66.02266666666667,FUN_043179-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),33.3,1426.0,9.8e-216,753.1,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_09988,1.0398354691818008,FUN_043182-T1,Peve_00043027,Pocillopora_meandrina_HIv1___RNAseq.g6806.t1,three_way,59.36083333333333,FUN_043182-T1,Q9Z136,,,,,38.8,361.0,3.4e-62,241.9,sp|Q9Z136|TSC1_RAT Hamartin OS=Rattus norvegicus OX=10116 GN=Tsc1 PE=1 SV=1,,,,,,
OG_09994,1.0482688399184634,FUN_043207-T1,Peve_00039862,Pocillopora_meandrina_HIv1___RNAseq.g6814.t1,three_way,65.258,FUN_043207-T1,Q6DCP1,,,,,40.3,273.0,5.8e-50,199.1,sp|Q6DCP1|FXRD1_XENLA FAD-dependent oxidoreductase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=foxred1 PE=2 SV=1,,,,,,
OG_10021,1.7951174093601194,FUN_043262-T1,Peve_00032608,Pocillopora_meandrina_HIv1___RNAseq.g8892.t1,three_way,72.44983333333333,FUN_043262-T1,Q9Z0H0,,,,,35.1,559.0,3.6e-82,307.4,sp|Q9Z0H0|CDC7_MOUSE Cell division cycle 7-related protein kinase OS=Mus musculus OX=10090 GN=Cdc7 PE=1 SV=2,,,,,,
OG_10060,1.098040056656853,FUN_043356-T1,Peve_00016651,Pocillopora_meandrina_HIv1___TS.g20685.t1b,three_way,83.92116666666666,FUN_043356-T1,Q9VE46,,,,,62.7,509.0,1.6e-169,597.4,sp|Q9VE46|SC5A7_DROME High-affinity choline transporter 1 OS=Drosophila melanogaster OX=7227 GN=ChT PE=2 SV=2,,,,,,
OG_10099,1.65733588654441,FUN_043435-T1,Peve_00028842,Pocillopora_meandrina_HIv1___RNAseq.g7834.t1,three_way,66.19233333333334,FUN_043435-T1,Q9WU63,,,,,37.7,151.0,4.9e-23,110.5,sp|Q9WU63|HEBP2_MOUSE Heme-binding protein 2 OS=Mus musculus OX=10090 GN=Hebp2 PE=1 SV=1,,,,,,
OG_10115,1.3023616829560054,FUN_043488-T1,Peve_00021724,Pocillopora_meandrina_HIv1___RNAseq.g7937.t1,three_way,57.274,,,,,,,,,,,,,,,,,
OG_10116,1.449482479646279,FUN_043491-T1,Peve_00008684,Pocillopora_meandrina_HIv1___RNAseq.g7963.t1,three_way,83.608,FUN_043491-T1,A8WGF7,,,,,26.4,406.0,2.9e-13,78.6,sp|A8WGF7|SPNS1_XENTR Protein spinster homolog 1 OS=Xenopus tropicalis OX=8364 GN=spns1 PE=2 SV=2,,,,,,
OG_10157,1.2024199271656124,FUN_043552-T1,Peve_00009534,Pocillopora_meandrina_HIv1___RNAseq.g8003.t1,three_way,72.05633333333333,,,,,,,,,,,,,,,,,
OG_10168,1.1841139832296714,FUN_043569-T1,Peve_00034600,Pocillopora_meandrina_HIv1___RNAseq.g8023.t1,three_way,58.73266666666667,FUN_043569-T1,A8WGS4,,,,,41.0,212.0,8.400000000000001e-33,142.1,sp|A8WGS4|TLCD2_DANRE TLC domain-containing protein 2 OS=Danio rerio OX=7955 GN=tlcd2 PE=2 SV=1,,,,,,
OG_10176,1.9560264466812576,FUN_043585-T1,Peve_00045227,Pocillopora_meandrina_HIv1___RNAseq.g6986.t1,three_way,56.91216666666666,FUN_043585-T1,Q9BYX4,IFIH1_HUMAN,,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),Homo sapiens (Human),27.6,1184.0,1.0000000000000001e-88,330.1,sp|Q9BYX4|IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IFIH1 PE=1 SV=3,GO:0002753; GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0038187; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051259; GO:0051607; GO:0060337; GO:0060760; GO:0071360; GO:0098586; GO:0140374,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0065003; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; hydrolase activity; isomerase activity; organelle; molecular transducer activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10177,1.1978851442225298,FUN_043586-T1,Peve_00045222,Pocillopora_meandrina_HIv1___RNAseq.g6984.t1,three_way,54.448,,,,,,,,,,,,,,,,,
OG_10180,1.2449514147517855,FUN_043593-T1,Peve_00010457,Pocillopora_meandrina_HIv1___RNAseq.g6971.t1,three_way,55.73066666666666,FUN_043593-T1,Q96PZ7,,,,,29.0,497.0,3.2e-52,208.4,sp|Q96PZ7|CSMD1_HUMAN CUB and sushi domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CSMD1 PE=1 SV=3,,,,,,
OG_10184,1.3421750042245402,FUN_043599-T1,Peve_00007612,Pocillopora_meandrina_HIv1___RNAseq.g6951.t1,three_way,61.132,FUN_043599-T1,Q68CP4,HGNAT_HUMAN,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Homo sapiens (Human),42.6,591.0,3.1e-113,410.6,sp|Q68CP4|HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens OX=9606 GN=HGSNAT PE=1 SV=2,GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0005886; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; plasma membrane; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10208,1.4152245618059491,FUN_043643-T1,Peve_00004207,Pocillopora_meandrina_HIv1___RNAseq.g7409.t1,three_way,56.01,,,,,,,,,,,,,,,,,
